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CHAPTER 1 
  
HISTORICAL BACKGROUND 
 
                                                                                                                                                  Where there is no 
vision the  people perish 
                                                                                                                                                                      —
Proverbs 29:18  
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Greek origins and is literally defined as observing within or looking inside. 
Its history has been slowly traced over centuries and lies in the issue of 
surgeries were almost unthinkable, as the mortality risk from 
ates’ treaty on fistula. Galen’s Levicom 
We cannot understand where we are going, if we do not remember 
where we come from. Never has there been a statement so aptly suited to 
hysteroscopy and, more widely, to endoscopy. The word endoscopy has 
categorization. What essentially is endoscopy? Is it an instrument or technique, a 
revolution or  an evolution? Many have come to understand the meaning of endoscopy as 
merely that of a technology or instrumentation. A more accurate definition, however, 
places endoscopy firmly in the realm of a new philosophy, one rooted in what is now 
referred to as minimally invasive surgery.  Interestingly, the idea of minimal intervention is 
not necessarily a modern phenomenon. Much of the Hippocratic 
Corpus may be interpreted as predominantly advocating this 
minimalist approach, as can be inferred by the modern version of 
the Hippocratic ancient edict “First, do no harm.” Hippocrates 
(fig.2) specifically instructed physicians to avoid as much as 
possible invasive methods, allowing instead allow for the body’s 
own miraculous powers of healing to take effect. Of course, this 
approach was certainly influenced by the fact that invasive 
infections was simply too great.  
The first instrument developed to look into deeper cavities was probably the rectal 
speculum; the earliest mention is found in Hippocr
Fig. 1 
Fig. 2 
refers to the catopter (now in the Naples Museum), an anal speculum. The ability to reflect 
light in deeply located organs was a central problem in designing open tubes to explore or 
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Fig. 3 
rn in 
1773 
creating admirable
Throughout th
ade of. However, engineers at 
Merce
 of a housing in which a candle was placed. On one 
side, 
the housing was an eyepiece. Bozzini was one 
a d mirrors 
u
functio ndosco
retract tissues and allow the examiner to observe these structures. To address the 
problem, the light guide system was developed. 
Philippe Bozzini (fig. 3), one of the critical workers in this field 
and nowadays known as the “father of endoscopy”, was bo
in Mainz, Germany, to an aristocratic Italian family. His father 
had been forced to flee his native country after coincidentally killing 
another aristocrat during a duel. Bozzini joined the Austrian army 
and became a medical officer following the French occupation of this 
part of Germany. He then moved to Frankfurt to avoid service under 
the French government. He became interested in mathematics, 
philosophy, and chemistry as well. He was also a gifted artist, 
 self-portrait, and even designed an early type of airplane. 
e history of endoscopy, many have denounced Bozzini’s device as 
rather simplistic in form, not the stuff turning points are m
 an 
des Benz, who were recently commissioned to reconstruct the Lichleiter using only 
Bozzini’s drawings, were in fact “very impressed” by the technical skill required to make 
the instrument.  
Bozzini’s light conductor, the Lichtleiter, as he named it (fig. 4-
fig.5), consisted
he attached open aluminium tubes in various sizes and 
configurations that could be introduced into externally accessible body 
cavities such as the mouth, nose, ears, vagina, cervix and uterus, 
urethra and urinary bladder, and rectum .  
He even devised one with a mirror to examine the vocal cords.  
On the opposite side of 
Fig.4.The Lichtleiter was a 
housing in which a candle 
was placed 
Fig. 5 
concepts nine h
of the first inventors to insert  reflecting, strategic lly angle
(flat, concave and convex) between the visual tract and the candlelight, 
so that the light would be reflected only toward the organ and not into 
the examiner’s eye.  Some aspects of Bozzini’s invention cannot be 
considered innovations at all. For instance, reflecting light using mirrors 
was not at all a new concept, since Al-Qasim experimented with similar 
ndred years earlier. Moreover, the technology required to make a 
pe had been available since at least 1710. This includes the lens 
system that Bozzini utilized, which had been derived from 17th century telescopes. 
nal e
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urt newspaper, it was not until 1805 that he announced, again in a newspaper, that 
he had
ased soul of Philip Bozzini, 
medica
ative potential and such designs truly establish the 
Nevertheless, Bozzini’s creative genius went beyond the work of earlier innovators, for he 
was the first ever to efficiently solve endoscopy’s main flaw: reflecting images back to the 
eye.  
Although Bozzini published a brief description of his instrument in 1804 in a 
Frankf
 created a device that made it possible to inspect the inner cavities of the human 
body. Bozzini’s colleagues were extremely hostile toward his endoscopic ventures and 
scorned his lectures and publications. In 1807, when he recommended that the first 
prospective study of this device be performed in military hospitals, he received his first 
positive response. Gynecologists and ear, nose, and throat specialists expressed 
particular interest. However, he came under harsh criticism from the influential Dr. Stifft, 
who held a prominent position at the medical academy in Vienna. The medical faculty 
dismissed his endoscope as a “new toy,” and opinion was sharply divided between the 
academy and the military hospitals about the usefulness of this so-called toy. The 
resistance from his colleagues was so strong that Bozzini was asked to take a state 
examination on the grounds that he came from another city. When he took it in 1803, he 
failed the first round. But thanks to his outstanding performance as an army doctor and 
after political pressure from the Austrian government, he passed a repeat examination and 
obtained permission to practice. During an epidemic of typhus, he, as a conscientious 
doctor, made house calls. He became infected and died from the disease at age 35 after 
an extremely hard life. He left his widow such poor financial conditions that she was 
unable to support their three children, who were later adopted. Bozzini’s ideas were, 
however, his vindication. Indeed, despite the limitations of his invention, he is remembered 
as the first to illuminate and examine deeply located organs. 
His epitaph, inscribed in Latin on a marble slab attached to an outside wall of the 
Frankfurt cathedral, reads: In memory of the devout, dece
l doctor. He, German born, was the first who tried to look into the hollow cavities of 
the human body by ingeniously conducted light. During the rage of a malignant fever which 
he bravely kept away from others and from which he cured many by his art and devotion, 
death took his life in his 36th year on the night of April 4th to 5th, 1809. Himself a victor, he 
became defeated. His faithful friends 
It is of great importance to mention that Bozzini did in fact understand the 
significance of the endoscope’s oper
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Lichlei
r uncertain operations, which depended on mere luck 
and ch
 is clear that most of the experiments 
conducted with the light conductor aimed at visualizing the 
 
least. Bo i is quoted 
ct and the 
bladde
d of 
Ireland, who learned from C
ter as one of the most significant precursors to operative endoscopy.  He described 
his hopes in the following passage: 
“Surgery will gain not only from the new operations that could not easily be 
performed until now, but also all othe
ance, will now be relieved of uncertainty by the influence of sight…But extirpation of 
carcinoma of the uterus, many of the unfortunate women who otherwise could not escape 
certain death will be returned to the enjoyment of life and health. Deformations of the 
uterine orifice, the vagina, polyps and ulcera of the same, and 
of the rectum and the bladder stone can be operated by sight” 
– Bozzini, 1805 
Although Bozzini personally did not use his Lichtleiter for 
hysteroscopy, it
Fig. 6 
n 
should be located in his
rectum and the uterus. In the obstetric and gynecologic field, 
Bozzini became especially frustrated that only blind palpation 
was available as a means of examination. In fact, a commo
saying during his time was that “the eye of the obstetrician 
fingertips.” (fig.6) Yet, this was a view Bozzini did not share in the 
as stating that such inspections relied “merely on good luck and chance.“ He firmly 
believed that such games of chance could finally be ended by using his device.  
In 1853, Antoine Jean Desormeaux of France 
developed an instrument to examine the urinary tra
zzin
r. He named it “endoscope.” (Fig.7-Fig. 8) This was 
the first time this term was used. Twelve years after the 
Desormeaux invention, Cruise, from Dublin, made some 
improvements to this endoscope, replacing the alcohol and 
turpentine by petroleum and aì little 
dissolved camphor and adding a small 
glass chimney to contain the vapors. 
Bozzini’s intuitions became true 60 
, in 1869 Commander DC Pantaleoni years after his death. Indee
ruise (fig.9) how to use the endoscope,  
performed the first hysteroscopy with the aid of Desormeaux’s 
endoscope (a modified cystoscope lit with reflected candle light) in a 
Fig. 7 
Fig. 8 
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 light transmission, bleeding inside the uterus, and the 
inabilit
e cumbersome uterine bleeding and maintain adequate uterine distension for 
panora
as most physicians prefer
60-year-old woman with abnormal uterine bleeding. He not only 
diagnosed an endometrial polyp, but also cauterized it with silver 
nitrate under hysteroscopic view. Three years earlier, he had tried 
to use the same endoscope to observe the nasal passages and 
treat some polyps in a similar way. Arguably, he was the first to 
combine the two main functions of the modern hysteroscopes: 
diagnosis and treatment. To other physicians who claimed that the 
same evaluations could be done with a finger palpation of the 
uterus, Pantaleoni cleverly responded that while this was true inan 
overdilated cervix after delivery, it was extremely difficult, if not impossible, in an undilated 
cervix. Moreover, when dilatation of the cervix was required for finger palpation, it had to 
be at least twice that required for his instrument. He added that, even granting that the 
finger could diagnose abnormal lesions, it certainly could not offer direct treatment. 
Other physicians followed suit after Pantaleoni’s first known hysteroscopic diagnosis 
and treatment; still, inadequate
Fig. 9 
y to distend the organ properly slowed the development and applications of 
hysteroscopy. Indeed, in subsequent years, hysteroscopy remained a curiosity rather than 
a truly useful clinical technique. It took over 100 years for the clinical importance of 
hysteroscopy to become apparent, thanks to developments in optic systems and 
distension media, which made it possible to obtain satisfactory visualization of the uterine 
cavity.  
Indeed, many ingenious modifications of the early endoscopes were introduced to 
overcom
mic viewing. In- and out-flow channels for uterine irrigation were independently 
introduced by Heineberg in 1914 and Seymour in 1926. The 
endoscope used by Heineberg had an internal channel for 
illumination and contained a system of irrigation with low-
viscosity fluids to wash any blood and permit uterine 
distension . This method was the beginning of continuous-
flow hysteroscopy and the basis for all such methods 
introduced late on. In 1925, Rubin reported on his experience 
and excellent results using CO2 to distend the uterine cavity 
for hysteroscopy. However, the use of this gas remained rare 
red working with low viscosity fluids, especially German 
Fig. 10 
physicians. Nevertheless, in the late 70s, Lindemann (Fig. 10- Fig. 11) proposed this 
method of distending the uterus as the best of hysteroscopy.   
In the same years, Menken published his pioneering 
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experience with high- viscosity fluids for uterine distension. 
Comp
s of transition, while investigators were 
struggling t
distension, others were opting for a return to 
fig.12-13). During his youth, 
Hamou was been first interested in math and physic
eroscopic tecnique s
went to USA to learn it. When he 
ared with low viscosity fluids, a lesser quantity of a 
high-density fluid (a mixture of linear polymers of different 
lengths and molecular weights) was needed for uterine 
distension, which meant a lesser chance of peritoneal spillage 
during hysteroscopy. However, because this medium is not 
biodegradable and has a yellowish tinge in solution, it was not 
use high-viscosity fluids or carbon dioxide gas for uterine 
low-viscosity fluids. In their 1972 publications 
of the results of their investigations regarding tubal sterilization by electrocoagulation of the 
cornual regions of the fallopian tubes, Quinones-Guerrero and collaborators reported 
delivering to the uterus a 5% water solution of dextrose and modernizing with special 
tourniquets and pumps Norment’s method of increasing intrauterine pressures. That same 
year, Sugimoto reported opting for low-viscosity fluids, particularly a normal saline solution, 
and combining gravity pressures with positive pressures provided by a 3-way connection 
and an attaches syringe to increase intrauterine distension selectively. Still, the problem 
remained of obtaining a continuous irrigation system that permitted a clear view while 
avoiding excessive vascular intravasation of the fluid used. 
Between the late 70s and early 80s Jacques 
Hamou revolutionized the field of hysteroscopy with a 
new and fine instrument (
Fig. 11 
widely adopted for hysteroscopy. In those time
o decide whether to 
 
before deciding to 
dedicate himself to 
medicine. He became 
o he 
came back to Paris, his 
native city, he was able to built a new device of a total 
diameter of no greater than 5 mm.   
very interested in emerging hyst
Fig. 13 
Fig. 12 
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The “Hamou I microcolpohysteroscope”, (fig.12-13)  as it was 
 
Throughout the 1980s, no significant technological 
hysteroscopes, very often cervical dilatation and local or 
 
owever, in the early 1990s, several developments in the 
chnical and instrumental areas made hysteroscopy less 
His new instrument consisted of an improved visual optics using a 4-mm rod lens system
scope inserted into a diagnostic sheath to guide the distension media into the uterine 
cavity.  
Fig.14 
called, offered a new combination of  hysteroscopy and 
microscopy. His device allowed for multiple magnifications (X1, 
X20, X60, and X150) for cellular exploration and it presented new 
diagnostic opportunities by combining the data offered by 
hysteroscopy, colposcopy, and cytology (fig. 14).  
 
 
 
improvements were reported in the field of hysteroscopy, 
which was invariably performed using the so called “traditional 
technique”. Speculum and tenaculum ( Fig. 15) were used to 
visualize and grasp the cervix, CO2 was the most commonly 
used distension medium, and, due to the wide diameter of the 
general anaesthesia with hospitalization were required.  
 
Fig. 15 Instrumentation for traditional 
hysteroscopy 
H
te
invasive and painful and increased its widespread use 
reducing the number of hysteroscopies performed in 
operating room and increasing those performed in outpatient 
setting ( Fig. 16). 
 
 
Fig. 16 
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uch developments included: 
 
umatic technique for the insertion of the scope inside the 
uterus without the aid of speculum or tenaculum (the so called: vaginoscopic approach or 
d 
he first randomized controlled 
study (Fig. 17) comparing 
 years, 
with inpatient hysteroscopy; presenting distinct advantages such as reduced 
S
- the introduction of an atra
no touch technique)  
- the miniaturization of the optics which allowed for the reduction of the total diameter of 
the hysteroscopes an
- the widespread use of saline as a distension medium  
 
T
inpatient and outpatient 
hysteroscopy demonstrated that 
despite similar patient 
satisfaction,  patients 
undergoing outpatient 
hysteroscopy recovered 
significantly more quickly than 
those undergoing inpatient 
hysteroscopy.   
Moreover, throughout the
several studies have 
demonstrated that outpatient 
hysteroscopy  shows good 
correlation of findings compared 
anaesthesiologic risks, enhanced time-cost effectiveness and patient’s preference. 
Currently outpatient hysteroscopy represents the gold-standard for the evaluation of the 
uterine cavity.  
Fig. 17 
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diagnostic work-up        
The single most important technical innovation contributing to the development and 
ibility of visual examination of the uterine 
can examine the cavity and take biopsy or treat 
time without any premedication or a
 simplification of instrumentation and a safer and easier delivery 
Throughout the 90s, a new philosophy started:  the so called “see & treat” hysteroscopy, or 
office operative 
hysteroscopy, which 
reduced the distinction (Fig 
18) between a diagnostic 
and an operative procedure, 
introducing the concept of a 
single procedure in which 
the operative part is 
perfectly integrated in the 
(Fig. 19).  Fig. 18 Fig. 19 
widespread diffusion of such philosophy was the development of small-diameter 
hysteroscopes with continuous flow features and operative sheaths, through which 
mechanical instruments could be introduced. 
The poss
cavity and contextual operative facilities has provided 
endoscopists with the perfect “diagnostic” tool: they 
benign intrauterine pathologies  in a relatively short 
naesthesia. Finally, a revolution occurred in 1997 with 
the introduction by Gynecare, Ethicon of a versatile electrosurgical bipolar system 
dedicated to hysteroscopy called Versapoint (Fig. 20) which represents a key point in the 
history of office operative hysteroscopy.  As a matter of fact, thanks to the use of 5 Fr 
bipolar electrodes the number of pathologies treated by office operative hysteroscopy has 
increased tremendously, reserving the use of resectoscope and operating room to a very 
limited number of cases.  
The future looks to further
Fig. 20 
of energy sources. The number of operative procedures performed in an office setting will 
increase as technological simplification increases safety and accuracy and expedites 
performance. In turn, this trend will increase the use of diagnostic and operative 
hysteroscopy. What is now the present was a distant future at the beginning of 
10 
 
hysteroscopy, and the future soon will be the present as we go on building on the 
foundations and pillars our predecessors have laid or erected.  
CHAPTER 2 
 
EQUIPMENT AND OFFICE SET-UP  
 
The term “hysteroscopy” is derived from the fusion of two ancient greek words 
“histeros” (uterus) and “scopeo” (to see) and refers to the “direct visual examination of 
uterine cavity”.  Indeed hysteroscopy is a procedure in which an illuminated scope called 
“hysteroscope” is inserted through the cervix into the uterine cavity that has been 
distended by a fluid or gas distension medium, in order to diagnose or eventually treat 
uterine abnormalities. Good visualisation is the key to a correct diagnosis and a precise 
treatment. The five essential elements for an optimal visualization include: Monitor, 
Endocamera, Light source, Light cable and Optic.  
 
ENDOCAMERA  
In modern hysteroscopy the human eye has been replaced by the endocamera 
(Fig. 1). Several types of endocamera are available, each differing from the other in three 
main characteristics:  
 
• Sensibility  
• Resolution 
• Definition   
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Sensibility, measured in lux, represents the minimal 
quantity of light necessary to make captable an image; 
resolution represents the number of vertical lines which 
constitute the image, which can be detected on the screen; 
picture definition is proportional to the number of picture 
elements, called pixels, produced by the chip. The chip is a 
microprocessor also called Charged Coupled Device (CCD) (Fig. 2) because it transforms 
the real image into an electronic signal. The image captured by the endocamera is split 
into the three main colours: red, green and blue, which are send either to one or to three 
Fig. 1 
Fig. 2 CCD Transforms the real 
image into an electronic signal 
12 
 
of the image. 
different chips, one for each colour. Obviously, the higher the number of chips, the better is 
the chromatic accuracy 
 
LIGHT SOURCE 
 
 
In 1960 Karl Storz (fig 3) discovered that it was possible to 
transmit light from a light source outside the body via a light cable 
through an endoscope to the examination site. This discovery marked 
the birth of “cold light endoscopy” (fig. 4) . During the last  40  years 
several types of light sources each one more 
powerful than the other have been developed in 
order to provide a clear vision inside the uterine 
cavity which is characterized by a high absorption of 
light, because of the predominance of  red color.  
Fig. 3  Karl Storz 
1911-1996 
 At present xenon light sources are preferred to  the halogen ones for 
several reasons: Fig. 4 The “cold light endoscope transmits light 
from a light source outside 
the body via a light cable.
 
 
• Produce twice the light output as a modern halogen lamp  
• Provide white light, which is ideal for endoscopy 
• The light  intensity  is uniform while  lamp lasts 
• Have a longer  duration (nearly 500 hours) 
• And a realer colour temperature (6000 K)  which results in better colour chromatic 
performance 
 
A 175 watt xenon light source gives good depth of field, enough to perform an adequate 
office operative hysteroscopy. A light source of 300W is recommended for video recording. 
 
 
 
 
 
 
 
 
 
LIGHT CABLE 
 
 Two types of cables can transmit the cold light from 
the light source to the endoscope. The transmission 
of light through a glass fiber cable depends on the 
phenomenon of total internal reflection. If a fiber is 
straight or curved, light entering one end travels in a 
zig-zag path, repeatedly reflecting off the internal 
surface of the fiber until it emerges from the other 
end, with the same angle of incidence of the entrance 
(fig. 5).  
13 
 
necessary distension for panoramic viewing.  
d world-wide 
in office setting: rigid and flexible ones (Fig.7) The rigid telescopes are based on glass 
These glass fibers are rather vulnerable: damage or 
rupture of these fibers caused by forced bending will 
immediately reduce the light intensity. The liquid 
crystal cables are made of a fluid medium, typically 
colesteric saline. These cables transmit a higher light 
intensity (fig. 6) for a similar power of light emission,  
in comparison with optical fiber cables. Despite their higher rigidity, which may often 
hamper the endoscopic procedures, it has the distinctive advantage of duration. 
Fig. 5 Light travels through the fiber in a zig- zag 
path
Fig. 6 
 
HYSTEROSCOPES 
 
Fundamentally, the hysteroscope only consists of an optical 
system (even called telescope) to carry light to the object 
being viewed and to convey the image back to the camera. 
In its simplest form, the telescope fits into a sheath through 
which a distension medium can be infused to provide 
Two different types of hysteroscopes are use
Fig. 7 
lens alternated with air bubbles. These constitute the transmission lens system. 
Surrounding the optical components are glass fiberoptic bundles that transmit cold light by 
way of a glass fiber cable from a xenon light source.   
 
Prof. John Hopkins from Baltimore
14 
 
, USA, introduced a great innovation by modifying the 
hape and length of the lens inside the instruments: from small lens with spherical shape 
tionary 2mm rigid optics with excellent quality of view.   
placed 1-1.5cm from the fundus, permits a rapid and easy evaluation of all the uterine 
e telescope tly on its 
s
(Fig 8a) to longer and cylindrical ones (Fig. 8b) This resulted in an inverted ratio between 
air and lens in favor of lens which  provided 
lower optical aberrations, greater brightness 
and higher definition. All the modern rigid 
hysteroscopes are based on Hopkins rod-
lens system From the  first generation rigid 
optics of the 1970s, characterized by a poor 
quality of vision and a diameter of 5.5-6mm, 
we have moved through the second 
generation optics ranging from 4mm to 
Rigid telescopes are available either with 0, 12, 30 or 70 
degree viewing angles (fig 9).  Selection of these angles is 
Fig.  8 a  Old lens based optic 
Fig. 8 b  Modern lens based optic (Hopkins system) 
2.9mm, to the current revolu
mostly a matter of personal preference. For the beginners, the 
0-degree (fig. 10) telescope is much easier to use because 
orientation is similar to that of normal vision. The view through 
the fore-oblique view scopes (typical of all the modern Hopkins 
lens-scope based hysteroscopes), once the tip of the scope is 
walls, the cornual recesses and tubal ostia by simply rotating th
axis to the right or left. On the contrary, the same 
view with a 0-degree scope is possible only by 
angulating the whole instrument to the left or 
right by lateral movements thus determining a 
major stretching of cervical myometrial fibers 
which is mostly responsible for patient’s 
discomfort.In the early 90s, together with the 
Fig. 9 
 sligh
Fig. 10 
15 
 
these scopes was hampered by the poor 
) OFFICE CONTINUOUS FLOW OPERATIVE HYSTEROSCOPE “SIZE 5” AND “SIZE 4’’  
One of the most commonly used rigid 
mm. Recently, a thinner version has been developed based on a revolutionary 2.0 mm rod 
lens system scope that reduces the final diameter of the hysteroscope to 4.0 mm.  
 
development of rigid hysteroscopes, improvements in fiberoptic technology allowed 
manufacturers to create 0-degree flexible hysteroscopes characterized by a smaller 
diameter thus less invasiveness in comparison with the rigid ones.  
At the beginning, the widespread acceptance of 
quality of the images (the so-called “fly view”), the high costs and a number of issues 
regarding their design, use and maintenance. Although recent technological advances 
have made it possible to achieve a image quality almost comparable to that of the rigid 
hysteroscope, these scopes are rarely used in office operative procedures. Optic 
miniaturization both for rigid and flexible hysteroscopes has been important for two 
reasons. Firstly, it has significantly improved patients’ compliance to the procedure; indeed 
a 1- to 2-mm reduction in the optical diameter and consequently of total hysteroscope size 
has reduced the instrument section area by about 50-75%. This makes the introduction of 
the instrument in the cervical canal and uterine cavity easier and less painful compared to 
the conventional larger-diameter hysteroscopes. This trend towards smaller instruments 
has largely contributed to the performance of hysteroscopy as an outpatient procedure. 
Secondly, the miniaturization of the optics has made it possible to produce not only very 
thin diagnostic sheaths, but also operative sheaths with a diameter equal to or less than 5 
mm, as was the case in the old generation of purely diagnostic scopes, including the 
working channel and continuous flow features. The possibility of making a visual 
examination of the uterine cavity and at the same time exploiting the contextual operative 
facilities represents the so called  “see & treat” philosophy , even called “Office Operative 
Hysteroscopy”.  
 
A
 
Fig. 11
hysteroscopes is the Office Continuous Flow 
Operative Hysteroscope (Fig 11) “size 5” 
developed by Storz, based on a 2.9 mm rod 
lens system with 30-degree foreoblique view, 
and  an outer diameter corresponding to 5.0 
 Both instruments feature two sheaths (one for 
irrigation and one for suction, thus creating a 
continuous flow system for the washing of the 
uterine cavity), an operative 5-Fr canal (of 
we want to insert a round hysteroscope
5mm in diameter through it we need to
spatial disposition of the muscle fibres
some of them, stimulating the sensitive fib
 
 
 has allowed the realization of 
alled Versascope   
), developed by Gynecare, 
 
inserted through it,  the continuous flow of di
approximately 1.6 mm) and are oval in shape, 
ideal for atraumatic insertion of the scope into 
the cervix. Indeed, the internal uterine orifice is 
normally oval, with a transverse main axis and a 
diameter of approximately 4-5mm; therefore, if 
 measuring 
 modify the 
, stretching 
res and as 
a result, causing pain to the patient (fig. 12). Instead,  
these two hysteroscopes  conform  more strictly  to 
the anatomy of the cervical canal;  thus a simple 
rotation of the scope on the endo-camera by 90-degre
longitudinal main axis of the scope with the transverse a
B) VERSASCOPE 
 
Recently the improvement in fiberoptic 
technology
Fig. 12 
Fig. 13 
e (Fig. 13) is adequate to align the
xis of the internal uterine orifice.  
a revolutionary semi-rigid 3.2mm 
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minihysteroscope c
(Fig. 14
Ethicon. It consists of a 1.8 mm fiberoptic 
scope with 0-degree angle of vision 
(which becomes 10-degree in sheath) and 
a single, disposable, outer sheath with 
both inflow/outflow channels. This sheath 
has an additional expanding plastic collap
Fig. 14 
sible channel: when the “outflow cannula” is
stension media is established and maintained. 
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rial mucosal lining has a tendency to 
leed on contact; therefore distension of the uterine 
iew within the uterus. Whether 
e best distension media in office setting is CO2 or 
performed. Indeed, apart from better patient tolerance 
ure bag 
Furthermore 7Fr semirigid mechanical instruments or 5Fr bipolar electrodes can be 
inserted through it, allowing immediate conversion from diagnostic to operative procedure. 
This instrument has the main advantage to be a-traumatic and easy to use, which allows 
the use of more robust 7 Fr mechanical instruments. Despite the great improvements in 
fiber-optic technology, Versascope still cannot match image quality of a rod-lens-based 
telescope system. However, because outflow (and not inflow!) is the working channel, it 
allows to maintain the same quality of image throughout the whole procedure, even when 
inserting instruments.  
 
DISTENSION MEDIA 
 
The endomet
b
cavity is necessary to v
th
normal saline is still very debated in literature. The 
available evidence seems to suggest that, even if CO2  
is generally well tolerated and does not distort the 
intrauterine view in 
normal saline should be preferred in office setting, 
particularly  if  o
and being cost effective, the main advantages of liquid 
distension include clearing of blood, blood clots and 
debris during the procedure, as well as the possibility 
to use bipolar instruments.  
The saline solution may be insufflated at 
atmospheric pressure (by means of two 3 or 5-
l bags connected by a urologic ‘Y’ outflow and 
located 1.5 m above the  patient (Fig. 15)) or 
at a pressure generated by a press
Fig. 15 
any way, uterine distension with 
perative procedures are to be 
Fig. 16 
(Fig. 16). However, to maintain a clear field of 
view and a constant distension of uterine 
Fig. 19 
cavity, an electronically controlled irrigation and suction device has to be recommended. 
The Hamou Endomat (Fig, 17) is particularly suitable for office operative hysteroscopy. 
The different parameters on the pump (flow, pressure, aspiration) are set to obtain an 
average constant distension of 30-40 m
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mHg. (Fig. 18) These values, lower than the 70 
 same size or smaller than the 
n 
 
 operative instruments have long 
been the only way to apply the “see and treat” 
philosophy in an outpatient setting.  
ove small 
e of the collected 
tissue. 
mmHg present within the tubes for the abdominal counter pressure, prevent the distention 
media from passing into the peritoneal cavity thus eliminating both patient’s pain and risk 
of vagal reaction. However, even with an electronic pump, it is still practically impossible to 
obtain clear intrauterine view using liquid distension without a continuous flow 
hysteroscope.   
The problem with non continuous flow system occurs 
when the cervical canal and the internal uterine 
ostium are the
hysteroscope. The liquid drains into the uterine 
cavity, because it cannot flow out or pass through 
the tubes into the abdomen. The view will be unclear 
due to the presence of hanging mucosa particles. In 
these cases many endoscopists will try to solve the 
problem, by raising the flow and so the intrauterine pre
liquid cannot flow out of the cervical canal, it will be
through the tubes, causing pain and risk to the patient.
 
 MECHANICAL INSTRUMENTS 
Mechanical
Fig. 18 
ssure. However, as the compressed 
 forced to move into the abdome
These instruments, available in two different 
size of 5 or 7 Fr (Fig.19), enables one to 
perform a target-eye biopsies, to rem
uterine polyps or lost intrauterine device and 
to cut adhesions or septa.   
As stated before, the 7 Fr instruments carry 
the notable advantages of a wider opening 
and an increased volum
Fig. 19
 BIPOLAR ELECTRODES 
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A) VERSAPOINT SYSTEM  
 
ver monopolar technology are well accepted in the medical 
eld. The most important benefit in hysteroscopy is the use of saline solution  as well as 
used for precise and controlled 
ise, 
The advantages of bipolar o
fi
the reduction of energy spread to the tissue during its activation. A versatile electrosurgical 
system dedicated to hysteroscopy called Versapoint Bipolar Electrosurgical System 
developed by Gynecare, Ethicon was introduced in 1997. It consists of a high-frequency 
bipolar electrosurgical generator and co-axial bipolar 5Fr (nearly 1.6mm) electrodes. The 
generator provides three different modes of operation: the vapour cut waveform, 
resembling a cut mode, the blend waveform and the desiccation waveform, resembling a 
coagulation mode. Versapoint electrodes utilise a revolutionary design where the active 
and return electrodes are placed “in-line”, with a ceramic insulator in between. During 
vapour-cut mode, when the electrode is activated in a conducting solution such as saline, 
an extremely high impedance vapour pocket is generated that surrounds and insulates the 
active electrode, preventing completion of the circuit until tissue contact is achieved. After 
tissue contact, the circuit is completed and the tissue between the active and return 
electrodes is vaporized accordingly. Desiccation 
dehydrates the cells and leads to hemostasis. During 
dessication mode, a vapour pocket does not form and 
tissue forms part of the return circuit. Thus Versapoint 
appears and performs like a monopolar device but retains 
all the inherent safety advantages of bipolar 
electrosurgery in saline.  
Three types of flexible electrodes are available (Fig. 20): 
the Twizzle, specifically 
vaporization, the Spring, used for diffuse tissue 
vaporization and the Ball, used to coagulate tissues.  
The Twizzle electrode is what we definitely prefer to the 
others in our clinical practice because it is a more prec
needle-like “cutting” instrument and it can work closer to 
the myometrium with lower power setting and 
Fig. 20 
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) OTHER MINIATURIZED BIPOLAR ELECTRODES 
ore recently a new generation of electrical generators, allowing the use of bipolar energy 
consequently with less discomfort to the patient. Once the 5 Fr Twizzle electrode is 
connected, the generator automatically adjusts to the default setting on VC1 and 100 W. 
However, according to the available international literature and to our clinical experience 
we believe that the mildest vapour cutting mode (VC3) and the halving of the power setting 
to 50 W together with the pulsed activation of the bipolar circuit, carry the advantage to 
produce minimal dissection of the tissue (resembling a precise cut) with minimal 
generation of bubbles and with high patient tolerance. A further advantage of Versapoint 
system is that the same electrosurgical generator can be also connected to disposable 
loops and vaporizing bars in order to be able to perform resectoscopic surgery in the 
operative room.  
 
B
 
M
on miniaturized electrodes, has been presented (Autocon 400 II, Karl Storz Endoscopy, 
Germany). Due to the increased efficiency and to the different “quality” of the energy 
produced, has been possible to develop a second generation of 5 Fr bipolar electrodes 
(Karl Storz Endoscopy, Germany). The main advantage of these instruments is to be 
reusable and therefore to reduce the costs of Office Operative procedures. The application 
of this electrode and the technique used to perform the procedures is the same of those 
described for the Versapoint system. 
 
OFFICE SET-UP 
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An appropriate office set-up is one of the 
keystones for the performance of a successful 
hysteroscopy. The procedure should preferably take 
place in an adequate outpatient unit in a hospital, 
clinic or private office where any unforeseen 
complications can be appropriately managed( Fig. 
proliferative phase of the cycle, as it is easy to pick up 
pathology The nurse should set up the room where the procedure takes place in order to 
ensure that all the necessary equipment and instruments are in proper working conditions 
and readily available. A comfortable electrohydraulically adjustable chair is always 
recommended as this will to add to the comfort of both the patient and the physician. The 
items needed for office hysteroscopy can be singularly arranged on a trolley or 
incorporated in a single compact device. Although rare, there is always the possibility of 
complications due to vasovagal response and adverse reactions.  Thus the nursing staff 
and physicians should always follow the procedure being prepared for emergency situation 
and a complete emergency set must be available in the procedure room. Patient
preparation is a key factor in ensuring a positive 
patient outcome. Ideally, patient preparation begins 
immediately after the patient and the physician have 
decided to proceed with an office hysteroscopy. It 
includes a clear explanation of the procedure, a 
thorough assessment of the patient’s understanding 
of information given and a period of time for question 
and answers during which the doctor may discuss and 
address any patient’s concerns about the procedure. It 
has been speculated that women who are anxious 
while undergoing a hysteroscopy usually experience 
more discomfort during the procedure. 
Therefore, if the doctor or a nurse is ab
21). Hysteroscopy should be scheduled in the early 
 
le to develop a 
anxiety, a more positive outcome and an increased 
Fig. 21 
Fig. 22 
plan of care that will help to minimize the patient’s 
Fig. 23 
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patient satisfaction can be expected. In our clinic neither analgesic nor mild sedative are 
administrated before the procedure. The gynaecologist should also ensure that the 
informed surgical consent is signed and that the medical record contains information about 
any pathological conditions or allergy the patient may have. A nurse or a resident should 
instruct the patient to empty her bladder and then accompany her to the procedure room, 
instruct her to undress from the waist down and position her on the examination table in a 
lithotomy position, ensuring that she is adequately draped to maintain her privacy. During 
the procedure, the nurse or a resident should provide emotional support to the patient and 
assistance to the physician as needed. Moreover, in order to further reduce the patient’s 
anxiety the physician may also get the patient more involved into the procedure by inviting 
her to look at the monitor and explaining the view or any abnormalities found. An additional 
monitor dedicated to the patient’s view may be useful to address such issue (Fig. 22). 
After the procedure, the patient generally does not need any recovery time and should be 
able to go home immediately. Therefore, the physician should review discharge instruction 
with the patient, including what to expect immediately after the hysteroscopy and during 
the first few days following the procedure such as mild cramping and vaginal spotting  
(Fig. 23). A non steroidal anti-inflammatory drug or a spasmolitic agent may be prescribed 
to control discomfort and the patient is instructed to notify the physician immediately if she 
notices any abnormal bleeding or pain. Normal activities restriction is usually not required 
after an outpatient hysteroscopy, even in case operative procedures are performed. 
 
 
CHAPTER 3 
  
FEASIBILITY AND ADOPTION 
 
 
Although it is well established that outpatient hysteroscopy with a success rate close to 
100% represents the gold standard for the evaluation of the uterine cavity, the number of 
gynecologists performing such procedure continues to be low.  
These figures drop further when considering the number of gynecologists who prefer to 
remove benign lesions in an outpatient setting rather than in the operating theatre. 
 
Several reasons given for this include:  
 
1. A perceived limited number of patients who would benefit from the procedure  
 
There are no scientific reasons as to why there should be any scarcity in the number of 
patients who would benefit from outpatient hysteroscopy specially when it has been proved 
beyond a shadow of doubt that patients who do not wish to or cannot undergo general or 
local anaesthesia as well as virgin patients who wish to preserve the integrity of their hymen 
can all be treated by hysteroscopy in an 
office setting (Fig.1). In this regard, Attilio Di 
Spiezio Sardo and coll, published a “Letter 
to the editor” (A. Di Spiezio Sardo, M. 
Guida, M. Pellicano, C. Nappi, S. 
Bettocchi. JMIG 2006; 13(5): 489-90) 
concerning the paper of Xu et al, entitled  
“Hysteroscopy for the diagnosis and 
treatment of pathologic changes in the 
uterine cavity in women with an intact 
Fig. 1 
23 
 
hymen” (JMIG 2006; 13:222-4). The author’s purpose was just to underline that office 
hysteroscopy with minihysteroscopes and vaginoscopic approach should always represent 
the first-line approach to a virgin patient who requires endoscopic investigation of the uterine 
cavity. 
At present, office hysteroscopy may be preferable in most situations where either a 
major or minor intrauterine anomaly is suspected, including asymptomatic patients.  
 
 
2. A duplication of procedures for patients who need surgery in the operating room 
 
The most common concern for any gynaecologist is that a patient who need surgery will 
undergo two procedures if there is a lesion to be removed. However modern hysteroscopic 
technology has made it possible to diagnose and treat most intrauterine pathologies in a 
single outpatient setting. 
 
3. High initial investment with poor payback 
 
It is undeniable that mandatory 
equipment for office hysteroscopy is 
expensive and payback depends 
primarily on location and customer 
affluence. However, from an overall 
perspective of both time and money,    
it can be argued that it is much more 
productive 
a rapid 
“see and treat” hysteroscopy within the office setting rather than 
to take a patient to the operating room (
to perform 
Fig. 2- Fig. 3). 
Fig. 2 
Fig. 3  
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4. The supposed high level of expertise needed to perform any operative procedure in 
an office setting  
 
Experience has shown that office operative hysteroscopy is not a 
difficult technique and that the learning curve may be further 
reduced by supervised training (Fig.4), proper knowledge of 
techniques and instruments as well as the use of minihysteroscopes 
with adequate optical features. A new generation of hysteroscopists, 
familiar with the modern hysteroscopes and able to simultaneously 
use the scope and the 5-Fr or 7-Fr instruments is on the increase 
particularly in Europe rather than in the USA.  
Fig. 4 
Currently, the main limiting factor to a widespread use of office hysteroscopy is pain and 
discomfort experienced by the patients during the procedure. Unfortunately, hysteroscopy 
continues to be perceived as an invasive and painful technique by most patients with many of 
them still preferring the inpatient approach, believing that it will be pain-free.  
Furthermore, many gynaecologists are themselves responsible for the poor diffusion of  
outpatient procedures because of their fear of inflicting pain on their patients. Coupled with 
this is the fact that most  gynaecologists are apprehensive at not to being able to perform the 
examination with the patient being awake witnessing and judging the performance. 
 
 
Pain during hysteroscopy is primarily due to: 
 
1. The introduction of hysteroscope through cervical canal, 
especially when it is pushed through the internal ostium 
(Fig.5) ;  
 
 
 
 
Fig. 5  
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2. The contractile activity of the myometrium caused by the 
distension of the cavity by means of distension medium 
(Fig.6);  
 
 
 
 
Fig. 6 
 
3. The direct stimulation of the uterine walls coming into 
contact with the instrument (Fig.7). 
 
 
 
 Fig. 7 
• VAGINOSCOPIC APPROACH 
 
In the last decade, all efforts have focused on maximizing the chance of success of the 
procedure by minimizing patients’ discomfort. Above all, the following have greatly increased 
the feasibility and acceptability of office hysteroscopy, making it nearly painless, quick and 
complication-free. 
 
- the use of saline as distension medium; 
- the availability of high resolution rigid and flexible mini-endoscopes; 
- and the introduction of a refined technique for the insertion of the hysteroscope in the 
external uterine orifice  which is less traumatic to the patient  
 
This vaginoscopic approach has been developed by Prof. Bettocchi in 
1995 (Fig. 8) and it avoids the need for a vaginal speculum and a cervical 
tenaculum. The vagina, being a cavity, can be distended by introducing the 
liquid distension medium through the hysteroscope placed into the lower 
vagina at the same pressure (30-40 mmHg) used for the subsequent 
Fig. 8 
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distension of uterine cavity. Then the scope is guided towards the external uterine ostium 
and through the cervical canal.  
Several retrospective and randomized studies have shown that vaginoscopic 
approach is effective and faster than conventional approach and also reduces patient 
discomfort. Particularly, Sharma, Attilio Di Spiezio and coll, conducted the first prospective 
randomized controlled study (M. Sharma, A. Taylor, A. Di Spiezio Sardo, L. Buck, G. 
Mastrogamvrakis, I. Kosmas, P. Tsirkas, A. Magos. Outpatient hysteroscopy: 
traditional versus the ‘no-touch’ technique. BJOG. 2005; 112: 963–967) in order to 
assess whether outpatient hysteroscopy using the ‘no-touch’ technique confers any 
advantages in terms of patient discomfort over the traditional technique. All women referred 
for outpatient hysteroscopy in a 12-month period were randomised to undergo either 
traditional saline hysteroscopy requiring the use of a speculum and tenaculum, or a ‘no-
touch’ vaginoscopic hysteroscopy which does not require a speculum or tenaculum. Each 
group was further subdivided to have hysteroscopy with either a 2.9-mm or 4-mm 
hysteroscope. Patients were asked to complete pre- and postprocedure questionnaires 
ranking pain scores. The main outcome measures were: the relative success of each of 
these techniques, requirement for local anaesthetic and pain scores at different times during 
the hysteroscopy were recorded at the end of the procedure. The time taken to carry out 
each procedure was also measured. One hundred and twenty women were recruited in this 
study: 60 were randomised to traditional hysteroscopy and 60 to ‘no-touch’ hysteroscopy. 
The overall success rate for hysteroscopy was 99%. There was no significant difference in 
the requirement for local anaesthetic between the two groups, but those who underwent ‘no 
touch’ hysteroscopy with a 2.9-mm hysteroscope had the lowest requirement of local 
anaesthetic (10% compared with 27% in the no-touch hysteroscopy with a 4-mm 
hysteroscope group). The time taken to perform hysteroscopy and biopsy was significantly 
shorter with ‘no-touch’ hysteroscopy (5.9 vs 7.8 min; difference 1.9, 95% CI 0.7–3.1). There 
were no differences in pain scores between the groups at different times during 
hysteroscopy. Therefore, the authors found that ‘No-touch’ or vaginoscopic hysteroscopy is 
significantly faster to perform than the traditional technique. Although there was no difference 
in pain scores between the two techniques, local anaesthetic requirements were least in 
those who underwent ‘no-touch’ hysteroscopy with a narrow bore hysteroscope. The echo of 
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this paper spread far and wide, so that it has been amply commented in “Obstetric and 
Gynecologic Survey” 
Pain reduction, during vaginoscopic hysteroscopy,  is mainly due to the first phase of 
the procedure being vaginal distension by means of liquid, which is not painful, whereas the 
introduction of even the smallest speculum is usually poorly tolerated. This could be 
particularly relevant considering that patients undergoing hysteroscopy are often very 
anxious; so lowering the pain sensation in the first phase of this procedure could contribute to 
a better global performance. 
Vaginoscopic approach requires a good knowledge of the 
physics and instrumentation as well as the operator’s ability to 
correlate the image on the 
screen with the actual position 
of the fore-oblique scope. 
should not appear in the middle of the screen, but in its lower 
half to enable the scope to be aligned with the mid-
longitudinal axis of the cervical canal (Fig. 9- Fig. 10).  
Until n
Indeed the required image 
with a fore-oblique view scope 
ow in all published studies, the vaginoscopic approach has been performed with 
differe
Fig. 9 
Fig. 10 
nt-sized standard rigid hysteroscopes. In the recent years, a semi-rigid 3.5-mm fibre-
optic minihysteroscope (Versascope, Gynecare, Ethicon) has been developed. In this regard, 
M.Guida, Attilio Di Spiezio and coll, conducted the first prospective randomized controlled 
study in order to compare surgeons and hysteroscopic methods (vaginoscopic and traditional 
approach), using this new semi-rigid hysteroscope, to assess whether vaginoscopic 
approach is associated with a lower pain score without any increase in procedure time. 
(M.Guida, A.Di Spiezio Sardo, G.Acunzo, S.Sparice, S.Bramante, R.Piccoli, G.Bifulco, 
D.Cirillo, M.Pellicano and C.Nappi. Vaginoscopic versus traditional office 
hysteroscopy: a randomized controlled study Human Reproduction . 2006.21;  12: 
3253–3257). In this trial three hundred patients were randomized in two groups: Group A, 
diagnostic hysteroscopy with vaginoscopic approach (150 patients) and Group B, diagnostic 
hysteroscopy with traditional approach (150 patients). All procedures were performed using a 
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semi-rigid 3.5 mm minihysteroscope with a 0° grade optic. Patients of each group were 
divided into three subgroups according to their reproductive status: fertile nulliparous (FN), 
fertile multiparous (FM) and post-menopausal (MEN) women. Women were asked to rate 
their degree of pain during four phases of the procedure: introduction of hysteroscope (Group 
A) or speculum (Group B) into the vagina (Phase I) and progression through cervical canal 
up to internal uterine orifice (IUO) (Phase II), inspection of uterine cavity (Phase III) and 
performing of endometrial biopsy (Phase IV). A total pain score was calculated for each 
group. For each patient, the duration of hysteroscopy was recorded from the introduction to 
the extraction of the scope (Group A) or of the speculum (Group B). Although the median 
total pain scores were 2 in each group, the 95% confidence interval for vaginoscopic 
hysteroscopy (1.86–2.01) was significantly (P < 0.05) lower than that for traditional 
hysteroscopy (2.10–2.26). Comparison between the corresponding phases of the procedure 
showed the only significant difference during Phase I of the procedure [Group A: 1 (95% CI 
1.0–1.18) versus Group B: 2 (95% CI 2.3–2.8); P < 0.05]. No significant differences in terms 
of duration of the procedure were observed between the two approaches. Therefore, the 
authors concluded that, when surgeons using vaginoscopic hysteroscopy with a semi-rigid 
minihysteroscope were compared with those using traditional approach and the same 
instrumentation, the operating times and the patients’ pain scores were similar. 
Obviously, high patient compliance during the procedure represents the key 
prereq
odern hysteroscopes and the availability of bipolar 
elect
ly 
safe 
1 the appropriate equipment 
ge of the correct techniques 
uisite not only to reach a correct diagnosis but also to possibly treat those pathological 
conditions found in the uterine cavity.  
However, without the advent of m
rodes respecting the sensitive anatomy of the uterus, the philosophy of office operative 
hysteroscopy would have neither broadened its indications nor increased its acceptability. 
As a matter of fact, today office operative hysteroscopy is considered to be absolute
and feasible, provided we have: 
 
) 
2) proper training and knowled
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Under these assumptions, nowadays it is possible to offer the patient an effective and 
painl
anaesthesia and associated risks and morbidity  
sage 
ating room in 
scopy is a tool which should belong to every 
 
 
ess treatment which also: 
1) avoids local and general 
2) allows quicker recovery time and return to mobility and full fitness 
3) reduces costs related to dedicated personnel and operating room u
4) reduces waiting lists for major surgery by avoiding the need for the oper
case of minor procedures 
For all these reasons office operative hystero
modern gynaecolosist. 
Nezhat et al1—more recently. The harmonic scalpel was
used in most of the steps of radical hysterectomy with the
advantage of not leaving staples in the pelvis unnecessarily.
After our experience in 48 cases, we are currently using a
new vessel-sealing technology (Ligasure Five LS 1500,
Autosuture, Valleylab, Boulder, CO) that produces a con-
sistent, reliable, permanent seal of veins, arteries, and tissue
bundles by fusing the collagen in vessel walls.
The use of standardized, strict, and correct terminology
for the description of total radical hysterectomy completed
exclusively by the laparoscopic route is essential for re-
search purposes, as well as for the comparison of surgical
results regarding morbidity and outcome of the procedure
reported by different groups.
Berta Díaz-Feijoo, MD
Antonio Gil-Moreno, MD, PhD
Jordi Xercavins, MD, PhD
Barcelona, Spain
doi:10.1016/j.jmig.2006.05.008
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Response:
In a recent publication, we described the technique of
total laparoscopic radical hysterectomy using the harmonic
shears as the sole instrument for dissection, division, and
maintenance of hemostasis of all major surgical pedicles.1
In this report, we provided a detailed description of our
procedure with the entire surgery being performed laparo-
scopically with the exception that the vagina was cut and
closed under direct visualization using a vaginal approach to
assure adequate surgical margins. In a letter to the editor,
Diaz-Feijoo and colleagues have brought up the important
issue of using standardized terminology for the description
of total laparoscopic radical hysterectomy and argue that the
use of the vaginal route to assure adequate margins during
our procedure should negate the ability to classify our pro-
cedure as a total laparoscopic radical hysterectomy.
We believe that the important steps of the radical hysterec-
tomy include the development of the avascular pelvic spaces,
ligation and division of the vascular pedicles, unroofing and
mobilization of the ureters with dissection down to their inser-
tion into the bladder, and division of the uterosacral/cardinal
ligaments with resection of the parametria. In our series, all
these steps were performed laparoscopically. In our opinion,
the vaginal cuff incision and vaginal cuff closure can be per-
formed either laparoscopically or vaginally. The vaginal ap-
proach offers better visualization of the vaginal resection mar-
gin with less manipulation of the cervix during specimen
removal. Our technique does not increase operation time, and
may lead to fewer vaginal cuff eviscerations which may be
attributable to laparoscopic vaginal cuff excision and closure.2
In 2000, Olive and colleagues3 published the American
Association of Gynecologic Laparoscopists (AAGL) classi-
fication system for laparoscopic hysterectomy, which de-
scribed a system of nomenclature based on the portion of
the procedure completed under laparoscopic direction. This
publication, however, did not address classification of lapa-
roscopic radical hysterectomy. A new guideline has been
developed by The Practice Guidelines Committee of the
AAGL describing the classification of laparoscopic radical
hysterectomy and is presently under review.
Farr Nezhat, M.D.
Nimesh P. Nagarsheth, M.D.
New York, NY
doi:10.1016/j.jmig.2006.06.009
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To the Editor,
We wrote this letter on the wave of the heterogeneous emo-
tions that the paper of Xu and his colleagues1 stirred up. Reading
its title, we got excited, imaging a proposal of a new technique to
perform hysteroscopy in “women with an intact hymen.”
Unfortunately, reading the article thoroughly, we felt very
disappointed when we became aware that the technique pro-
posed by the authors was no less than the vaginoscopic ap-
proach (no-touch technique), a well-recognized and widely
used technique since the beginning of the 1990s.2
Several studies have already demonstrated that the vagi-
noscopic approach is effective, reduces patient discomfort,
and increases the possible applications of hysteroscopy,
being ideal in patients who otherwise might require general
anesthesia, such as older women with somewhat stenotic
vaginas and virgin patients.2–4
The vaginoscopic approach together with technical and
instrumental improvements has significantly increased the
feasibility and acceptability of hysteroscopy, allowing the
performance in outpatient settings of some minor and major
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procedures (e.g., see-and-treat hysteroscopy) that otherwise
would require general anesthesia, cervical dilatation, and
the use of the wider resectoscope.5
We would expect that Xu et al would treat intrauterine
pathologies in such virgin patients using the new minihys-
teroscopes with mechanical or bipolar 5F or 7F instruments
and without general anesthesia,5 maybe with some specific
tricks related to the presence of an intact hymen.
Nothing of that was described in the paper, with all the
14 reported hysteroscopies performed under general anes-
thesia using a classic vaginoscopic approach and a 4.5-mm
hysteroscope, replaced by a wider 6.5- or 8-mm operative
hysteroscope when intrauterine lesions had to be removed.
Apart from the “maneuvers for a successful procedure,” which
may facilitate the access to the external uterine ostium and cervical
canal in a virgin patient, nothing of the described “surgical pro-
cedure” seemed to represent an innovation worthy to be followed
when a virgin patient has to undergo an operative hysteroscopy.
In particular, we were really surprised about the possi-
bility of introducing an 8-mm resectoscope into the cervical
canal without mechanically dilating it. Whereas Xu and his
colleagues propose the preoperative use of rectal misopros-
tol to soften the cervix, anyone who performs operative
hysteroscopies knows the extreme difficulty in entering the
internal cervical os with an 8-mm instrument in a cervical
canal of a nulliparous patient, which has a diameter varying
from 4 to 5 mm; the moreso when an intact hymen prevents
the possibility of performing wider movements!
In conclusion, we are firmly convinced that office hys-
teroscopy with minihysteroscopes and vaginoscopic ap-
proach should always represent the first-line approach to a
virgin patient who requires endoscopic investigation of the
uterine cavity. The 5F or 7F mechanical and bipolar instru-
ments might offer the possibility to perform biopsies and to
treat most of the intrauterine pathologies simultaneously.
According to our experience, the use of the resectoscope
should be reserved only for such intrauterine pathologies
that cannot be treated with 5F or 7F instruments (i.e., my-
oma  2 cm).5
Attilio Di Spiezio Sardo, MD
Maurizio Guida, MD
Massimiliano Pellicano, MD
Carmine Nappi, MD
Naples, Italy
Stefano Bettocchi, MD
Bari, Italy
doi:10.1016/j.jmig.2006.06.031
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Response:
Thank you very much for taking the time to review and
comment on our article. We welcome all comments and
criticism, although in this technique we are in nearly com-
plete agreement with your opinion. Small differences are
likely the result of varying surgical experiences and skills in
accomplishing the same goal.
In fact, the technique proposed by us was similar to the
vaginoscopic approach (no touch technique).1 However, our
procedure is not the same as that previously reported:1–3
1. All of our patients were women with an intact hymen.
2. We carried out not only the diagnostic, but also the
operative hysteroscopy.
3. We employed hysteroscopes with a diameter ranging
from 4.5 mm to 8 mm.
4. The main goal of our procedure was to preserve the intact
hymen under the special cultural background in China.
5. We did some preoperative preparation, such as using
misoprostol to soften the cervix.
6. We used the loop-electrode to curette the thickened en-
dometrium mechanically to control uterine hemorrhage
in women with dysfunctional uterine bleeding.
According to our experience, general anesthesia is re-
quired, because virgin patients are too nervous to cooperate
with doctors without general anesthesia during the proce-
dure, which may cause possible injury of the intact hymen.
In our study, because of the preoperative use of miso-
prostol and the persistent uterine bleeding, it is less difficult
to introduce a 6.5-mm or 8-mm hysteroscope into the cer-
vical canal without mechanically dilating it.
We hope these explanations will further assist with
adopting this technique.
Dabao Xu, MD
Changsha, China
doi:10.1016/j.jmig.2006.07.005
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Outpatient hysteroscopy: traditional
versus the ‘no-touch’ technique
M. Sharma, A. Taylor, A. di Spiezio Sardo, L. Buck,
G. Mastrogamvrakis, I. Kosmas, P. Tsirkas, A. Magos
Objective To assess whether outpatient hysteroscopy using the ‘no-touch’ technique confers any advantages
in terms of patient discomfort over the traditional technique.
Design Prospective randomised controlled study.
Setting Outpatient hysteroscopy clinic in a large university undergraduate teaching hospital.
Population All women referred for outpatient hysteroscopy in a 12-month period.
Interventions Women were randomised to undergo either traditional saline hysteroscopy requiring the use of
a speculum and tenaculum, or a ‘no-touch’ vaginoscopic hysteroscopy which does not require a speculum or
tenaculum. Each group was further subdivided to have hysteroscopy with either a 2.9-mm or 4-mm
hysteroscope. Patients were asked to complete pre- and postprocedure questionnaires ranking pain scores.
Main outcome measures The relative success of each of these techniques, requirement for local anaesthetic
and pain scores at different times during the hysteroscopy were recorded at the end of the procedure. The
time taken to carry out each procedure was also measured.
Results One hundred and twenty women were recruited in this study: 60 were randomised to traditional
hysteroscopy and 60 to ‘no-touch’ hysteroscopy. The overall success rate for hysteroscopy was 99%. There
was no significant difference in the requirement for local anaesthetic between the two groups, but those who
underwent ‘no-touch’ hysteroscopy with a 2.9-mm hysteroscope had the lowest requirement of local
anaesthetic (10% compared with 27% in the no-touch hysteroscopy with a 4-mm hysteroscope group). The
time taken to perform hysteroscopy and biopsy was significantly shorter with ‘no-touch’ hysteroscopy
(5.9 vs 7.8 min; difference 1.9, 95% CI 0.7–3.1). There were no differences in pain scores between the
groups at different times during hysteroscopy.
Conclusions ‘No-touch’ or vaginoscopic hysteroscopy is significantly faster to perform than the traditional
technique. Although there was no difference in pain scores between the two techniques, local anaesthetic
requirements were least in those who underwent ‘no-touch’ hysteroscopy with a narrow bore hysteroscope.
INTRODUCTION
Hysteroscopy is widely accepted to be the gold standard
for direct visualisation of the endometrial cavity. The most
common indications are abnormal uterine bleeding and
subfertility. It has been shown to be well tolerated as an
outpatient procedure with a high success rate.1 However,
one of the most common reasons for failure is pain,
especially during introduction of the hysteroscope, and this
can occur even if local anaesthesia is used. Pain may arise
as the cervix is dilated with the hysteroscope, or when the
uterine walls are distended with the distension medium.
Anaesthetic requirements tend to be greater in nulligravid
and postmenopausal women. The rate of local anaesthetic
use is around 30% with the use of traditional hysteroscopic
techniques.1,2
A variety of refinements have been tried to improve
tolerability of the procedure. Local anaesthetic has been
used in the form of either intracervical or paracervical
instillation, or topically with a gel or spray, often with con-
flicting results. Intracervical local anaesthetic was found
to be no more effective than placebo in a study involving
100 women.3 Two randomised studies of paracervical
anaesthesia reached opposite conclusions about the ef-
ficacy of the preparation to reduce pain in postmenopausal
women.4,5 Lignocaine spray to the cervix has been com-
pared with placebo and failed to show any significant
difference in pain scores for hysteroscopy, the only be-
nefit being reduction in pain as the cervix was grasped.6
Local anaesthetic cream, local anaesthetic gel and place-
bo, all applied to the cervix, resulted in significantly less
pain than treatment with placebo,7 but local anaesthetic
gel alone was not found to confer any benefit to outpatient
hysteroscopy.8
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Large diameter hysteroscopes have been compared with
narrower scopes in terms of tolerability and accuracy in
evaluating the endometrium. Narrow hysteroscopes reduce
pain while giving equally satisfactory views of the endo-
metrial cavity with lower failure rates and fewer incidences
of vasovagal side effects compared with standard 4 mm
hysteroscopes.9–11
A vaginoscopic or ‘no-touch’ approach to hysteroscopy
has been described, avoiding the need to introduce a
vaginal speculum and tenaculum to expose and grasp the
cervix.11–14 We have conducted a randomised controlled
trial to ascertain whether there was a true difference in the
discomfort of outpatient hysteroscopy using this approach
compared with the traditional technique, and whether this
led to a difference in the need for local anaesthesia.
METHODS
Ethical approval for this study was obtained from the
Royal Free Hospital Local Research Ethics Committee
(No. 6056). Women who attended for outpatient hysterosco-
py were invited to take part. Following a detailed history,
the women were asked to complete a preprocedure ques-
tionnaire scoring their level of anxiety, concurrent abdom-
inal pain and backache utilising a 10-cm visual analogue
scale (0 ¼ no symptoms, 10 ¼ worst possible symptoms).
Following informed consent, the women were random-
ised to one of two groups:
Group 1: Traditional technique with speculum and
tenaculum
Group 2: ‘No-touch’ technique
Both groups were further randomised to different size of
hysteroscopes:
A: 4 mm 30 single-flow rigid hysteroscope (5 mm sheath)
B: 2.9 mm 30 single-flow rigid hysteroscope (3.7 mm
sheath)
Randomisation was based on a computer-generated
randomisation table, and was performed using opaque
envelopes immediately prior to the hysteroscopy. The
hysteroscopy was performed by one of seven operators
attending the clinic each of whom had performed at least
Fig. 1. Consort diagram.
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20 traditional and ‘no-touch’ diagnostic hysteroscopies
previously.
For the traditional technique, following a bimanual
examination, a Collins bivalve speculum was inserted into
the vagina to expose the cervix. The anterior cervical lip
was grasped with Littlewood’s forceps. The cervical canal
was only dilated if it was judged to be too narrow to admit
the hysteroscope. Intracervical local anaesthesia (2.2 mL of
3% prilocaine with felypressin 0.03 U/mL) was not given
routinely but was available if requested by the patient.
Hysteroscopy was performed using normal saline as the
distension medium at a pressure of 150 mmHg, and was
guided through the cervix making adjustments to allow for
the angle of the optic.15 The uterine cavity and the endo-
cervical canal were inspected in a systematic fashion. If
an endometrial biopsy was required, a Pipelle de Cornier
sampler was used.
For the ‘no-touch’ technique, following a bimanual ex-
amination, the hysteroscope was placed into the lower va-
gina and the normal saline was turned on at 150 mmHg
pressure. The instrument was directed towards the cervix,
and on identifying the external os, was introduced into the
cervical canal and guided into the uterine cavity. The
uterus was inspected as previously described before being
withdrawn. If an endometrial biopsy was indicated, a spec-
ulum was inserted to expose the cervix and the cervix was
held with Littlewood’s forceps. Cervical dilatation or in-
tracervical local anaesthesia was only used if needed, in
which case the hysteroscopy was converted to the tradi-
tional technique.
Success of the investigation (defined as adequate inspec-
tion of the canal and endometrial cavity) by the intended
technique, and need for local anaesthesia were recorded.
Other parameters assessed included the need for cervical
dilatation and the duration of the procedure (defined as the
interval between the vagina being instrumented to the time
the last instrument was removed from the vagina). Patients
were asked to complete a postprocedure questionnaire
immediately following the investigation scoring their dis-
comfort at various phases of the hysteroscopy [e.g. inser-
tion of speculum (if used), local anaesthetic injection (if
required), insertion of the hysteroscope, inspection of the
uterine cavity, endometrial biopsy (if done), and immedi-
ately after and 30 min after hysteroscopy]. In addition, they
were asked if they would recommend the procedure to a
friend, if they would prefer general anaesthetic in future
and how acceptable they found the procedure.
We used the need for local anaesthesia as our primary
outcome measure. We hypothesised that with a no-touch
technique only 10% of patients would require analgesia
compared with the figure of 30% for the group who had
traditional hysteroscopy.1,2 For the probability of a type 1
statistical error to be less than 0.05 and the probability of a
type 2 statistical error to be less than 0.2, we calculated that
we would need 60 patients in the traditional and ‘no-touch’
groups, respectively. Our secondary outcome measures
included procedure time and the effect of hysteroscope
size, but we made no attempt to power the study for these
particular variables.
Analysis was by intention to treat. Data were analysed
using Student’s t test for continuous variables which were
normally distributed, and the Mann–Whitney U test if they
were not. Confidence intervals for difference in means were
calculated for continuous variables if the distribution was
normal. Relative risk and confidence intervals were calcu-
lated for nominal variables. All tests were two-sided and
a result of P < 0.05 was considered statistically significant.
Table 1. Patient characteristics. Data are mean [SD]; median (range) or
number (%).
Traditional technique
(n ¼ 60)
‘No-touch’ technique
(n ¼ 60)
Age (years) 45 [7.5] 43 [8.0]
Parity 2 (0–5) 2 (0–10)
Nulliparous/multiparous 18 (30) 20 (33)
Postmenopausal 9 (15) 6 (10)
Indications*
Menorrhagia 35 (58) 36 (60)
Prolonged periods 10 (17) 5 (8)
Postmenopausal bleeding 9 (15) 5 (8)
Intermenstrual bleeding/
Postcoital bleeding
10 (17) 10 (17)
Subfertility 4 (7) 6 (10)
Miscellaneous indications 2 (3) 1 (2)
* Some patients had more than one indication for hysteroscopy.
Table 2. Outcomes between traditional and ‘no-touch’ hysteroscopy. Data are number (%) except where indicated.
Traditional technique ‘No-touch’ technique Difference between means
or relative risk
95% CI
Procedure time (min), mean (SEM) 7.8 (0.5) 5.9 (0.4) 1.9 0.7–3.1
Cervical dilatation 15 (25) 10 (17)y 0.8 0.4–1.3
Local anaesthetic 13 (22) 11 (18)* 0.9 0.6–1.5
2.9 mm optic 7 3
4 mm optic 6 8
Biopsy taken 42 (70) 40 (67) 1.1 0.8–1.3
* Eleven patients required local anaesthetic (one for biopsy only).
y These 10 patients were converted to traditional technique.
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RESULTS
The flow of patients through the trial is shown in Fig. 1.
Patient characteristics and indications for hysteroscopy are
shown in Table 1. There were no significant differences in
any demographic variables, preprocedural anxiety, stomach
pains and backache scores. The outcomes for the two
groups are shown in Table 2. Overall, 119/120 hysteros-
copies (99%) were carried out successfully; only one
hysteroscopy was judged to be non-diagnostic because of
bleeding which obscured the hysteroscopic view. No-touch
hysteroscopy was significantly quicker to perform. A fifth
of patients required local anaesthesia during hysteroscopy
with no statistical significance between treatment groups.
The influence of optic size was not statistically significant,
but women undergoing ‘no-touch’ hysteroscopy using a
2.9-mm hysteroscope had the lowest requirement for local
anaesthesia (3 of 30, 10%) (Table 2).
Pain scores at various stages of the hysteroscopy are also
shown in Table 3. The only statistically significant differ-
ence in pain scores between the two main groups at any
phase of the hysteroscopy was in relation to endometrial
sampling, which was more painful in the ‘no-touch’ group.
Overall, the highest pain scores were for pain from local
anaesthetic injections in women allocated to the no-touch
group who had to be converted to the traditional technique
(median score 6).
Ninety-three percent of our patients said that they would
recommend this procedure to a friend who needed this
investigation. Twenty-one percent of participants said that
if they required hysteroscopy again they would prefer a
general anaesthetic (15% with a 2.9-mm hysteroscope and
27% with a 4-mm hysteroscope, P ¼ 0.18). Ninety-two
percent of women found outpatient hysteroscopy very or
fairly acceptable with no difference between the two groups.
DISCUSSION
This is the first randomised controlled trial to compare
traditional hysteroscopy with the vaginoscopic or ‘no-
touch’ approach. Our findings confirm that outpatient hys-
teroscopy is a successful procedure which is generally well
tolerated by patients. Although we have failed to demon-
strate significant differences in pain for the ‘no-touch’
technique, we have shown that it is significantly quicker
to perform. The advantage that the ‘no-touch’ technique
was found to be about 25% quicker to perform is important
for those patients who are anxious about undergoing what
they consider to be an embarrassing procedure.
Our results are at considerable variance with the scant
published data. In our study, only one patient scored zero
for pain during the hysteroscopy, and one in six requested
local anaesthesia. In contrast, in an observational study,
Bettocchi and Selvaggi12 reported that 96% of women
undergoing vaginoscopic hysteroscopy reported no discom-
fort or pain, and none were given local anaesthesia. In that
study, CO2 was used as the distension medium, which
typically causes more discomfort than fluid distension
because of diaphragmatic irritation. It is difficult to explain
the discrepancy between our results and that of the Italian
study and we wonder if there are cultural reasons for these
differences.
Nonetheless, the lack of advantage of ‘no-touch’ hys-
teroscopy in terms of the need for local anaesthesia was
unexpected, both from the published literature and our prior
clinical experience. We can think of three reasons for this.
Firstly, based on our earlier studies,1,2 we expected 30% of
women undergoing traditional hysteroscopy to require local
anaesthesia, but in fact only 20% did so. As a result, our
study was underpowered and we would have had to
investigate 200 patients in each group to confirm that
‘no-touch’ hysteroscopy reduced this rate to 10%. Second-
ly, the finding that ‘no-touch’ hysteroscopy with the larger
optic proved to be the most painful of all the techniques
further compromised our study. Over 25% of patients
required local anaesthesia, a rate quite different from the
10% with the narrow optic. It may be relevant that fewer
women required cervical dilatation with the smaller hys-
teroscope. Our overall results were, therefore, distorted by
including two sizes of hysteroscopes in this study. Al-
though such a large effect of optic size was not expected,
it is noteworthy that the surface area of the larger hystero-
scope is almost twice as large as that of the narrower optic
(19.64 mm2 vs 10.756 mm2). Thirdly, we analysed our data
by intention to treat, which means that the results for the
no-touch group includes those who required conversion,
whereas there was no similar conversion option for the
traditional group. This aspect of our study was likely to
dilute any real difference between the two techniques.
Similarly, there were no major differences in pain scores
recorded by our patients. However, this finding is more
difficult to interpret because of the use of local anaesthesia
in some. What our data does confirm is that cervical injec-
tion remains themost painful part of outpatient hysteroscopy.
In summary, our study confirms that no-touch hyster-
oscopy is feasible in the majority of patients attending for
outpatient hysteroscopy. We have found that ‘no-touch’
hysteroscopy was no less painful than when a traditional
Table 3. Pain scores during hysteroscopy. Data are median (range).
Comparisons are by Mann–Whitney U test.
Traditional
technique
‘No-touch’
technique
P
Insertion of hysteroscope 5 (0–10) 3 (0–9) 0.62
Hysteroscopic inspection 5 (0–10) 5 (0–10) 0.12
Speculum 3 (0–8) 3 (0–9) 0.84
Local anaesthetic 4 (0–6) 6 (2–9) 0.15
Biopsy 5 (0–9) 5 (0–10) 0.04
End of procedure 3 (0–10) 3 (0–10) 0.52
30 minutes after procedure 1 (0–8) 1 (0–9) 0.49
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technique is used but was significantly quicker by an
average of 2 min. We did, however, find some evidence
that the ‘no-touch’ approach is less uncomfortable when a
narrow optic is used, and this deserves further study. Since
completing this study, we have developed a device for
obtaining an endometrial biopsy without the need for a
vaginal speculum which is applied through the diagnos-
tic sheath of the hysteroscope once the optic has been
removed.16 It is anticipated that this will not only reduce
the time taken for hysteroscopy and biopsy even further, but
hopefully will also reduce the discomfort of the biopsy
process.
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Vaginoscopic versus traditional office hysteroscopy: 
a randomized controlled study
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BACKGROUND: A randomized, controlled study was performed to compare vaginoscopic versus traditional (speculum
with or without tenaculum) hysteroscopy in terms of pain score and procedure time. METHODS: Three hundred
patients were randomized in two groups: Group A, diagnostic hysteroscopy with vaginoscopic approach (150
patients) and Group B, diagnostic hysteroscopy with traditional approach (150 patients). All procedures were
performed using a semi-rigid 3.5-mm minihysteroscope with a 0° grade optic. Patients of each group were divided
into three subgroups according to their reproductive status: fertile nulliparous (FN), fertile multiparous (FM) and
post-menopausal (MEN) women. Women were asked to rate their degree of pain during four phases of the proce-
dure: introduction of hysteroscope (Group A) or speculum (Group B) into the vagina (Phase I) and progression
through cervical canal up to internal uterine orifice (IUO) (Phase II), inspection of uterine cavity (Phase III) and
performing of endometrial biopsy (Phase IV). A total pain score was calculated for each group. For each patient, the
duration of hysteroscopy was recorded from the introduction to the extraction of the scope (Group A) or of the
speculum (Group B). RESULTS: Although the median total pain scores were 2 in each group, the 95% confidence
interval for vaginoscopic hysteroscopy (1.86–2.01) was significantly (P < 0.05) lower than that for traditional hyster-
oscopy (2.10–2.26). Comparison between the corresponding phases of the procedure showed the only significant
difference during Phase I of the procedure [Group A: 1 (95% CI 1.0–1.18) versus Group B: 2 (95% CI 2.3–2.8);
P < 0.05]. No significant differences in terms of duration of the procedure were observed between the two
approaches. CONCLUSIONS: When surgeons using vaginoscopic hysteroscopy with a semi-rigid minihysteroscope
were compared with those using traditional approach and the same instrumentation, the operating times and the
patients’ pain scores were similar.
Key words: pain score/procedure time/traditional hysteroscopy/vaginoscopic hysteroscopy introduction
Introduction
Hysteroscopy can be regarded as the gold standard for the
evaluation of the uterine cavity and subsequent detection of
intrauterine pathology.
It is a safe and simple procedure and, if it can be carried out
successfully in an outpatient setting without anaesthesia, it
would be an attractive practice.
Notwithstanding, the international literature suggests that
outpatient hysteroscopy without any form of analgesia or
anaesthesia is a well-tolerated procedure with a high success
rate (Finikiotis, 1990; Nagele et al., 1996; Lau et al., 1999; De
Iaco et al., 2000; Kremer et al., 2000; Cameron et al., 2001;
Yang and Vollenhoven, 2002)—in general, it continues to be
considered an invasive and painful technique by most gynae-
cologists and patients.
Indeed, pain experienced during the procedure continues to
represent the most common reason for failure, and this can
occur even if local anaesthesia is used (Marana et al., 2001;
Yang and Vollenhoven, 2002; De Angelis et al., 2003; Sharma
et al., 2005).
Thus, pain continues to represent the main limiting factor to
a large-scale use of office hysteroscopy (Campo et al., 2005).
To minimize patient’s discomfort and maximize the chance
of success of the procedure and its widespread use, a new tech-
nique based on the employment of small-diameter rigid and
flexible hysteroscopes and an atraumatic insertion technique
(vaginoscopic approach) has been developed. This technique
has permitted complete elimination of any kind of premedica-
tion, analgesia or anaesthesia, making the procedure faster and
complication-free (Bettocchi and Selvaggi, 1997; Campo et al.,
1999; Cicinelli et al., 2003; Cicinelli, 2005).
Until now in all published studies, the vaginoscopic approach
has been performed with different-sized standard rigid hystero-
scopes (Bettocchi and Selvaggi, 1997; Paschopoulos et al.,
M.Guida et al.
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1997; Campo et al., 1999; Cicinelli et al., 2003; Pellicano
et al., 2003; Sharma et al., 2005).
In the recent years, a semi-rigid 3.5-mm fibre-optic minihys-
teroscope (Versascope, Gynecare, Ethicon) has been developed.
No studies comparing this semi-rigid hysteroscope with a stand-
ard rigid one of same size of pain score have been reported.
However, our clinical experience and the technical features of
semi-rigid hysteroscopes suggest that hysteroscopic procedures
performed with this instrument might offer a better compliance.
However, the flat tip of the scope and the standard 0° angle
of vision may interfere with cervical penetration and cavity
exploration (Cicinelli, 2005).
The aim of this prospective, randomized, controlled study
was to compare surgeons and hysteroscopic methods (vagino-
scopic and traditional approach), using this new semi-rigid
hysteroscope, to assess whether vaginoscopic approach is asso-
ciated with a lower pain score without any increase in proce-
dure time.
Materials and methods
The protocol of the study was approved by our Institutional Review
Board, and the study was conducted according to the guidelines of
the Declaration of Helsinki (1975). Patients’ flow chart is shown in
Figure 1.
From February 2003 to November 2004, all patients who were
referred to the Unit of Hysteroscopy of the Department of Obstetrics
were asked to participate in a study on two different approaches of
diagnostic hysteroscopy. Three hundred and eighty-five patients were
considered eligible for the study. Three hundred and twenty-two
patients accepted to participate, with 22 of these refusing the randomi-
zation process, thus leaving a population of 300 patients who were
included in this randomized trial (Figure 1).
Before entering the study, the purpose of the study was clearly
explained to women attending our Unit of Hysteroscopy, and a printed
explanatory consent form was signed and obtained by all subjects
enrolled.
Indications for hysteroscopy included abnormal uterine bleeding,
increased endometrial thickness at ultrasound, suspect of endometrial
polyp, myoma or carcinoma, endocervical polyp and repeated sponta-
neous abortion or unexplained infertility. The contraindications
were the presence of active infection of the genital tract, cervical can-
cer, heavy bleeding, severe cardiovascular disease and suspected
pregnancy.
The primary outcome measure was the median pain score. On the
basis of the existing literature (Sharma et al., 2005) and our prelimi-
nary results, a sample of 100 patients in each group would provide
90% power to detect a difference of 25% in the median pain score dur-
ing all phases of the procedure with significance level of 5%, assum-
ing a baseline value of 2 and given that the expected SD in the pain
scores would be 0.67 pain score units.
All patients were prospectively randomized and divided into two
groups consisting of 150 patients each. Randomization was achieved
with sealed envelopes containing computer-generated random num-
bers in blocks of 6.
Randomization and recruitment to the study were carried out
independently of the clinician who later performed the hysteroscopy.
Patients in Group A were subjected to vaginoscopic hysteroscopy,
whereas patients in Group B underwent traditional hysteroscopy for
scope introduction into the external uterine orifice (EUO).
Figure 1. Patients’ enrolment and randomized assignation.
Group A: Vaginoscopic hysteroscopy
(study group)
(150 patients)
Group B: Traditional hysteroscopy
(control group)
(150 patients)
Fertile
Nulliparous
(FN-A)
(32 pts)
(14 biopsies)
Fertile
Multiparous
(FM-A)
(65 pts)
(38 biopsies)
Postmenopausal
(MEN-A)
(53 pts)
(41 biopsies)
Fertile
Nulliparous
(FN-B)
(37 pts)
(12 biopsies)
Fertile
Multiparous
(FM-B)
(61 pts)
(42 biopsies)
Postmenopausal
(MEN-B)
(52 pts)
(39 biopsies)
300 enrolled patients
Computerized randomization
1 failed 
hysteroscopy
for severe
vaginal
prolapse
2 failed hysteroscopies
- cervical 
stenosis
- severe pain
29  successfully
performed
hysteroscopies
65 successfully
performed
hysteroscopies
2 failed hysteroscopies
- Retroverted  
uterus
- Severe 
vaginal 
prolapse
51 successfully 
performed 
hysteroscopies
Converted to traditional
approach
2 failed hysteroscopies 
for severe vaginism
1 failed hysteroscopy for 
cervical stenosis
34  successfully  
permormed 
hysteroscopies
1 failed 
hysteroscopy 
for bleeding
60 
successfully 
performed 
hysteroscopies  
1 failed 
hysteroscopy 
for severe
pain
51 
successfully 
performed 
hysteroscopies 
Converted to vaginoscopic 
approach
Both  successfully performed hysteroscopies
Both  successfully performed hysteroscopies
Converted to traditional
approach
Successfully performed hysteroscopy
385 eligible patients
85 refusing patients 
-  63 refusing to participate
-  22 refusing randomization
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Vaginoscopic technique
The technique avoids the need to introduce a speculum and a tenacu-
lum; the vagina, being a cavity, can be distended by introducing the
distension medium through the hysteroscope placed into the lower
vagina; the anatomy can then be followed by gentle movements of the
instrument towards the cervix and cervical canal.
Traditional technique
A speculum is inserted in the vagina to visualize the cervix, and a
tenaculum (if required) is applied to the anterior lip of uterine cervix
to create counter-traction and to facilitate the insertion of the optic.
Patients of each group were divided into three subgroups based on
their reproductive status: fertile nulliparous (FN), fertile multiparous
(FM) or post-menopausal (MEN). Patients from Group B were con-
sidered as control group.
Women were considered ‘fertile’ if they were in the period of their
life lasting from the menarche to the menopause.
Hysteroscopy was performed using a 3.5-mm minihysteroscope
(Versascope, Gynecare, Ethicon, Sommerville, NJ, USA) with a 0°
grade optic. Illumination was provided by a 250-W Xenon light
source. The images were viewed on a high-resolution colour monitor
using one-chip camera, and unusual lesions were recorded by video.
Normal saline was used for uterine distension and was instilled from a
flexible 500-ml bag wrapped in a pressure cuff connected to a
manometer and pumped up to 80–120 mmHg.
No pharmacological preparations or local anaesthetics were admin-
istered before the examination. Women in whom vaginoscopic
approach failed underwent traditional hysteroscopy; women in whom
traditional approach failed underwent vaginoscopic approach; and
women in whom both approaches failed were planned for hysteros-
copy under general anaesthesia.
The endometrial surface was inspected systematically, and the tubal
ostia were identified. The hysteroscope was then pulled back towards
the internal uterine orifice (IUO) to obtain a panoramic view of the
whole cavity.
If indicated, endometrial biopsy tissue was taken with the biopsy
forceps under direct visualization. When indicated, two or three biop-
sies for each patient were performed. The endocervical canal was
inspected during withdrawal of the hysteroscope.
All vaginoscopic hysteroscopies were performed by the most expe-
rienced operators (A.D.S.S., M.P. and S.B.) for vaginoscopic tech-
nique. Similarly, traditional hysteroscopies were performed by
operators with most experience on using this technique (G.A., M.G.
and R.P.).
Operative time was recorded from the introduction to the extraction
of the scope (Group A) or of the speculum (Group B).
Women were asked to rate their degree of pain during four phases
of the procedure: introduction of hysteroscope (Group A) or speculum
(Group B) in vagina (Phase I), progression through cervical canal up
to IUO (Phase II), inspection of uterine cavity (Phase III) and
performing of endometrial biopsy (Phase IV). A second operator
(G.B.), next to the patient, quizzed the patient during the procedure.
During the different phases of hysteroscopy, patients were asked to
record their degree of pain with a visual analogue scale (VAS).
Specifically, pain sensation was scored on a scale of 1 to 5, indicating
1 = no pain, 2 = slight pain, 3 = tolerable pain, 4 = severe pain and 5 =
intolerable pain (Guida et al., 2003).
A total pain score was calculated considering all the individual pain
score values in all phases of the procedure for each group.
Statistical analysis was performed using the SPSS 9.0 (SPSS,
Chicago, IL, USA).
The Shapiro–Wilk’s test was performed to evaluate data distribu-
tion of all variables. Age, weight, parity, uterine size and procedure
time showed a normal distribution, and differences between groups
were evaluated by two-tailed Student’s t-test for independent data.
Differences in pain score between the groups were calculated by
Mann–Whitney U-test. Statistical significance was set at P < 0.05.
Results
No significant differences in age, weight, uterine size and par-
ity between patients of Groups A and B (Table I) were
observed. Patients’ allocation and randomization are shown in
Figure 1.
No major adverse events were recorded during hysteroscop-
ies performed.
Hysteroscopy failed in five patients, and an additional five
patients had to undergo an alternate hysteroscopy to the one
they were assigned. These 10 patients were excluded from the
statistical analysis. For further details, please refer to Figure 1.
Directed biopsies were performed in 14 FN-A patients, 38
FM-A patients, 41 MEN-A patients, 12 FN-B, 42 FM-B and 39
MEN-B patients.
Data on pain score in Groups A and B are shown in Figure 2.
Primary analysis showed that although the median total pain
scores were two in both Groups A and B, the 95% confidence
interval for vaginoscopic hysteroscopy (1.86–2.01) was signif-
icantly (P < 0.05) lower than that for traditional hysteroscopy
(2.10–2.26).
The secondary analysis of corresponding phases showed a
significantly higher pain score during Phase I in Group B in
comparison with Group A [2 (2.3–2.8 95% CI) versus 1 (95%
CI 1.0–1.18), P < 0.05], whereas no significant differences
were detected during the Phases II, III and IV (median pain
score 2 in all phases of both groups) (Figure 2).
In subgroup analysis, we observed a trend to have lower pain
score values during Phase I in FN [1 (0.9–1.2 95% CI) versus 2
(1.7–2.9 95% CI)] and MEN women [1 (1.1–1.4 95% CI) versus
3 (2.1–2.6 95% CI)] undergoing vaginoscopic hysteroscopy.
The time required for the procedures is summarized in Table II.
Regardless of the hysteroscopic approach, the duration of the
procedure was significantly longer (P < 0.001) in patients who
underwent endometrial biopsy. However, no statistically sig-
nificant differences in procedure time were detected between
Groups A and B, irrespective of whether endometrial biopsies
were performed or not.
In subgroup analysis, we observed a trend of reduction in
time procedure in FN and MEN women undergoing vagino-
scopic approach, and in FM women undergoing traditional
approach.
Table I. Patient’s characteristics
All values are mean ± SD.
Characteristic Group A 
(vaginoscopy)
Group B 
(traditional)
Significance
Age (years)  43 ± 14.6  40 ± 15.6 Not significant
Weight (kg) 69.7 ± 14.8 72.2 ± 13.7 Not significant
Uterine size 
(hysterometry) (cm)
7.6 ± 2.1 7.9 ± 3.4 Not significant
Parity 1.5 ± 0.7 1.3 ± 0.8 Not significant
M.Guida et al.
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Discussion
Nowadays office hysteroscopy represents the gold standard tech-
nique for intrauterine diagnostic evaluation. The main limitation to
its widespread use is higher pain and lower patients’ compli-
ance in comparison with other less invasive diagnostic tools
(i.e. ultrasonography).
In recent years, the reduction of hysteroscope calibre, the
rare need for anaesthetics or analgesia and the introduction of
vaginoscopic technique have significantly improved patients’
compliance to hysteroscopy. Furthermore, according to several
authors (Campo et al., 1999; Cicinelli et al., 2003; Pellicano
et al., 2003), vaginoscopic approach for hysteroscopy avoids
the need for any premedication and renders the procedure
faster with a very low rate of complications.
The aim of this study was to compare surgeons and hystero-
scopic methods (vaginoscopic and traditional approach) using
a semi-rigid mini-hysteroscope to verify whether vaginoscopic
approach is associated with better compliance without expan-
sion of the procedure time.
A serious limitation to this study was that the two hystero-
scopic techniques were performed by different operators.
This was because vaginoscopic approach is a relatively recent
technique; therefore, it was not possible to select an operator
with identical skills in the two techniques at our institute.
Three operators with the highest skill were selected for carry-
ing out the vaginoscopic technique. The skill level was based
on the number of hysteroscopies performed, years of place-
ment at the hysteroscopic unit and the frequency of visits to
foreign centres in which vaginoscopy was routinely per-
formed. Similarly, three operators deemed to have the highest
skill in the traditional technique were also selected. This
Figure 2. Pain score distribution in Groups A and B. The number of patients for each phase (left side) and median pain score with 95% confid-
ence interval (right side) are shown in each graphic. Group A, vaginoscopic group and Group B, traditional group. Phase I: introduction of hyster-
oscope (Group A) or speculum (Group B) in vagina; Phase II, progression through cervical canal up to internal uterine orifice; Phase III,
inspection of uterine cavity and Phase IV, performing of endometrial biopsy. Pain sensation was scored on a rank scale ranging from 1 to 5, indi-
cating 1 = no pain, 2 = slight pain, 3 = tolerable pain, 4 = severe pain and 5 = intolerable pain. *P < 0.05 versus Group B.
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Table II. Duration of procedure
Group A, vaginoscopic approach; Group B, traditional approach; FN, fertile 
nulliparous women; FM, fertile multiparous women; MEN, post-menopausal 
women.
*P < 0.001 versus A + B without biopsy.
Groups Number of 
patients
Procedure 
time ± SD (s)
A 145 273.29 ± 68.87
B 145 269.11 ± 62.48
A without biopsy 54 215.08 ± 57.82
B without biopsy 55 214.56 ± 46.14
A with biopsy 91 308.97 ± 49.86
B with biopsy 90 302.55 ± 45.31
A + B with biopsy 181 305.75 ± 47.62*
A + B without biopsy 109 214.83 ± 52.08
FN-A with biopsy 13 291.70 ± 33.20
FM-A with biopsy 38 322.10 ± 54.11
MEN-A with biopsy 40 302.40 ± 48.02
FN-B with biopsy 11 317.68 ± 45.80
FM-B with biopsy 41 281.08 ± 38.80
MEN-B with biopsy 38 322.21 ± 41.28
FN-A without biopsy 16 199.20 ± 42.0
FM-A without biopsy 27 233.25 ± 58.02
MEN-A without biopsy 11 199.85 ± 69.20
FN-B without biopsy 23 221.68 ± 45.20
FM-B without biopsy 19 193.04 ± 46.21
MEN-B without biopsy 13 231.25 ± 38.24
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ensured that the bias related to inter-operator differences was
at its lowest level possible.
Data obtained showed that even if the median total pain
scores were similar in both groups, the 95% confidence inter-
val for the vaginoscopic group was significantly lower than
that for the traditional group.
However, this difference, although statistically significant, was
not clinically important. Indeed, as the mid-points of the 95% con-
fidence interval ranges are 1.94 for vaginoscopic hysteroscopy
and 2.18 for traditional hysteroscopy, that 0.24 difference between
the two groups accounts for just over 4% of the range in the pain
score from 1 to 5 and therefore cannot be clinically important.
In subgroup analysis, we observed a trend to have lower pain
score values during Phase I in FN and MEN women undergo-
ing vaginoscopic hysteroscopy, a finding that may be worth
testing in a subsequent larger randomized controlled trial.
These data could be particularly relevant considering that
patients undergoing hysteroscopy are often very anxious; so
lowering the pain sensation in Phase I of this procedure could
contribute to a better performance mainly in those patients
(nulliparous and old women.) who might otherwise require
local or general anaesthesia (Bettocchi and Selvaggi, 1997).
No significant differences of duration of procedure were
detected between the two hysteroscopic approaches.
In subgroup analysis, we observed a trend of reduction in
time procedure in FN and MEN women undergoing vagino-
scopic approach and in FM women undergoing traditional
approach. These data might be tested in a subsequent larger
randomized controlled trial.
These data are in disagreement with those of other authors
(Sharma et al., 2005), who have recently demonstrated that
vaginoscopic hysteroscopy with either a 2.9-mm or a 4-mm 30°
scope is significantly quicker to perform than the traditional
technique independent of the reproductive status of patients.
However, our data can be explained by the fact that the use
of a 0° hysteroscope that lacks foreblique viewing makes it
more difficult and subsequently longer for the operator to
detect and to get through the OUE, especially in cases of very
anteverted or retroverted uteri.
In conclusion, our data demonstrate that when surgeons
using vaginoscopic hysteroscopy with a semi-rigid minihyster-
oscope were compared with those using traditional approach
and same instrumentation, the operating times and the patients’
pain scores were similar. Further studies comparing rigid and
semi-rigid hysteroscopes with vaginoscopic approach are
needed to better evaluate the real impact of vaginoscopic approach
on patients’ compliance.
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CHAPTER IV 
 
TRADITIONAL TECHNIQUES OF “SEE AND TREAT” 
HYSTEROSCOPY ( 1995- 2006) 
 
With ongoing developments in the field of hysteroscopy during the last fifteen years, 
hysteroscopic surgery is becoming safer and less invasive for the patient. Improved 
technology has enabled us to perform many operative procedures in an office setting 
without significant patient discomfort and with potentially significant cost savings.  
31 
 
starts from the myometrium out, while the endometrium and 
? ENDOMETRIAL BIOPSY 
he standard technique of biopsy traditionally used 
is defined as a “punch” biopsy
ll diameter of the operative 
jaws of the forceps, whi
The rationale assuring that most of these procedures 
can be performed easily without use of analgesia or 
anaesthesia lies in the anatomical characteristics of the 
uterus; indeed, the sensitive innervations of the uterus (Fig.1) 
any fibrotic tissue present are not sensitive.  
 
Fig.1 
 
T
 (Fig.2), where the biopsy 
forceps bite into the endometrium, and are then closed. 
The mucosa remains inside the jaws and partially around 
them. The instrument is then extracted through the 
operative channel while the hysteroscope remains inside 
the uterine cavity. However, 
during the process of extracting 
the instrument, due to the sma
channel, the surrounding material is shaved away from around 
the tip (Fig.3). Thus the final amount of tissue to be sent to the 
pathologist is strictly related to the internal volume of the two 
ch very often results in an inadequate amount of tissue for 
histological diagnosis. 
Fig.2 
Fig.3 
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increased volume for 
endometrium is atrophic and an 
atypica
In order to routinely collect enough 
endometrium for a correct histological 
examination, Bettocchi modified such technique 
by proposing  the so-called “grasp biopsy” (Fig.4). 
The biopsy forceps are placed with the jaws open, 
against the endometrium to be biopsed; they are 
then pushed into the tissue and along it for around 
0.5-1cm, avoiding contact with the muscle fibers. 
Once a large portion of mucosa has been 
detached, the two jaws are closed and the whole hysteroscope is removed from the 
uterine cavity, without pulling the tip of the instrument back into the channel. In this way, 
not only the tissue inside the forceps jaws but also the surrounding tissue protruding 
outside the jaws can be retrieved, thus providing the pathologist with a large amount of 
tissue. Even in patients with endometrial carcinoma, this surgical technique makes it 
possible to collect enough endometrium (also including its deeper layers) for a correct 
histological examination (A. Di Spiezio Sardo, M. Guida, G. Bifulco, M. Borriello, C. 
Nappi. Could office endometrial biopsy be accurate as EBHR for assessing the 
preoperative tumor grade? Eur J Surg Oncol. 2007;33(8):1047-8.)  
7Fr instruments 
has the notable 
advantage of a wider 
opening and an 
collected tissue 
(Fig.5). Among 5Fr instruments, the grasping forceps 
with teeth (even called “crocodile” forceps) (Fig.6) are 
preferred to spoon biopsy ones as they can collect a 
larger amount of tissue thanks to the double length of 
the two jaws and the presence of small teeth on both 
sides of the jaws to keep hold of the material obtained. 
When the 
l area needs to be biopsied, bipolar electrodes 
Fig.4 
Fig. 6 
Fig.5 
Fig.7 
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entified and 
artially cut, allowing grasping forceps with teeth to remove the atypical area. 
? POLIPECTOMY 
 forceps (Fig.8), 
primar
ently push toward the 
 
of the 
ion between polyp 
and in
(
ent of the polyp 
from i
might be used (Fig.7). The technique consists of drawing with the electrode a sort of 
square surrounding the target area; the sub-myometrial tissue is then id
p
 
  
Small endometrial and cervical polyps 
(< 0.5 cm) are preferably removed using 5Fr 
or 7Fr mechanical instruments such as sharp 
scissors and/or grasping
ily for cost reasons.  
For endometrial polyps the technique 
consists of grasping its base with open jaws, 
to close them and to g
uterine fun
Cervical polyps, however, have to be treated 
with sharp scissors because of their fibrotic base, 
which precludes the use of grasping forceps, which 
could leave some well-vascularized tissue (the base
Fig.8 
dus( Fig. 9)  
polyp) that can result in regrowth of the polyp. 
Larger endometrial polyps require different 
techniques, according to the relat
ternal uterine ostium sizes.  
The polyps could be removed intact only if the internal uterine ostium is wide 
enough for their extraction. The base of the polyp might be cut with scissors or better by 
Fig. 10). An alternative is presented by adopting the 
same technique used for smaller polyps, repeating 
it several times up to the detachm
Fig.9 
using a Versapoint twizzle electrode 
ts base in the myometrium.  
When the endometrial polyp has a larger 
size than the internal uterine ostium it cannot be 
removed intact otherwise its extraction might 
represent an arduous and lengthy process with low 
patient’s satisfaction. These polyps have to be Fig. 10 
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through the uterine cavity using 5 Fr crocodile 
Fig.11)   
de can be bent by 25-30°, enough to 
obtain
polyps (> 0.5cm) usually require the Versapoint twizzle electrode to cut their fibrotic base.  
? MYOMECTOMY 
 a comprehensive review of surgical techniques. Hum 
Repro
sliced with the Versapoint twizzle electrode from the free edge to the base into two/three 
fragments, large enough to be pulled out 
forceps or 7 Fr grasping forceps(
To remove the entire base of the polyp 
without going too deep in the myometrium, in some 
case the electro
 a hook electrode. 
The bending of the electrode may be obtained 
by pushing it against the cervix or by the operator’s 
finger and then introducing the hysteroscope in the 
uterine cavity with the electrode’s tip just outside the operating channel. Large cervical 
Fig.11 
 
 
A technique similar to polypectomy is applied on totally intracavitary myomas (< 
1.5cm) with the difference that, due to their higher tissu
two half-spheres and then each of these is sliced 
(Fig.12) as described for polyps. Particular attention 
has to be paid in case of partially intramural myomas. 
To avoid any myometrial stimulation or damage of the 
surrounding healthy myometrium, the myoma is first 
gently separated from the pseudo-capsule using 
mechanical instruments (grasping forceps or scissor) 
or the bipolar electrode in a mechanical way, as already described for “cold loop” 
resectoscopic myomectomy .  Once the intramural section becomes intracavitary, it is  
then sliced with the Versapoint Twizzle electrode. Recently, this surgical techniques have 
been amply described by Attilio Di Spiezio Sardo and coll in a late review. (A. Di Spiezio 
Sardo, I. Mazzon, S. Bramante, S. Bettocchi, G. Bifulco, M. Guida, C. Nappi 
Hysteroscopic myomectomy:
e density, they are first divided into 
Fig.12 
d Update, 2007: 1–19). 
Besides, Bettocchi, Attilio Di Spiezio Sardo and coll, have recently provided several 
evidences suggesting that submucous myomas should be always treated, independently 
on the presence of associated symptomatology. (S. Bettocchi, C. Siristatidis, G. 
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ucous myomas in women of reproductive age? Fertil Steril 
007; 90(4): 905-910) 
? METROPLASTY 
and bicornuate uteri. JMIG 2007; 14: 324–328; Letter 
to the editor. JMIG 2008; 15(1): 125-6) have identified 
? INTRAUTERINE ADHESIOLYSIS 
trauterine adhesions, particularly those that are focal and thin can be easily 
divided
 
Pontrelli, A. Di Spiezio Sardo, O. Ceci, L. Selvaggi. The destiny of myomas: should 
we treat small subm
2
 
 
Recently Bettocchi and his colleagues (S. 
Bettocchi, O. Ceci, L. Nappi, G. Pontrelli, L. Pinto, M. 
Vicino. Office hysteroscopic metroplasty: Three 
“diagnostic criteria” to differentiate between septate 
three diagnostic criteria to make a differential diagnosis 
between bicornuate and septate uterus allowing a safe and effective office metroplasty 
without prior assessment of the true anatomy of the uterus. Such distinction (Fig.14) arises 
from the observation that the uterine septum, due to its fibrotic nature, is whitish, with no 
vessels and no sensitive innervations, while the wall of a bicornuate uterus, due to its 
muscle fibers, is pinkish, rich with vessels and with sensitive nerve terminals. Thus, when 
a double uterine cavity is diagnosed at hysteroscopy, the resection of the supposed 
septum should be started in its middle portion by means of sharp scissors or Versapoint 
twizzle electrode (mostly if bent!) and continued until the three septate uterus diagnostic 
criteria are present. On the contrary, the resection should be discontinued when at least 
two of the bicornuate uterus diagnostic criteria become evident.  
 
Fig.13 
 
In
 in the middle with sharp hysteroscopic scissors. Whether diffuse or firm, the 
Versapoint twizzle electrode may be a valuable tool. 
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 CERVICAL ADHESIOLYSIS 
ibrotic processes may involve the external cervical ostium as well as the internal 
uterine
rformed at a 
Teach
The fibrotic ring may be cut at two or three point by 
te between septate and 
avoiding the 
false passage. The section of se
?
 
F
 ostium, thus resulting in a reduction of the cervical canal’s diameter.  
Indeed, in a recent revision of 5000 ambulatory hysteroscopies, pe
ing Hospital Base, the authors demonstrated that cervical stenosis represents one of 
the principle causes of failed hysteroscopies (A. Di Spiezio Sardo, A. Taylor, P. Tsirkas, 
G. Mastrogamvrakis, M. Sharma, A. Magos.  Hysteroscopy: a technique for all? 
Analysis of 5.000 outpatient hysteroscopies. Fertil Steril 2008; 89(2):438-43) The 
knowledge of the available techniques to treat such stenosis represents the pre-requisite 
to reduce the number of failed hysteroscopies. No sensitive nerve terminals or blood 
vessels have been demonstrated on the white fibrous tissue, thus allowing the use of 5-Fr 
or 7-Fr mechanical instruments. 
using sharp scissors or may be stretched by grasping 
forceps first inserted within it with the jaws closed and 
then gently opened. (Fig. 15) 
The criteria used to differentia
bicornuate uterus may help the operator to distinguish 
between fibrotic tissue and muscle and mucosa, thus 
possibility to create a 
vere stenosis of the 
external cervical ostium may be also performed by means 
of a radial incision with the Versapoint Twizzle electrode.  
This technique allows to increase or even, in some cases, 
to create a point of access to the cervical canal.( Fig.16) 
 
 
Fig.15 
Fig.16 
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? HYSTEROSCOPIC STERILIZATION 
ly used 
method of hysteroscopic sterilization is the 
Essure
reducing the risks arising from general or lo
 
Currently, one of the most wide
 (Fig.17) system, that involves placement 
of a foreign object in the horns of the uterus, 
which stimulates scar tissue formation, and 
ultimately, a mechanical occlusion. There is then 
no way for the egg and the sperm to meet. 
Recent reports have shown the possibility to 
perform such procedure in an office setting, 
effectiveness. 
 
cal  anaesthesia, and increasing its cost-
Fig.17 
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EJSO xx (2007) 1e2 www.ejso.comCould office endometrial biopsy be accurate as EBHR
for assessing the preoperative tumor grade?
Sir,
First of all, we would like to congratulate Cutillo and his
co-workers as they have tried to throw light on the role of
hysteroscopy in the pre-operative work-up of endometrial
cancer.1
According to their data, endometrial biopsy by means of
the hysteroscopic resectoscope seems to be a ‘‘very accu-
rate diagnostic procedure for assessing the preoperative
tumor grade in patients with endometrial carcinoma’’
with a concordance with definitive pathologic examination
of nearly 97%. Indeed the hysteroscopy resectoscope
makes it possible to perform multiple, eye-mirated, 5-mm
thick cancer biopsies, thus offering the pathologist ‘‘a
surgical specimen which is highly representative of
endometrial tumor’’.
However a serious consideration arises from their
study. As it emerges from their Materials and methods
section, patients undergoing EBHR had been previously
diagnosed with an early-stage endometrioid adenocarci-
noma. In other words, it means that they had already un-
dergone an endometrial assessment by the means of blind
office endometrial biopsy or target office hysteroscopic bi-
opsy or, at worst, by means of dilatation and curettage
(D&C) under local or general anesthesia. Taking into ac-
count that all the patients then underwent first an EBHR
under general anesthesia and second a definitive laparo-
tomic surgery (with a median interval range between the
two procedures of 10 days!), it results that every patient
was subjected to three invasive procedures in a short
time with at least two of them under general anesthesia!
Furthermore we should consider that most patients with
endometrial carcinoma are in old age and the risks of two
general anesthetics in a short time should not be
underestimated.
As the main advantage of EBHR is to offer the patholo-
gist an adequate specimen we propose to reach the same
objective with a less invasive procedure and in an outpatient
setting.2
DOI of original article: 10.1016/j.ejso.2006.11.020.0748-7983/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ejso.2007.01.019
Please cite this article in press as: Bettocchi S et al., Could office endometrial b
J Surg Oncol (2007), doi:10.1016/j.ejso.2007.01.019To collect enough endometrium (also including its
deeper layers) for a correct histological examination, we
perform the so-called ‘‘grasp biopsy’’ by means of 5Fr
grasping forceps inserted through the operative channel
of a 4 mm continuous-flow operative office hysteroscope
with a 2.0 mm rod lens (Bettocchi office hysteroscope
‘‘size 4’’, Karl Storz, Tuttlingen, Germany). The grasping
forceps are placed, with the jaws open, against the endo-
metrium to be biopsed; then they are pushed into the tis-
sue and along it for around 0.5e1 cm, avoiding touching
the muscle fibers. Once a large portion of mucosa has
been detached, the two jaws are closed and the whole hys-
teroscope is pulled out of the uterine cavity, without pull-
ing the tip of the instrument back into the channel. In this
way, not only the tissue inside the forceps jaws but also
the surrounding tissue protruding outside the jaws can
be retrieved, thus providing the pathologist with a large
amount of tissue. Furthermore if the two jaws are placed
profoundly in the endometrium to be biopsed, we should
be sure to collect its deeper layers with a higher possibil-
ity that endometrial stroma tissue could also be repre-
sented in the biopsy specimen.
Furthermore if we are not satisfied with the endome-
trium collected with the ‘‘grasp biopsy’’ we perform
wide biopsies of endocavitary lesions by means of 5Fr
bipolar Twizzle electrodes inserted through the operative
channel of the hysteroscope. These electrodes are con-
nected via a flexible cable with a versatile electrosurgical
system dedicated to hysteroscopy (Versapoint Bipolar
Electrosurgical System, Gynecare, Ethicon Inc., NJ,
USA).
We have already demonstrated that lowering the power
of the generator to the mildest level and reducing the
power setting by half (50 W), with the Twizzle electrode
it is possible to produce minimal dissection of the tissue
(resembling a precise ‘‘cut’’), with minimal generation of
bubbles obscuring the visual field, and with high patient
tolerance.3
In conclusion we agree with Cutillo and his co-workers
regarding the need to further test the EBHR ‘‘for the eval-
uation of tumor grade and histotype’’, but we propose a ran-
domized clinical trial comparing such technique not with
D&C, but with standardized office hysteroscopic biopsy
(‘‘grasp biopsy’’ plus bipolar electrodes).iopsy be accurate as EBHR for assessing the preoperative tumor grade?, Eur
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Hysteroscopic myomectomy: a comprehensive
review of surgical techniques
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Hysteroscopic myomectomy currently represents the standard minimally invasive surgical procedure for treating
submucous fibroids, with abnormal uterine bleeding and reproductive issues being the most common indications.
While hysteroscopic myomectomy has been shown to be safe and effective in the control of menstrual disorders,
its effects on infertility remain unclear. The review provides a comprehensive survey of all hysteroscopic techniques
used to treat fibroids found completely within the uterine cavity (G0) and those with intramural development
(G1 and G2). MEDLINE and EMBASE searches identified published papers from 1970. The choice of the technique
mostly depends on the intramural extension of the fibroid, as well as on personal experience and available
equipment. ‘Resectoscopic slicing’ still represents the ‘gold standard’ technique for treating fibroids G0, even if
several other effective techniques including ablation by neodymium-yttrium-aluminum-garnet laser, morcellation
and office myomectomy have been proposed. On the other hand, the present review clearly indicates that there is
still no single technique proven to be unequivocally superior for treating fibroids G1 and G2. Most techniques aim
at the transformation of an intramural fibroid into a totally intracavitary lesion, thus avoiding a deep cut into
the myometrium. At present, the ‘cold loop’ technique seems to represent the best option as it allows a safe and
complete removal of such fibroids in just one surgical procedure, while respecting the surrounding healthy
myometrium.
Keywords: hysteroscopic myomectomy; fibroids; menstrual disorders; infertility; complications.
Introduction
Uterine fibroids (also known as myomas or leiomyomas) are the
most common benign solid tumours found in the female genital
tract. They occur in 20–25% of women of reproductive
age (Fernandez et al., 2001; Valle and Baggish, 2007) causing
3–5% of gynaecology consultations (Vidal, 1998).
Uterine leiomyomas arise from the muscular part of the uterus.
As they grow, they usually migrate to a place of lower resistance:
towards the abdominal cavity, thus becoming subserous masses
or following the path of the intrauterine cavity thus becoming sub-
mucous fibroids (5–10% of uterine fibroids) (Ubaldi et al., 1995).
Localization of uterine fibroids seems to be an important factor
in determining frequency and severity of symptomatology. Indeed,
submucous fibroids may induce severe clinical symptoms such as
excessive bleeding, usually during menses, colicky dysmenor-
rhoea (as the uterus tries, by means of contractions, to expel
fibroids), and are thought to predispose patients to reproductive
failure (Fernandez et al., 2001; Litta et al., 2003; Takeda et al.,
2004; Indman, 2006; Sutton, 2006; Valle and Buggish, 2007). Fur-
thermore, submucous fibroids are associated with chronic endome-
tritis, they may have a greater risk for malignant change (Valle and
Buggish, 2007) and are source of pre-term delivery, abnormal
presentation, post-partum haemorrhage and puerperal infections
(Bernard et al., 2000).
Most submucous fibroids occur at the corporeal sites of the
uterine cavity. Some are fundal, others are anteriorly, posteriorly
or laterally situated. Small fibroids may also arise from the
cornual regions, thus interfering with the utero–tubal junction
lumen. A few are located at the cervical canal (Valle and
Buggish, 2007).
Hysterectomy and laparotomic excision have long been con-
sidered the two standard routes of surgical treatment for sympto-
matic submucous fibroids (Garcia and Tureck, 1984; Smith and
Uhlir, 1990; Verkauf, 1992, Sudik et al., 1996; Glasser, 1997;
Haney, 2000; Munoz et al., 2003; Campo et al., 2005).
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In particular, hysterectomy has been routinely proposed to those
patients in whom the desire to procreate had been satisfied, while
the abdominal myomectomy has represented the only possible sol-
ution in young patients desiring a pregnancy.
However, the conservative approach requires the opening of the
uterine cavity, which may be one of the factors responsible for
altering the likelihood of subsequent conception (Berkeley et al.,
1983). Furthermore, such an approach may compromise any
future parturition as it requires caesarean section; in addition, it
may lead to the development of pelvic post-operative adhesions
which may further reduce rather than enhance fertility (Buttram
and Reiter, 1981; Starks, 1988; Ubaldi et al., 1995).
The development of hysteroscopic techniques
The development of endoscopy has made these fibroids accessible
and resectable from the inner surface of uterus (Walker and
Stewart, 2005; Bradley, 2005).
At the beginnings of endoscopic surgery, the lesions were
removed by somewhat rugged methods (e.g. ovum forceps were
used to twist pedunculated fibroids off their pedicles and scissors
were inserted outside the hysteroscopic sheath to cut the fibroid
pedicle).
The first reported hysteroscopy myomectomy was performed in
1976, when Neuwirth and Amin resected a fibroid using an urolo-
gic resectoscope, monopolar current and 32% dextran 70 as disten-
sion medium.
In 1987, Hallez (1995) reported on the development of a gynae-
cologic resectoscope, changing the urologic instrument into a
continuous-flow device with a 08 optic; cutting current was used
but with 1.5% glycine as the distension medium.
During the last 20 years, thanks to advances in instruments and
the refining of techniques, hysteroscopic myomectomy has
acquired the status of ‘surgical technique’ and, at present it rep-
resents the standard minimally invasive surgical procedure for
treating fibroids entirely or mostly located within the uterine
cavity (Vercellini et al., 1999; Takeda et al., 2004).
Indications for hysteroscopic myomectomy
Abnormal uterine bleeding (AUB) represents the most common
indication for hysteroscopic myomectomy in most publications
reviewed with a percentage ranging from 60 to 84.1% (Neuwirth
and Amin, 1976; Brooks et al., 1989; Derman et al., 1991;
Indmann, 1993; Wamsteker et al., 1993; Donnez et al., 1994;
Wortman and Dagget, 1995; Hallez, 1995; Phillips et al.,
1995; Glasser, 1997; Emanuel et al., 1999; Hart et al., 1999; Ver-
cellini et al., 1999; Munoz et al., 2003; Loffer, 2005; Campo et al.,
2005; Marziani et al., 2005; Polena et al., 2007). Indeed, submu-
cous fibroids have been advocated more than subserous and intra-
mural ones as a cause of AUB, presumably due to distortion of the
cavity and to an increase in the bleeding surface of the endome-
trium (Maher, 2003).
Although most women affected with fibroids are fertile, avail-
able evidence suggests that fibroids may interfere with fertility,
with submucousal fibroids being reported to exert the most detri-
mental effects on pregnancy rates (Pritts, 2001; Donnez and
Jadoul, 2002; Benecke et al., 2005; Somigliana et al., 2007).
Even though this association is not supported by a clear biologi-
cal rationale, several hypotheses have been suggested to explain
how submucous fibroids may cause infertility or repeated abor-
tions. However, at present, none of these hypotheses is definitive
(Somigliana et al., 2007).
Fibroids might interfere with sperm migration, ovum transport
or embryo implantation; these effects might be mediated by altera-
tion of uterine cavity contour causing mechanical pressure or by
the occurrence of abnormal uterine contractility (Buttram and
Reiter, 1981; Richards et al., 1998; Bettocchi et al., 2002; Farrugia
et al., 2002; Oliveira et al., 2004). Fibroids may also be associated
with implantation failure or gestation termination due to focal
endometrial vascular disturbances, endometrial inflammation,
secretion of vasoactive substances or an enhanced endometrial
androgen environment (Buttram and Reiter, 1981; Cicinelli
et al., 1995; Richards et al., 1998; Ng and Ho, 2002).
Reproductive problems represent the second leading indication
for intervention, though the lack of randomized studies does not
allow any definitive conclusion to be drawn regarding the
improvement of spontaneous fertility after hysteroscopic myo-
mectomy (Donnez and Jadoul, 2002; Somigliana et al., 2007; Sta-
matellos and Bontis, 2007).
Less frequent reported indications include dysmenorrhea
(Hallez, 1995), aspecific pelvic pain (Munoz et al., 2003) and
asymptomatic submucous fibroid in a woman candidate to start
hormone replacement therapy (Hallez, 1995).
With the present review, we offer gynaecologists with special
interest in endoscopy information regarding the instrumentation
required to perform hysteroscopic myomectomy and the diagnos-
tic tools and medications commonly used for an appropriate pre-
surgical evaluation. Furthermore, it provides a comprehensive
survey of all techniques used to treat fibroids completely within
the uterine cavity as well as those with intramural development.
Finally, the effects on menstrual pattern and infertility and the
operative and long- term complications have been reviewed.
Materials and Methods
This review includes medical papers published in the English
language on hysteroscopic myomectomy since 1970 and identified
through a MEDLINE and EMBASE search using combinations of
medical subject heading terms: hysteroscopy, myomectomy, pharma-
cological agents, gynaecological surgery, surgical technique, fibroid,
fibroid, loop, laparoscopy and resectoscope. All pertinent articles
were retrieved and reports were then selected through systematic
review of all references. In addition, books and monographs of differ-
ent languages on hysteroscopy and gynaecological surgery were
consulted.
Pre-surgical evaluation of submucous fibroids
As hysteroscopic myomectomy may be sometimes a highly
complex procedure, its real feasibility must be thoroughly evalu-
ated preoperatively in order to minimize the incidence of incom-
plete resection and the complications that might occur during
procedure.
The most widespread investigative techniques for pre-surgical
evaluation are office hysteroscopy, transvaginal ultrasound scan-
ning (TVS) and sonohysterography (SHG) (Fedele et al., 1991;
Fukuda et al., 1993; Dodson, 1994; Cicinelli et al., 1995;
Corson, 1995; Tulandi, 1996; Laifer-Narin, 1999; Perez-Medina
Di Spiezio Sardo et al.
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et al., 2000; Cheng and Lin, 2002; Clark et al., 2002; Leone et al.,
2003, 2007; Trew, 2004; Lasmar et al., 2005; Murakami
et al., 2005; Salim et al., 2005; Vilos and Abu-Rafea, 2005;
Sutton, 2006; Alborzi et al., 2007).
Besides giving us the certainty of the presence of the submucous
fibroid, office hysteroscopy also enables the assessment of the
intracavity component of the mass, its localization, its relationship
with the uterine structures, the characteristics of the endometrium
as well as the presence of possible associated intracavitary
pathologies. Furthermore, it provides subjective assessment of
fibroid size and indirect information regarding the depth of myo-
metrial extension (Fedele et al., 1991; Corson, 1995; Emanuel
and Wamsteker, 1997; Emanuel et al., 1997, 1999; Wieser
et al., 2001; Clark et al., 2002; Murakami et al., 2005; Lasmar
et al., 2005; Sutton, 2006).
However, even if a protruding dome of fibroid is identified at
outpatient hysteroscopy, there is the possibility that it could sink
into the myometrium (‘sinking fibroid’) during a hysteroresecto-
scopic procedure because of an increase in intrauterine pressure
caused by the distension medium (Lin et al., 2000; Murakami
et al., 2005).
TVS is not as useful as hysteroscopy in assessing the degree of
intracavitary development of the fibroid. However, it is irreplace-
able in the preoperative assessment as it provides two elements
which would be otherwise unobtainable: the ‘myometrial free
margin’ (thickness of the outer myometrial layer of the fibroid)
as well as the presence of any other possibly associated pathology.
For a submucous fibroid to be approached hysteroscopically, the
‘myometrial free margin’ should be at least 1 cm thick or in
more expert hands at least a few millimetres thick. Scanning evi-
dence of other associated pathologies (multiple fibroid, adnexial
pathologies) may indicate the need for a different surgical
approach. Furthermore, ultrasound scanning allows to evaluate
the real size of the nodule (Lasmar et al., 2005; Murakami
et al., 2005; Sutton, 2006).
SHG has been demonstrated to be superior to TVS in terms of
diagnostic accuracy; furthermore, it allows to identify the exact
location of the fibroid as well as the portion protruding into the
cavity (Fukuda et al., 1993: Cicinelli et al., 1995; Farquhar
et al., 2003; Leone et al., 2003, 2007; Salim et al., 2005; Botsis
et al., 2006; Alborzi et al., 2007). Although many authors report
that SHG could reduce the number of diagnostic hysteroscopies
for pre-surgical evaluation (Turner et al., 1995; Bronz et al.,
1997; Saidi et al., 1997; Williams and Marshburn, 1998;
Bonnamy et al., 2002; Leone et al., 2003, 2007), this technique
is limited by the inability or difficulty in obtaining tissue diagnosis
(Botsis et al., 2006).
In case of a large uterus, with multiple fibroids, or if ultrasound
scanning is technically difficult (i.e. obese patients), magnetic
resonance imaging (MRI) can provide valuable information,
being also helpful in differentiating between fibroids and adeno-
myosis (Hricak et al., 1986; Takeda et al., 2004; Lasmar et al.,
2005; Murakami et al., 2005; Indman, 2006). Costs have
prohibited its general use in clinical practice (Valle and
Buggish, 2007).
Recently, Takeda et al. (2004) have proposed the use of ‘virtual
hysteroscopy’ for preoperative evaluation of submucosal fibroids.
Virtual endoscopy is a non-invasive technology used to display the
image of the cavity inside the organ by processing the images
acquired by a multislice helical computed tomography (CT)
scanner using 3D computer graphics (3DCG) software as if one
is observing the organ by real endoscopy.
Hysteroscopic classification of submucous fibroids
As the intramural extension of submucous fibroids may consider-
ably vary, thus influencing the chance of achieving complete
resection, a classification of different types of submucous fibroids
was shown to be indispensable since the beginning of resecto-
scopic surgery for weighting the limits of surgical technique.
The classification developed by Wamsteker et al. (1993) and
adopted by the European Society for Gynaecological Endoscopy
(ESGE), which considers only the degree of myometrial pen-
etration of the submucous fibroid, is currently worldwide used.
According to this classification, a fibroid G0 is completely
within the uterine cavity and appears only jointed to the cavity
wall by a thin pedicle; a fibroid G1 has its larger part (.50%)
in the uterine cavity; and a fibroid G2 has its larger part
(.50%) in the myometrium (Wamsteker et al., 1993; Salim
et al., 2005).
Lasmar et al. (2005) recently proposed a new preoperative
classification of submucous fibroids which considers not only
the degree of penetration of the fibroid into the myometrium,
but also other parameters including the extension of the base of
fibroid with respect to the wall of the uterus, the size of the
nodule (cm) and the topography of the uterine cavity. A score
ranging from 0 to 2 is given for each parameter and the patients
are then allocated into one of the three groups of the classification
on the basis of the total score (Table I). The authors found a higher
correlation of this new scoring system with completeness of the
myomectomy, time spent in surgery and fluid deficit, than
scoring only based on the percentage of myometrial penetration
(Lasmar et al., 2005).
Preoperative hormonal treatment
Whether treatment with GnRH agonist before myomectomy offers
any significant advantage is still a matter of debate (Lethaby et al.,
2001, 2002). However, a recent review by Gutmann and Corson
(2005) reports that ‘the most clinically relevant indication for pre-
operative GnRH agonist use appears to be in patients with submu-
cous fibroids’.
Table I: Lasmar’s pre-surgical classification of submucous myomas
Points Penetration Size, cm Basea Third Lateral
wall (þ1)
0 0 2 1/3 Lower
1 50% .2–5 .1/3 to
2/3
Middle
2 .50% .5 .2/3 Upper
Score þ þ þ þ ¼
aIt refers to the extension of the base of the nodule with respect to the
uterine wall on which the myoma is located. Score 0–4 (Group I): low
complexity hysteroscopic myomectomy. Score 5–6 (Group II): complex
hysteroscopic myomectomy, consider preparing with GnRH analogue and/or
two stage surgery. Score 7–9 (Group III): recommend an alternative
non-hysteroscopic technique.
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Benefits claimed include the following:
(i) resolution of preoperative anaemia: these drugs create a
state of amenorrhea, thus enabling patients suffering
from menorrhagia to build up their blood counts and redu-
cing the need for transfusion (Donnez et al., 1989, 1992,
1993; Isaacson, 2003)
(ii) reduction of endometrial thickness as well as the size and
vascularization of fibroids (Donnez et al., 1989, 1992,
1993; Mencaglia and Tantini, 1993). This results in an
improved operator’s visibility by limiting blood loss; fur-
thermore, it leads to a reduced fluid absorption (through a
reduction of uterine blood flow) (Parazzini et al., 1998)
and a reduced length and difficulty of surgery.
(iii) possibility of surgical scheduling. Indeed, as patients do
not necessarily need to be operated in the early prolifera-
tive phase, preoperative treatment also has a practical
benefit in that it allows surgery to be performed at any
time (Parazzini et al., 1998)
Universally accepted guidelines on the indications and duration
of pretreatment with GnRH agonist (administered either as a long-
acting monthly intramuscular injection or with daily dosing) are
lacking in the international literature.
Hallez (1995, 1996) does not recommend any preoperative
treatment; Hart et al. (1999) does not believe analogue use to be
a risk factor for submucous fibroid reintervention; Donnez et al.
(1995) claims that fibroids up to 2 cm do not require any prep-
aration, those ranging from 2 to 4 cm have to be treated for 3
weeks with a progestogen or danazol, while GnRH agonist
should be reserved only for those fibroids .4 cm. Other authors
consider a large size as a contraindication for GnRH agonist
therapy as severe haemorrhage after the administration of these
drugs has been described (Indman, 1993).
We agree with those authors who consider these drugs particu-
larly indicated for those fibroids with a diameter of .3 cm and/or
with intramural portion as well as for patients suffering from sec-
ondary anaemia (Romer, 1998; Tulandi and al-Took, 1999; Romer
et al., 2000; Valle and Buggish, 2007). A 6–8 weeks adminis-
tration of GnRH agonist preoperatively is sufficient to shrink the
fibroid by 30–50% (Donnez et al., 1992; Perino et al., 1993;
Mencaglia and Tantini, 1993), for patients presenting with
anaemia and a large submucous fibroid, such therapy can be pro-
longed up to 2–4 months to correct anaemia (in combination with
iron supplement therapy) as well as to shrink the intrauterine
lesion (Stamatellos and Bontis, 2007).
Evidence supporting the use of these drugs before hysteroscopic
myomectomy only comes out from a few small [n ¼ 20, Donnez
et al. (1989); n ¼ 25, Mencaglia and Tantini (1993); n ¼ 58,
Perino et al. (1993)] prospective studies. In the only one random-
ized study, Perino et al. (1993) have compared the post-operative
outcomes following resectoscopic myomectomy for submucous
fibroids ,3 cm, showing a decreased volume of distension fluid,
surgical time and bleeding in those patients (n ¼ 33) preopera-
tively treated with GnRH agonist in comparison with controls
(n ¼ 25).
Conversely, it is well known that the preoperative treatment
with these drugs is associated with some disadvantages including:
(i) high costs; (ii) side effects (i.e. hot flushes, spotting);
(iii) increased recurrence rate (these drugs may render small
fibroids less visible) (Fedele et al., 1990) and (iv) increased risk
of uterine perforation (due to a reduced myometrial thickness)
(Bradley, 2002) and an increased risk of the ‘sinking’ phenomenon
(due to a decreased elasticity of myometrial tissue caused by estro-
gen deficiency) (Lin et al., 2000).
Furthermore, a recent retrospective study by Campo et al.
(2005) suggests that preoperative treatment with GnRH agonist
does not seem to offer any advantage in terms of short- and long-
term outcomes. In particular, those patients treated with GnRH
agonist had significantly longer surgical times, compared with
untreated patients, which has been ascribed by the authors to an
increased cervical resistance to dilatation. However, such data
needs to be confirmed by larger randomized studies.
Instrumentation
The operating hysteroscope (resectoscope) is the instrument that
allows the performance of a submucous myomectomy under
direct and constant visual control. It includes a straight-forward
telescope (08) or a slightly fore-oblique 12–30-8 telescope with
an outer diameter of 3–4 mm; an internal and an external
sheaths of 24–27 Fr outer diameter (Table II) that provide a con-
stant inflow and outflow of distension fluid for generating a con-
tinuous and efficient lavage system of the uterine cavity.
The operating hysteroscope contains a working element
wherein electrosurgical (thermal loops and vaporizing electrodes)
(Fig. 1) and mechanical instruments (cold loops) (Fig. 2) for the
traditional resectoscopic surgery or laser fibres or a new Intra
Uterine Morcellator (IUM) (Fig. 3) device can be attached.
The application of resectoscopic surgery has been made pos-
sible by using the electric current. The electrosurgical system can
be monopolar or bipolar: in the monopolar one, from the extremity
of the resectoscope (active electrode) the flow of current, in order
to close the circuit, must reach the plate (passive electrode). The
use of monopolar electrodes requires non-conducting distending
solution (sorbitol 5% or glycine 1.5%). The use of a bipolar set
of instruments, in which both electrodes are introduced into the
thermal loop, would be much safer. In this way the current will
only have to pass through the tissue with which the thermal loop
comes into contact, thus minimizing the danger deriving from
the random passage through the corporeal structures. An intrauter-
ine bipolar diathermy allows the use of an electrolitic uterine dis-
tension medium (normal saline). The passage of the electrical
energy from the thermal loop to the tissues determines the
cutting or coagulation action of the resectoscope.
Table II. Main characteristics of the widely-used resectoscopes
Manufacturer Diameter Telescope Electrosurgical system
Storz 26 Fr 08, 128, 308 Monopolar
Bipolar
Circon ACMI 25 Fr 128, 308 Monopolar
Wolf 27 Fr 308 Monopolar
Bipolar
Gynecare 27 Fr 128, 308 Bipolar
Olympus 26 Fr 08, 128 Monopolar
Bipolar
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There are various types of thermal loops with different shapes
and sizes (Fig. 1A–F).
The diameters of thermal loops for bipolar resectoscopes are
usually smaller than loops for a monopolar instrument with the
same outer diameter, thus increasing the time required for resec-
tion (Indman, 2006). The bipolar loop operates in a similar way
to a monopolar electrode; however, as tissue contact is not neces-
sary for activation, the electrodes do not ‘stick’ in the tissue while
cutting (Stamatellos and Bontis, 2007).
The cold loops are structurally more robust than the others as
they are used in a mechanical way without electrical energy to
carry out the enucleation of the intramural component of the
fibroid (Fig. 2).
The resectoscope can also fit bipolar and monopolar vaporiz-
ing electrodes (Fig. 1H); The power required to vaporize tissue
is 150–300 W of pure cut current delivered by any electrosurgi-
cal generator (Brooks, 1995; Vilos and Abu-Rafea, 2005). The
vaporizing electrodes are also useful mechanical tools to be
used to dissect the fibroid from its bed without electrosurgical
activation.
Figure 1: Conventionally-used thermal loops for resectoscopic myomectomy
(A) 24 Fr 308 U-shaped cutting loop for monopolar 26 Fr resectoscope (Karl Storz GmbH Co., Tuttlingen, Germany): it has a maximum cutting depth of 4 mm and
represents the most frequently used loop; (B) 5 mm equatorial loop for monopolar 26 Fr resectoscope (Karl Storz GmbHCo); (C) 458 loop electrode with a short-arm
safeguard (Olympus Medical System GmbH); (B) and (C) are used to treat submucous fibroids arising from uterine fundus; (D) 3 mm equatorial loop for monopolar
26 Fr resectoscope (Karl Storz GmbH Co): it is used to resect submucous fibroids located near the interstitial portions of the Fallopian tubes; (E) 8 mm 908 U-shaped
cutting loop for bipolar 26 Fr resectoscope (Karl Storz GmbH Co): the direct current return via the electrode (arrow) prevents a current flow via the sheath; (F)
Magnified view of 2.5 mm cutting loop for bipolar 27 Fr resectoscope (Gynecare; Ethicon Inc., Somerville, NJ); (G) Collin’s Electrode (Karl Storz GmbH Co):
it is a cutting knife electrode, conventionally used to perform hysteroscopic metroplasty; however it can also be employed to perform hysteroscopic myomectomy
(i.e. enucleation in toto); (H) Vaporizing electrodes (Karl Storz GmbHCo): they can have a cylindrical or spherical shape or a multidentate surface; this design works
like an array of electrodes which, whether provided with pure cutting energy of high power, can vaporize tissue quite quickly and effectively without generating the
‘chips’ created by loop resection
Figure 2: Mazzon’s mechanical loops (Karl Storz GmbH Co) used for ‘cold
loop’ myomectomy
A) Pointed loop (Knife-shaped): used to hook and lacerate the connective
bridges which join the fibroid and the adjacent myometrium; (B) Rake loop
(rake shaped with teeth): nearly completely replaced by pointed loop;
(C) Cutting loop (rectangular): used to identify the cleavage plane between
the fibroid and myometrium
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The transhysteroscopic approach for the treatment of submu-
cous fibroid includes also the use of lasers and of a new instrument
called IUM.
Although argon, krypton and neodymium-yttrium-aluminum-
garnet (Nd:yAG) lasers have all been successfully used, only the
latter has found widespread application in hysteroscopic surgery
(Ubaldi, 1995), being very popular in the late 1980s and early
1990s. Two techniques ‘touch’ and ‘non-touch’ may be used in
hysteroscopic Nd:yAG laser surgery (Goldrath et al., 1981;
Loffer, 1987). In the former, the laser fibre is in contact with the
surface to be treated, whereas in the latter it is separated from it
by a few millimetres. In hysteroscopic myomectomy both tech-
niques are used (Ubaldi, 1995).
The 4–5 mm IUM (prototype: Smith & Nephew Endoscopy,
Andover, MA) represents a new cutting device inserted into a
straight working channel of a continuous flow 9 mm rigid operat-
ing hysteroscope (Fig. 3).
Hysteroscopic techniques
The choice of the technique for the hysteroscopic removal of sub-
mucous fibroids mostly depends on its type and location within the
endometrial cavity. Furthermore, personal experience and the
available equipment might then favour a particular technique
rather then the other ones.
Fibroids completely within the uterine cavity (G0)
The operator has the possibility to choose among several alterna-
tive procedures: all of them are usually performed in the operating
theatre under general anaesthesia, except office myomectomy.
Resectoscopic excision by slicing
The classical resectoscopic excision of intracavitary fibroid is
carried out with the technique of slicing. It consists of repeated
and progressive passages of the cutting loop, carried out with
the standard technique (loop carried beyond the neoformation,
with cutting only taking place during the backward or return
movement of the loop). Excision usually begins from the top of
the fibroid, progressing in a uniform way towards the base, also
in the case of a pedunculated fibroid (Neuwirth and Amin, 1976;
Mazzon and Sbiroli, 1997; Isaacson, 2003; Indman, 2006).
During the resection of the fibroid, particularly when there are
voluminous neoformations or small cavities, the fragments sec-
tioned and then accumulated into the cavity may interfere with a
clear vision. Thus they must be removed from the uterine cavity
by taking out the resectoscope after grasping the loose tissue
elements with the loop electrode. Although the removal of tissue
under visual control with the resectoscope is the most effective
way, it requires a large number of steps which are tiring in the
long run (Mazzon and Sbiroli, 1997; Emanuel and Wamsteker,
2005). Recently, a resectoscope with automatic chip aspiration
(Resection Master by Gallinat, Richard Wolf GmbH, Knittlingen,
Germany) has been developed. Thanks to an extremely effective
pump with integrated pulse aspiration, the chips are aspirated
immediately after they are produced and removed from the
uterine cavity without the uterine water distension being impaired
(Gallinat, 2005).
When dealing with the base of the fibroid, care must be taken to
limit the surgical traumatism only to the area of the implant, thus
avoiding the damage of the surrounding structures. As soon as the
excision of the fibroid is finished, the base of the implant must be
cleaned out until smooth and regular; the operation should be con-
sidered finished when the fasciculate structure of the myometrium
is visualized.
It is well ascertained that intracavitary fibroids can be easily
removed in a one-step procedure with fibroid size representing
the main limiting factor. The operation may also be carried out
by operating surgeons with average resectoscopic experience
(Mazzon and Sbiroli, 1997; Isaacson, 2003; Indman, 2006).
Cutting of the base of the fibroid and its extraction
Ideally, when approaching a peduncolated fibroid, the basis of the
pedicle might be cut by resectoscopic loop (Murakami et al., 2005)
or Nd:yAG laser with the ‘no-touch’ technique (Valle and
Baggish, 2007) or vaporizing electrode (Glasser, 1997). The
resected node is then usually extracted with forceps. The fibroid
can be grabbed blindly with a Corson forceps (Thomas Medical,
Inc., Indianapolis, IN) or under direct visualization with an Isaac-
son optical tenaculum (Karl Storz Endoscopy, Culver City, CA)
(Isaacson, 2003). Some other reports suggest that the resected
fibroid node should be left in place until the remnant fibroid is
excreted spontaneously during the first menstruation after
surgery (Donnez et al., 1990; Isaacson, 2003). This is an attractive
Figure 3: Intrauterine morcellator (IUM) (prototype: Smith & Nephew Endo-
scopy, Andover, MA)
It consists of a set of two metal, hollow, rigid, disposable tubes (A) that fit into
each other and then are inserted into the working channel of a 9 mm operating
hysteroscope (B). The inner tube rotates within the outer tube, driven mechani-
cally by an electrically powered control unit and controlled by a foot pedal that
activates rotation and regulates the direction of rotation of the inner tube. The
control unit is connected to a handheld motor drive unit in which the IUM is
inserted. Both tubes have a window-opening at the end with cutting edges.
The rotary morcellator (A1) is recommended for polypectomy, while the reci-
procating one (A2) for myomectomy. By means of a vacuum source (C) con-
nected to the inner tube, the tissue is sucked into the window-opening and
cut and ‘shaved’ as the inner tube is rotated. The removed tissue is discharged
through the device and is available for pathology analysis
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procedure but limited by frequent side effects including continu-
ous colicky pain and intrauterine infection (Darwish, 2003).
Ablation by Nd:yAG laser
For fibroids 2 cm or less in diameter the Nd:yAG laser fibre may
be used to ablate the fibroid. The technique first coagulates the
surface vessels with the defocused laser fibre. Then the fibre is
dragged repetitiously over the fibroid until it is flattened (touch
technique). The disadvantages with this method are the time
expended to reduce the fibroid and the lack of a tissue specimen
for pathologic evaluation (Donnez et al., 1990; Gallinat et al.,
1994; Smets et al., 1996; Valle and Baggish, 2007). Furthermore,
laser equipment at present tends to be very expensive which sig-
nificantly reduces its widespread use.
Vaporization of fibroid
The vaporization of fibroid is performed using spherical or cylind-
rical electrodes (Fig. 1H); the electrode is dragged along the surface
of the fibroid until the nodule is reduced to a size compatible with
removal by themeans of Corson forceps or Isaacson optical tenacu-
lum. The depth of vaporization depends on duration of contact,
resistance (debris on the electrode) and wattage of the generator.
It is important to move the electrode slowly across tissue, applying
current only when moving in the direction towards the operator.
Prolonged pressure in one spot exposed to this high current could
result in uterine perforation (Glasser, 1997).
Fibroid vaporization has been reported to be significantly faster
than traditional resectoscopic surgery (no fibroid chips to be
removed) with an estimated blood loss ,100 ml and a discre-
pancy between inflow and outflow volumes ranging 0–200 ml
(Brooks, 1995; Vilos and Abu-Rafea, 2005).
The main disadvantage of vaporizing electrodes is the lack of
tissue sample for pathology. While uterine sarcomas are vary
rare, unfortunately they are not homogeneous. Therefore, a
simple sample prior to vaporization does not rule out the disease.
Consequently, it is mandatory that no fibroid be vaporized in its
entirety but that substantial portions been retrieved for microscopic
examination (Brooks, 1995; Glasser, 1997; Isaacson, 2003).
Another disadvantage is related to the use of high power which
produces numerous gas bubbles which enter the vascular system.
Providentially, these bubbles dissipate rapidly in the blood; as
long as the rate of formation does not exceed the rate of dissipa-
tion, there are no significant clinical sequelae. A constant monitor-
ing of patient’s end-tidal CO2 together with a close cooperation
between surgeon and anaesthesiologist is needed to avoid
serious complications (Isaacson, 2003).
Morcellation by IUM
Contrary to some other alternative techniques that use heat, coagu-
lation or vaporization, the morcellation by IUM represents a new
alternative technique which preserves tissue for histological
examination.
Recently, Emanuel and Wamsteker (2005) have conducted a
retrospective comparison between this technique and conventional
resectoscopy.
They have shown that morcellation by IUM was effective for
the treatment of fibroid G0 and G1 and faster than conventional
resectoscopy. Indeed, the aspiration of tissue fragments through
the instrument allowed the surgeons to save much time.
However, further data are needed to evaluate long-term follow-up
and to demonstrate whether this new technique might result in
fewer fluid-related complications (physiological saline solution
is used for distension and irrigation) and a shorter learning curve.
On the other hand, it should be underlined that this new tech-
nique cannot be used for the treatment of submucous fibroids
with .50% intramural extension (G2).
Office hysteroscopic myomectomy
The development of smaller diameter hysteroscopes (,5 mm)
with working channels and continuous flow systems has made it
possible to treat several uterine pathologies in outpatient
regimen without cervical dilatation and consequently without
analgesia and/or local anaesthesia.
This new philosophy (‘see and treat hysteroscopy’) has reduced
the distinction between a diagnostic and an operative procedure,
introducing the concept of a single procedure in which the operat-
ive part was perfectly integrated in the diagnostic work-up (Bet-
tocchi et al., 2003).
Mechanical operative instruments (scissors, biopsy cup, grasp-
ing and corkscrew) have long been the only way to apply the
see and treat procedure in an outpatient setting (Bettocchi et al.,
2004). The advent of bipolar technology, with introduction of elec-
trosurgical systems dedicated to hysteroscopy and several types of
5 Fr electrodes, has increased the number of pathologies treated by
office operative hysteroscopy, including fibroids ,1.5–2 cm.
Endocavitary fibroids (G0) are first divided into two half-
spheres and then each of these is sliced from the free edge to the
base into two/three fragments (Fig. 4). These fragments must be
large enough to be pulled out through the uterine cavity using 5
Fr. grasping forceps (Bettocchi et al., 2002).
Few studies have investigated the effectiveness of this new
approach (Farrugia and McMillan, 2000; Bettocchi et al., 2002;
Clark et al., 2002) and are characterized by potential methodologi-
cal weaknesses including the lack of a control group of women
(Farrugia and McMillan, 2000; Bettocchi et al., 2002; Clark
et al., 2002) and the relatively short-term follow-up (Farrugia
and McMillan, 2000; Bettocchi et al., 2002; Clark et al., 2002).
Larger prospective comparative studies are needed to better evalu-
ate this promising approach in terms of symptom response and
cost saving.
Figure 4: Slicing technique to treat totally intracavitary and partially intra-
mural submucous fibroid in office setting with 5Fr bipolar electrodes
‘a’ refers to the first half-sphere and ‘b’ to the second. Modified from Bettochi
et al. (2002)
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Fibroids with intramural development (G1-G2)
It is advisable to use expert operating surgeons for hysteroscopic
resection of fibroids with intramural extension as it is technically
difficult with a slow learning curve and it is associated with an
higher risk of complications (Emanuel et al., 1999). The intra-
mural extension of submucous fibroids influences the chance of
achieving complete resection in one surgical session.
Conventionally, fibroids G1 and G2 should not exceed 5–6 and
4–5 cm, respectively, to be removed hysteroscopically, even if
reports of removal of larger fibroids are available in the English
literature (Neuwirth, 1983; Fried and Hulka, 1987; Hamou,
1993; Donnez et al., 1995; Phillips et al., 1995).
Several techniques have been proposed for the treatment of such
submucous fibroids, most of them sharing the objective of produ-
cing an intracavitary protrusion of the intramural component. The
advantages and limits of the most widely-used techniques are
shown in Table III.
Excision only of the intracavitary component
In the past, several authors have proposed a progressive resecto-
scopic excision of only the intracavitary component of those
fibroids with extensive intramural involvement (Neuwirth,
1978). Indeed, it was believed that the endometrium would reco-
lonize the surgically operated area and that the residual intraparie-
tal component of the fibroid would remain in the thickness of the
wall, behaving like an intramural fibroid (usually asymptomatic).
However, the constant intracavitary expulsion and the subsequent
volumetric increase of the residual intramural component of the
fibroid lead to the persistence of the initial symptomatology.
That explains the clinical uselessness of such a treatment and its
consequent fall into disuse.
Complete excision of fibroid by a two-step procedure
The observation of the rapid migration of the residual intramural
component of the fibroid towards the uterine cavity (Loffer,
1990), with the parallel increase of myometrial thickness during
hysteroscopic myomectomy (Yang and Lin, 2001), is the basis
of this treatment, which represents the logical evolution of the
earlier treatment which involved the excision of the only intraca-
vitary component of the fibroid.
The technique described by Donnez et al. (1990) represents an
effective mixture of hormonal treatment and hysteroscopic laser
surgery. After 8 weeks of preoperative GnRH agonist therapy, a
partial myomectomy of the intracavitary portion of the fibroid is
carried out. The Nd:yAG laser fibre is then directed, as perpendi-
cularly as possible, at the remaining (intramural) fibroid portion
with the aim to reduce its size by decreasing its vascularity (trans-
hysteroscopic myolysis). After another 8 weeks course of GnRH
agonist therapy, a second hysteroscopic myomectomy is per-
formed to remove the remnant intramural portion of the fibroid
protruded in the uterine cavity as a consequence of uterine shrink-
age. This technique has been successfully reported in 12 patients
by Donnez in his original paper (Donnez et al., 1990), with a res-
toration of normal menstrual flow in all of them. In his largest
series of fibroids with the biggest portion located into the uterine
wall (n ¼ 78), the author reports a success rate of 95% with only
four patients requiring a third-look laser hysteroscopy to comple-
tely remove the fibroid (Donnez et al., 1995).
At present, most surgeons prefer to remove a fibroid through a
two-steps procedure, by means of traditional resectoscopic
surgery, as originally hypothesized by Loffer (1990). The tech-
nique consists of the following steps:
(i) First surgical operation: excision only of the intracavitary
portion of the fibroid, by means of the usual progressive
resectoscopic excision. A hysteroscopic reassessment is
carried out 20–30 days after the operation or after the
first menstruation to verify that the intracavitary migration
of the residual intramural component of the fibroid has
taken place: once this has been verified, the second oper-
ation can be done.
(ii) Second surgical operation: complete excision, by means
of slicing, of the residual component of the fibroid,
which has now become intracavitary.
Optionally, first and second surgical operation can be preceded
by GnRH agonist therapy.
Complete excision of fibroid by a one-step procedure
Excision of intramural component by slicing
With this technique, after the usual progressive excision of the
intracavitary portion of the fibroid, the operation continues with
the slicing of the neoformation, included into the thickness of
the uterine wall, until the operation is completed (Fig. 5). The
main limit of this technique is the use of electrosurgery during
the removal of the intramural component of the fibroid with the
inevitable damage of the surrounding healthy myometrium
(either directly during the cutting or indirectly because of
thermal damage) and the increased risk of operative complications
(such as perforation, bleeding, intravasation).
‘Cold loop’ myomectomy
This technique, developed byMazzon (1995), is characterized by a
sequence of three different operating steps:
(i) Excision of the intracavitary component of the fibroid: this
is carried out with the usual technique of slicing. It con-
sists of repeated and progressive passages of the monopo-
lar angled cutting loop, carried out with the standard
technique. This action must stop at the level of the plane
of the endometrial surface, so that the identification of
the passage between the fibroid and the adjacent myome-
trial tissue is not impaired (cleavage plane).
(ii) Enucleation of the intramural component of the fibroid:
once the cleavage plane is identified the usual cutting
loop of the resectoscope is substituted by a suitable
blunt dissection cold loop. Usually the rectangular loop
is used first. This loop, once inserted into the plane
between the fibroid and myometrium, is used in a mechan-
ical way along the surface of the fibroid (usually clearly
recognizable by its smooth, white and compact surface),
thus bringing about its progressive blunt dissection from
the myometrial wall (Fig. 6A). Then the single tooth
loop is used to hook and lacerate the slender connective
bridges which join the fibroid and the adjacent
Di Spiezio Sardo et al.
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Table III: Advantages and limits of the most widespread techniques for hysterosocpic treatment of myomas G1-G2
Author (year) Technique Advantages Limits
Loffer et al. (1990) Two-step myomectomy: the
procedure can be performed
only by means of traditional
resectoscopic surgery (Loffer
et al., 1990) or by Nd:yAG
laser (Donnez et al., 1990).
- Safeness (possibility to operate at an intracavitary level) - Two separate interventions
Donnez et al. (1990) - High costs (GnRH agonist therapy, Nd:yAG laser, two surgeries)
- Only myomas with a reduced intramural development or of small
dimensions can be treated with this technique. Indeed, in the case of
myomas with a volumetrically significant intramural component, the
part which remains after the first surgical operation may be
excessively big: such a component, when migrating to the uterine
cavity, will meet with resistance to its progression caused by the
controlateral myometrial wall. As a result, during the second operation
we will find a myoma which still has a significant intramural
component, which will remain in the thickness of the wall at the end
of the new excision only of the intracavitary part: it will therefore be
necessary to carry out more surgical operations. However this limit
might be solved by GnRH agonist therapy.
- ‘Sinking’ phenomenon (due to GnRH agonist therapy)
- Increased recurrence rate (due to GnRH agonist therapy)
Mazzon (1995) ‘Cold loop’ myomectomy - Theoretically one intervention - Availability of cold loops
- Safeness (although the surgical action goes deeply into the uterine wall
during enucleation with a cold loop, it always follows a reference plane
(the surface of the intramural pole of the myoma) and constantly
maintains the loop action under direct visual control; this means a
smaller possibility of complications (perforation, bleeding)
- Training and high experience
- Respect of the surrounding healthly myometrium avoiding any needless
cutting of the muscular fibres adjacent to the surgical area and reducing
the thermal damage deriving from the loop of the resectoscope. This
avoids any negative effect on the likelihood of subsequent conception
and the uterine wall resistance
- Suitable also for large myomas
- Suitable also in case of myometrial free margin ,1 cm
Lasmar et al. (2002) ‘Enucleation in toto’ - Theoretical one intervention - The success of the procedure is higher for myomas with a intramural
development .50%
Litta et al. (2003) - Safeness (possibility to operate at an intracavitary level) - The expulsion force of the myometrium is inversely correlated with
the diameter of uterine cavity
- Theoretical respect of the surrounding health myometrium
Hamou (1993) Hydromassage - Theoretical one intervention - Need of electronically controlled irrigation and suction device
- Safeness (possibility to operate at an intracavitary level) - The contractile reaction of the myometrium to such manoeuvres is
neither predictable nor standardizable
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myometrium (Fig. 6B). During the entire phase of enu-
cleation, electric energy must not be used in the thickness
of the wall, and the loop must be used ‘cold’ or in a mech-
anical way.
(iii) Excision of the intramural component: at the end of the
enucleation phase, the intramural part of the fibroid is
totally dislocated inside the uterine cavity. At this point
it can be treated as a neoformation with a total intracavi-
tary development and therefore it can be completely and
safety excised by means of the usual progressive excision
using an angled cutting loop.
At present, studies evaluating of the effects of this technique are
still lacking in the international literature. However, this technique
is largely widespread through the Europe and since 1992, Mazzon
himself has carried out .2000 hysteroscopies using this technique
reporting good functional and anatomical results and a low com-
plication rate (,2%). The fibroid was completely removed in
one-step procedure in nearly 80% of cases (unpublished data).
‘Enucleation in toto’
Litta’s technique: an elliptic incision of the endometrial mucosa
that covers the fibroid is performed with a 908 Collins electrode
(Fig. 1G), at the level of its reflection on the uterine wall until
the cleavage zone of the fibroid is reached. Connecting bridges
between fibroid and surrounding myocytes are slowly resected.
The effect of such action is that the fibroid protrudes into the
cavity, thus facilitating its removal by traditional slicing. The
fibroid is pushed into the uterine cavity, enabling the surgeon to
work safely and completely resect the intramural component
with an angled cutting loop. This technique has been successfully
reported in 41 out of 44 women with submucous fibroids G2
ranging from 2 to 4 cm (means diameter 3.2 cm) and myometrial
free margin .4 mm at ultrasound (Litta et al., 2003).
Lasmar’s technique: the Collins electrode is used in shape of a
‘L’, to dissect the endometrium around the fibroid until getting to
it. At this time, the direct mobilization of the fibroid is started in all
directions, doing the coagulation only of the vessels that are
Figure 5: Excision of intramural component by slicing: the electrosurgery is
used to slice the neoformation, included into the thickness of the uterine wall
(Image kindly donated by I. Ardovino)
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bleeding. When the fibroid is in the cavity it is possible to remove
it with grasping forceps (small fibroids) or to slice it in several
pieces using the Collins electrode. This technique has been suc-
cessfully reported in 98 cases (50 out of 98: direct mobilization
plus grasping; 46 out of 98: direct mobilization plus slicing)
(Lasmar and Barrozo, 2002).
Technique of ‘hydromassage’
Starting form the observation that the intramural portion of a
submucous fibroid squeezes out of its base after contractions of
the uterus during the removal of tissue chips (Loffer, 1990),
Hamou (1993) proposed a ‘fibroid massage’ through rapid
changes of intrauterine pressure using an electronically controlled
irrigation and suction device (Endomat; Karl Storz GmbH Co.,
Tuttlingen, Germany). Indeed, interrupting and restarting the
supply of distension liquid several times, myometrial contraction
is stimulated, obtaining the maximum possible migration of the
intramural component of the fibroid into the cavity. At present,
series evaluating the effects of this technique are lacking in
international literature.
‘Manual massage’ technique
At the beginning of 1990s, Hallez (1995) introduced a single-stage
technique in which, after a partial myomectomy of the protruding
dome of the fibroid, uterine contractions were induced by finger
massage of the uterus (similar to obstetric manoeuvres as
Crede’s one), thus expelling the residual intramural fibroid into
the uterine cavity and making it accessibile for a safe hystero-
scopic resection. Hallez (1995) reports good anatomical and func-
tional results after resection with such technique of 222
submuocus fibroids with intramural development.
‘Two-resectoscope technique’
Lin et al. (2000) proposed a one-procedure hysteroscopic myo-
mectomy by using two resectoscopes. A 7-mm resectoscope is
first used to cut the capsule of the fibroid next to muscular layer
of the uterus. This prevents the fibroid from sinking in the muscu-
lar layer as the procedure progresses. The fibroid is then dissected
from the muscular layer. Then, after the fibroid has been dissected
from the muscular layer, a standard resectoscope with a 9-mm
external outer sheath is used to shave the body of the fibroid.
A Lin fibroid grasper (Atom Medical Co., Tokyo, Japan) may be
used to pull the fibroid further into the intrauterine cavity. The pro-
cedure is continuously monitorized by ultrasonography. The index
technique has been successfully reported in only two infertile
women presenting with menorrhagia.
Office hysteroscopic myomectomy
Fibroids ,1.5–2 cm, with a minimal intramural component, can
be removed in outpatient setting using smaller diameter hystero-
scopes and 5Fr mechanical and bipolar instruments. In these
cases, to avoid any myometrial stimulation or damage of the sur-
rounding healthy myometrium, the fibroid is first gently separated
from the capsule using mechanical instruments (grasping, forceps
or scissor) as described for ‘cold loop’ resectoscopic myomect-
omy. Once the intramural section becomes intracavitary then it
is sliced with the bipolar electrode (Fig. 5B) (Bettocchi et al.,
2002).
Pharmacological-aided techniques
Several drugs may stimulate uterine contractions pushing the
intramural part of the fibroid into the cavity, thus anticipating
what generally happens spontaneously during the weeks following
the operation. Murakami and colleagues (2003, 2006) proposed a
transabdominal injection of prostaglandin F (PGF)-2a under
laparoscopic monitoring, while Indman (2004) reported the suc-
cessful use of intracervical carboprost, a methyl analogue of
PGF-2a, in 8 out of 10 cases in which the drug was administered
to facilitate resection of fibroids that otherwise could not be
resected completely.
Global endometrial ablation
New instrumentation and the off-label use of some global (non-
hysteroscopic) ablation techniques allow some selected patients
with submucous fibroids, who have completed their family plan-
ning, to be treated only by endometrial ablation (Hickey and Far-
quhar, 2003; Loffer, 2006).
Conventional endometrial ablation techniques cannot be used
when the uterine cavity is remarkably enlarged (.12 cm) and dis-
torted as result of submucous or intramural myomas. Indeed, in
such situation it is hard for most devices with a rigid intrauterine
probe to access all areas of the endometrium.
Hydrothermal ablation system circulates free heated saline
under hysteroscopic visualization and thus very readily adapts to
Figure 6: (A) The rectangular loop is inserted into the plane between the fibroid and myometrium to progressively dissect it from the myometrial wall
(B) Connective bridges which join the fibroid and the adjacent myometrium are hooked by the single tooth cold loop (Images by I. Mazzon)
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an irregular cavity. It has already been demonstrated to be safe and
effective in treating women with menorrhagia and submucous
fibroids up to 4 cm in diameter (Glasser and Zimmerman, 2003).
Microwave endometrial ablation (MEA) is based on a generator
supplying microwave energy to a 8 mm hand-held reusable probe.
This results in a reliable 5–6 mm depth of endomyometrial pen-
etration. Recently, a thinner (4 mm) curved microwave probe
has been developed, in order to accomplish the complete coverage
of the uterine cavity, even in case of enlarged (12–16 cm in
length) and distorted cavity as a result of large submucous fibroids
(Kanaoka et al., 2003, 2005). Available data about the outcome of
MEA in patients with menorrhagia caused by submucous myomas
are few but encouraging. The improvement of menorrhagia is
accompanied with a significant shrinkage of myoma related to a
necrotic degeneration recognizable by MRI 1–2 months after
the procedure (Kanaoka et al., 2003, 2005).
Effects of hysteroscopic myomectomy on menstrual
pattern and infertility
No meta-analysis of the association of submucous fibroids and
AUB has been performed; however, most studies have shown that
hysteroscopic myomectomy is safe and effective in the control of
menstrual disorders with a success rate ranging from 70 to 99%.
Usually the success rate declines as the follow-up period increases;
this could be to due to a number of factors including the incomplete
removal of fibroid (which could in time become larger and cause
bleeding) as well as the occurrence of other dysfunctional factors
as a cause of menorrhagia (Mazzon and Sbiroli, 1997).
The hysteroscopic technique (Table IV) adopted does not seem
to significantly affect the success rate.
The failure of hysteroscopic treatment seems to be related to the
growth of fibroids in other sites, the association of fibroids with
adenomyosis and the incomplete treatment of partially intramural
submucous fibroids (Donnez et al., 1995). The complete resection
of the intramural part of the fibroid is certainly advisable to
improve the control of menorrhagia, with lower chance of sub-
sequent recurrence (Wamsteker et al., 1993; Parent et al., 1994;
Van Dongen et al., 2006).
Furthermore, uterine size (Emanuel et al., 1999; Hart et al.,
1999), fibroid size (Hart et al., 1999) and the number of fibroids
(Emanuel et al., 1999) found at hysteroscopy seem to have an
independent prognostic value for recurrence of AUB.
In women who have completed their family planning, good
long-term results in controlling bleeding have been achieved by
concomitant hysteroscopic endometrial ablation which leads to
an amenorrhoic status in up to 95.5% of patients (Brooks et al.,
1989; Derman et al., 1991; Phillips et al., 1995; Glasser, 1997;
Loffer, 2000, 2005; Polena et al., 2007).
The effects of hysteroscopic myomectomy on the reproductive
outcome in infertile women have been investigated by several
authors (Hunt and Wallah, 1974; Donnez et al., 1990; Valle,
1990; Corson and Brooks, 1991; Goldenberg et al., 1995;
Preutthipan and Theppisai, 1998; Giatras et al., 1999; Varasteh
et al., 1999; Vercellini et al., 1999; Bernard et al., 2000; Fernandez
et al., 2001; Pritts, 2001; Donnez and Jadoul, 2002; Munoz et al.,
2003; Shokeir, 2005; Stamatellos et al., 2006; Somigliana et al.,
2007), but unfortunately the evidence thus far is not of the highest
quality. Reported post-surgical pregnancy rate varies from 16.7 to
76.9% with a mean of 45%. This large variation may be mainly
related to difficulty in controlling for multiple infertility factors, to
sample size and follow-up discrepancies and to differences in
patients’ (i.e. age, primary or secondary infertility) and fibroid
characteristics (i.e. number, size, intramural portion and presence
of concomitant intramural fibroids) (Cheong and Ledger, 2007;
Somigliana et al., 2007).
Uterine fibroids as an isolated cause of infertility are very
uncommon. Two papers (Buttram and Reiter, 1981; Verkauf,
1992), generally cited as sources of epidemiological data about
this issue, reported that uterine fibroids as an isolated cause of infer-
tility range from 1 to 2.4%. However, these studies do not provide a
reliable estimate of the real impact of fibroids on infertility as
routine diagnostic evaluations performed were not listed and they
precede the advent and widespread use of new instrumentations
(i.e. TVS and endoscopic procedures) (Somigliana et al., 2007).
Several studies (Ubaldi et al., 1995; Bernard et al., 2000;
Fernandez et al., 2001) have shown that post-operative reproductive
outcome is adversely affected by the presence of additional inferti-
lity factors. Particularly, Fernandez et al. (2001) reported in their ret-
rospective series that the pregnancy rate was 41.6%when the fibroid
was the only apparent cause, compared with 26.3% with the pre-
sence of one factor and 6.3% with two or more additional factors.
In another retrospective study (Bernard et al., 2000) a statisti-
cally significant difference in delivery rate was found between
patients with one fibroid and those with a number of fibroids
equal or superior to two. Furthermore, the authors report that
patients without an intramural fibroid associated had a signifi-
cantly greater delivery rate and a significantly shorter delay of con-
ception than those found in patients with associated intramural
fibroids. These differences cannot be due to uterine cavity abnorm-
alities as the associated intramural fibroids did not cause any dis-
tortion of the uterine cavity as assessed by an office hysteroscopy
performed four weeks after resection. These results reinforce the
hypothesis that other mechanisms associated with fibroids may
contribute to infertility.
In a recent prospective study, Stamatellos et al. (2006) has
reported increased fertility rates after hysteroscopic myomectomy
of type 0 and type 1 fibroids in previously infertile women. Inter-
estingly, in patients with type 2 fibroids fertility rate did not
increase, in contrast with patients with type 2 fibroids who
received expectant management (control group).
Fernandez et al. (2001) described higher pregnancy rates after
the removal of larger fibroids, although the difference was not stat-
istically significant. Indeed, the pregnancy rate after the removal
of fibroids .5 cm in size was 57%, whereas it was 23% for
fibroids ,5 cm.
Finally, assessing the real impact of hysteroscopic myomect-
omy on subsequent fertility seems to be highly hampered by the
fact that most studies addressing this issue were retrospective
(Donnez et al., 1990; Goldenberg et al., 1995; Giatras et al.,
1999; Varasteh et al., 1999; Vercellini et al., 1999; Bernard
et al., 2000; Fernandez et al., 2001; Munoz et al., 2003) and
did not have a control group (Donnez et al., 1990; Valle,
1990; Hallez, 1995; Goldenberg et al., 1995; Vercellini et al.,
1999; Giatras et al., 1999; Bernard et al., 2000; Fernandez
et al., 2001; Munoz et al., 2003; Shokeir, 2005).
Only one study (Varasteh et al., 1999) had a control group of
infertile women and the authors showed that the removal of
Di Spiezio Sardo et al.
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Table IV: Bleeding control after hysteroscopic myomectomy (1976–2007)
Author Cases (n) Main indications (%) Technique (n) Follow-up yearsa Bleeding control (%)
Neuwirth and Amin (1976) 5 80 AUB Resectoscopic excision of myoma by slicing 5 100
20 Infertility
Brooks et al. (1989) 62 79 AUB Resectoscopic excision of myoma by slicing (57) .3 months 74
21 AUBþinfertility Resectoscopic excision of myoma by slicing with endometrial ablation (5)
Derman et al. (1991) 156 90.4 AUB Resectoscopic excision of myoma by slicing (94) 4 (1–16) 83.9
9.6 Infertility Endometrial ablation with or without resectoscopic myomectomy (62) 77.5
Indmann (1993) 51 100 AUB Resectoscopic excision of myoma by slicing (1–5) 94
Wamsteker et al. (1993) 51 100 AUB Resectoscopic excision of myoma by slicing 1.7 (0.8–2.5) 94.1
Donnez et al. (1994) 366 100 AUB Resectoscopic excision of myoma by slicing and Nd:yAG laser (two-step procedure) 2 89
Wortman et al. (1995) 75 100 AUB Resectoscopic excision of myoma by slicing with endometrial ablation (1–5) 84
Brooks (1995) 12 100 AUB Hysteroscopic myomectomy by electrosurgical vaporization (0.5–1) 100
Hallez (1995) 284 79 AUB Resectoscopic excision of myoma by slicing (0.5–8.8) 76.3
11 Infertility
Phillips et al. (1995) 208 100 AUB Resectoscopic excision of myoma by slicing (120) (0.5–6) 84.1
Resectoscopic excision of myoma by slicing with endometrial ablation (88) 88.5
Glasser (1997) 35 100 AUB Hysteroscopic myomectomy by electrosurgical vaporization (6) 2 97
Hysteroscopic myomectomy plus endometrial ablation by electrosurgical vaporization (29)
Vercellini et al. (1999) 101 71 AUB Resectoscopic excision of myoma by slicing 3.4+1.9b 70
29 AUBþinfertility
Hart et al. (1999) 122 93 AUB Resectoscopic excision of myoma by slicing 2.3 (1–7.6) 81.9
7 Infertility
Emanuel et al. (1999) 266 100 AUB Resectoscopic excision of myoma by slicing 3.8 (0.1–8.6) 84.5
Munoz et al. (2003) 96 84 AUB Resectoscopic excision of myoma by slicing 2.8 (1–7) 88.5
12 Infertility
Loeffer (2005) 177 91 AUB Resectoscopic excision of myoma by slicing (104) (1–15) 80.8
9 AUBþinfertility Resectoscopic excision of myoma by slicing with endometrial ablation (73) 95.9
Campo et al. (2005) 80 79 AUB Resectoscopic excision of myoma by slicing (0.5–2) 69.5
17 Infertility
Marziani et al. (2005) 107 78 AUB Resectoscopic excision of myoma by slicing (2–5) 80.9
23 Infertility
Polena et al. (2007) 235 84.7% AUB Resectoscopic excision of myoma by slicing (with endometrial ablation in 37% of patients) 3.3 (1.5–5.5) 94.4
6.8% Infertility
AUB includes menorrhagia, metrorrhagia, post-menopausal bleeding, menorrhagia or metrorrhagia on hormonal replacement therapy. aData are expressed as median (range) if not otherwise stated;
bmean+SD.
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submucosal fibroids .2 cm carried a significant benefit in terms of
pregnancy and live birth rates. However, the limited sample size
(control group: n ¼ 19; myomectomy group: n ¼ 36) reduces
the strength of these results.
Only a randomized controlled study would provide a definitive
assessment of the advantages of such technique on reproductive
outcomes and would be useful to confirm that fibroids are not
purely coincidental with infertility (Donnez and Jadoul, 2002,
Somigliana et al., 2007); such a study should be performed com-
paring pregnancy rates between infertile women with submucous
fibroids resected or left in situ (Pritts, 2001). However, such a
study would be hard to justify because such lesions often cause
menorrhagia, they require histologic diagnosis and they are
likely to contribute to infertility (Varasteh et al., 1999).
Also, technical factors such as the surgeon’s skill and experi-
ence as well as the applied techniques surely play an important
role (Stamatellos et al., 2006). Thus, as similar studies are
lacking in international literature, it might be interesting to evalu-
ate whether the choice of a myometrial sparing technique would
further increase the reproductive outcomes.
The advent of assisted reproductive techniques and in particular of
IVF has offered a useful tool to elucidate the impact of fibroids on
embryo implantation. However, there is no definite consensus on
whether fibroids affect the outcome and should be removed prior
to any attempt. Their location, followed by size, is considered the
main factor determining this impact (Gianaroli et al., 2005;
Kolankaya and Arici, 2006).
Four meta-analysis (Pritts, 2001; Donnez and Jadoul, 2002;
Benecke et al., 2005; Somigliana et al., 2007) have aimed to
assess the impact of fibroids on IVF cycles.
Pritts (2001) reported significantly lower pregnancy (RR 0.32),
implantation (RR 0.28), and delivery (RR 0.75) rates in patients
with submucosal fibroids and abnormal uterine cavities in com-
parison with infertile controls without fibroids. Results from
Donnez and Jadoul (2002) confirm a negative impact only of sub-
mucous fibroids on embryo implantation.
Conversely, Benecke et al. (2005) reported a negative impact also
of intramural fibroids. Recently, Somigliana et al. (2007) performed
an updated meta-analysis reporting significantly lower pregnancy
and delivery rates for patients with submucosal fibroids [odds
ratio (OR): 0.3; OR: 0.3) and intramural fibroids (OR: 0.8; OR: 0.7).
The impact of hysteroscopic myomectomy on IVF outcome
has been less extensively investigated. Among the three studies
evaluating the impact of previous myomectomy on IVF cycles
(Seoud et al., 1992; Narayan et al., 1994; Surrey et al., 2005),
only two (Narayan et al., 1994; Surrey et al., 2005) include
patients operated for submucousal fibroids.
Meta-analysis of these two studies reports that hysteroscopic
myomectomy does not appear to negatively affect the chance of
pregnancy in IVF cycles (Somigliana et al., 2007). However,
positive answers could be doubted, as they were based on two
retrospective studies only, both of them characterized by a
limited number of patients.
Operative and long-term complications
Hysteroscopic myomectomy is one of the most advanced operat-
ive hysteroscopic procedures as it is associated, particularly for
complex cases, with a significantly higher rate of complications
than other hysteroscopic procedures (Jansen et al., 2000; Propst
et al., 2000; Aydeniz et al., 2002; Murakami et al., 2005).
Reported data show a rate of complication ranging from 0.3 to
28%, fluid overload and uterine perforation being the most fre-
quent complications occurring during surgery (Loffer, 1990;
Valle, 1990; Corson and Brooks, 1991; Derman et al., 1991;
Serden and Brooks, 1991; Pace, 1993; Wamsteker et al., 1993;
Hallez, 1995; Jansen et al., 2000; Propst et al., 2000; Agostini
et al., 2002; Darwish, 2003). Other intraoperative complications
include bleeding, cervical trauma and air embolism, while late
complications include post-operative intrauterine adhesion (IUA)
(Wamstecker et al., 1993; Hallez, 1995; Giatras et al., 1999;
Taskin et al., 2000; Acunzo et al., 2003; Guida et al., 2004;
Nappi et al., 2007) and uterine rupture during pregnancy
(Derman et al., 1991; Yaron et al., 1994; Darwish, 2003; Valle
and Buggish, 2007).
Uterine perforation
Uterine perforation may occur during cervical dilatation,
hysteroscope insertion and intramyometrial tissue resection. In
particular, the risk of perforation increases in case of fibroids
with intramural component whereas an aggressive uterine fibroid
resection into the myometrium is carried out (Mazzon, 1995;
Murakami et al., 2005). In case of uterine perforation, the
procedure should be terminated immediately and, if there is a
mechanical perforation in which bowel damage is not suspected,
the patient can be observed and discharged if stable (Indman,
2006). If a perforation occurs secondarily to an activated electrode
then it should be assumed that there is a bowel injury until
proven otherwise, and laparoscopy must be done without delay
(Indman, 2006).
Intravasation and electrolyte imbalance
The most dangerous complication during hysteroscopic myomect-
omy is an excessive intravasation of the fluid used to distend and
irrigate the uterine cavity. Severe fluid overload can cause pul-
monary edema, hyponatremia, heart failure, cerebral edema and
even death (Emanuel et al., 1997). Fluid absorption occurs
through the open veins of the fibroid and possibly through trans-
peritoneal absorption from retrograde flow through the Fallopian
tubes. Guidelines indicate that fluid intravasation of 750 ml
during surgery requires planned termination of the operation
(Loffer, 2000) and that the intervention must be immediately
stopped when balance exceeds of 1000 ml (Munoz et al., 2003)
or, according to other authors, 1500–2000 ml (West and Robinson,
1989; Baumann et al., 1990; Istre et al., 1994). The risk factors for
intravasation during hysteroscopic myomectomy are not comple-
tely elucidated because no studies have tested their independent
contribution or relation to fluid loss. The main factor seems to be
the intramural extension of the fibroid (Emanuel et al., 1997);
indeed, in cases of fibroids with deep intramural extension, intra-
vasation will increase mainly because of damage to larger-sized
vessels (Emanuel et al., 1997). Other reported factors possibly
associated with a higher risk of intravasation include the length
of the operation (Corson et al., 1994, Emmanuel et al., 1997), the
size of the fibroid (Maher and Hill, 1990) and the total inflow
volume (Corson et al., 1994).
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Management of this risk relies on close monitoring of the fluid
balance and interruption of the procedure before excessive fluid
absorption occurs. The difference between the amount of inflow
and outflow fluid (including also fluid leaking from the vagina)
could be assessed by dedicated operating room personnel or
by modern electronic balances and pumps (i.e. Hydromat Gyn
and Equimat, Karl Storz GmbH Co., Tuttlingen, Germany;
HysteroBalance/HysteroFlow, Olympus Medical System GmbH,
Hamburg, Germany).
The use of normal saline combined with bipolar energy reduces
the risk of hyponatremia (eliminating the problem of the accumu-
lation of the free water), but an excessive intravasation
(.1500 ml) still remains a risk and might cause cardiac overload
(Murakami et al., 2005).
Post-operative IUA
The incidence of post-operative IUAs represents the major long-
term complication of hysterosocpic myomectomy ranging from
1 to 13% (Wamstecker et al., 1993; Hallez, 1995; Giatras et al.,
1999). To minimize the risk of post-operative IUA, it is necessary
to avoid forced cervical manipulation, and trauma of healthy
endometrium and myometrium surrounding the fibroid; it is also
advisable to reduce the usage of electrosurgery especially during
the removal of fibroids with extensive intramural involvement
(Mazzon, 1995) and multiple fibroids on opposing endometrial
surfaces (Indman, 2006). An early second-look hysteroscopy
after any hysteroscopic surgery is another effective preventive
and therapeutic strategy (Wheeler and Taskin, 1993).
Several pharmacologic (conjugated estrogen, levonorgestrel-
releasing intrauterine device) and barrier agents, including
foley catheter, hyaluronic acid gel and hyaluronic acid and
carboxymethylcellulos (Seprafilm) have been used to reduce
IUA development. A recent review has clearly indicated that
there is no single modality proven to be unequivocally effective
at preventing post-operative adhesion formation for hysteroscopic
surgery (Nappi et al., 2007).
Uterine rupture during pregnancy
Uterine rupture may occur in a subsequent pregnancy after surgery
invading the myometrium, perforation during entry or during
surgery. Therefore when any of the above events occurs, it is
important that the surgeon explains to the patient about the risk
of uterine rupture in a subsequent pregnancy and to document
this discussion clearly in the medical records (Valle and
Buggish, 2007).
A recent review of the complications after hysterosocpic
myoemctomy only reports two cases of uterine rupture following
such surgery (Derman et al., 1991; Yaron et al., 1994).
According to some authors the interval between uterine
operation infringing on the myometrium and attempts for
pregnancy should not be less than one year from the date of
uterine surgery (Valle and Buggish, 2007). Although some
surgeons believe that caesarean section should be preferred when-
ever you are dealing with fibroids with intramural development
(Keltz et al., 1998; Cravello et al., 2004), currently there is lack
of strong evidence to suggest this mode of delivery to reduce the
risk of uterine rupture.
Conclusions
Hysteroscopic myomectomy currently represents one of the great-
est advances in the field of hysteroscopic surgery. Ideally, it should
result in the complete removal of the fibroid (reducing the chance
of recurrence and re-growth) (Wamsteker et al., 1993; Parent
et al., 1994; Van Dongen et al., 2006) without traumatizing the
normal surrounding uterine tissue.
It is well ascertained that fibroids developing completely within
the uterine cavity can be easily removed in a single procedure with
fibroid size representing the main limiting factor (Mazzon and
Sbiroli, 1997; Isaacson, 2003; Indman, 2006).
Resectoscopic slicing still represents the standard widely-used
technique for treating such fibroids (Neuwirth, 1995; Mazzon
and Sbiroli, 1997; Isaacson, 2003; Gallinat, 2005; Indman,
2006) though several other techniques have been introduced. It
is less expensive than laser treatment and quick to perform when
you have adequate training. Recently, an innovative and effective
device called IUM has been proposed and it may become in the
near future a valid alternative to the traditional transcervical resec-
toscopic myomectomy (Emanuel and Wamsteker, 2005).
Furthermore, the development of smaller diameter scopes with
working channels and continuous flow systems together with the
establishment of bipolar technology, have made possible the
outpatient treatment of small (,1.5–2 cm) totally intracavitary
fibroids as well as those with minimal intramural development
thus avoiding both cervical dilatation and any anaesthesia or
analgesia (Bettocchi et al., 2002; Clark et al., 2002).
On the other hand, the resection of fibroids with intramural
extension is advisable only for expert surgeons as it is technically
difficult and has a higher risk of complications than other hystero-
scopic procedures (Propst et al., 2000). The frequency of compli-
cations and the chance of achieving the complete resection of the
lesion at one surgical time, may widely vary depending on the
extension of intramural component and the operative technique
(Loffer, 1990; Valle, 1990; Derman et al., 1991; Corson and
Brooks, 1991; Serden and Brooks, 1991; Pace, 1993; Wamsteker
et al., 1993; Hallez, 1995; Jansen et al., 2000; Propst et al.,
2000; Agostini et al., 2002; Darwish, 2003; Van Dongen et al.,
2006). Furthermore, while differences in equipment do not seem
to have significant effects on surgery for fibroids G0, advanced
‘state of the art’ equipment is necessary for carrying out safe hys-
teroscopic myomectomy for fibroids with intramural extension
(Murakami et al., 2005).
Several techniques have been developed to completely remove
such fibroids, all of those aiming at the transformation of an intra-
mural fibroid into a totally intracavitary lesion, thus avoiding a
deep cut into the myometrium.
While G1 fibroids may be often completely removed in one
step, as the uterus contracts and tends to expel the intramural com-
ponent into the cavity during surgery, the removal of G2 fibroids
may be much more problematic.
In such cases, despite of recent evidence indicating that an
incomplete removal does not always necessitate subsequent
surgery, patients should always be advised regarding the possi-
bility of another surgical step (Van Dongen et al., 2006).
The present review clearly indicates that there is still no single
technique proven to be unequivocally superior to the others for
treating fibroids with intramural development (G1-G2). The
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two-step technique seems to be very effective and safe; however,
the extended GnRH agonist treatment and repeated hysteroscopies
can cause greater distress in patients. One-step myomectomy
remains more desirable and the ‘cold loop’ myomectomy seems
to represent the best option as it allows a safe and complete
removal of such fibroids in just one surgical procedure, while
respecting the surrounding healthy myometrium. This might
reduce the risk of operative (i.e. bleeding, perforation) and long-
term complication (i.e. IUA and uterine rupture).
Other techniques including ‘enucleation in toto‘, ‘hydromassage’
and pharmacologic aided-techniques may be helpful to induce the
shrinkage of the intramural portion in the uterine cavity, but the
contractile reaction of the myometrium is neither predictable nor
standardizable, and this represents an uncertain variable.
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The destiny of myomas: should we treat small
submucous myomas in women of reproductive age?
Stefano Bettocchi,a Charalampos Siristatidis,b Giovanni Pontrelli,a Attilio Di Spiezio Sardo,c
Oronzo Ceci,a and Luigi Selvaggia
a Department of Obstetrics, Gynecology and Neonatology, II Unit of Obstetrics and Gynaecology, University of Bari, Bari;
b Third Department of Obstetrics and Gynecology, ‘‘Attikon’’ Hospital, University of Athens, Greece; and c Department of
Obstetrics and Gynecology, University of Naples ‘‘Federico II’’, Naples, Italy
By using their current knowledge and presenting what they consider to be the best available evidence, the inves-
tigators performed a thorough analysis aimed at demonstrating that a so-called wait-and-see approach is no longer
acceptable in women of reproductive age with small (<1.5 cm) submucous myomas, especially if the lesion could
be easily and safely removed by hysteroscopy in an outpatient setting, with minimal patient discomfort. (Fertil
Steril 2007;-:-–-. 2007 by American Society for Reproductive Medicine.)
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Hysterectomy and laparotomic excision have long been
considered the two standard routes of surgical treatment for
symptomatic submucous myomas (1–5).
The development of endoscopy has made these myomas
accessible and resectable from the inner surface of the uterus
(6, 7). Currently, hysteroscopic surgery is considered to be
the first-line conservative therapy for the management of
symptomatic submucous myomas. It can be tailored to the
woman’s needs and geared toward alleviating her symptoms
(8).
Resectoscopic myomectomy with monopolar or bipolar
cutting loops still represents the standard surgical approach
for the treatment of such myomas, with the first experiences
being published almost 30 years ago (9, 10). However, such
an approach has a number of disadvantages, including the
need for an operating room and, subsequently, for personnel
and more intensive postoperative surveillance, as well as the
necessity of both cervical dilatation and general or epidural
anesthesia. Furthermore, several quite-serious complications,
such as hemorrhage, infection, genital tract trauma, and fluid
overload (11), have been reported to occur in%5% of resec-
toscopic myomectomies.
In the last 15 years, the development of smaller diameter
hysteroscopes (<5 mm) with working channels and continu-
ous flow systems has made possible the treatment of most
uterine and cervical pathologies under an outpatient regimen,July 12, 2007; revised and accepted September 7, 2007.
uests: Attilio Di Spiezio Sardo, Department of Gynecology and
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102
103
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Dwith no need for either cervical dilatation or any analgesia
and/or local anesthesia.
This new philosophy (see-and-treat hysteroscopy) has re-
duced the differences between a diagnostic and an operative
procedure by introducing the concept of a single procedure,
in which the operative part is perfectly integrated in the diag-
nostic workup (12).
Mechanical operative instruments (scissors, biopsy cup,
grasping, corkscrew) have long been the only way to apply
the see-and-treat procedure in an outpatient setting (13).
The advent of bipolar technology, together with the introduc-
tion of electrosurgical systems dedicated to hysteroscopy, as
well as several types of 5-Fr electrodes, have led to a remark-
able increase in the number of pathologies that are treated by
office operative hysteroscopy, including submucous myomas
of <1.5 cm in diameter, which long have represented the cut-
off for office hysteroscopic treatment (14).
Data available in the international literature regarding the
necessity of treating such small myomas (although they usu-
ally are asymptomatic), apart from the surgical route (re-
ferred to ½as office or resectoscope treatment), are scant and
controversial. However, the current clinical trend clearly is
shifted toward a wait-and-see approach (15, 16), and expec-
tant management has been suggested as the norm (17, 18).
However, let us ½suppose, for a moment, that during a diag-
nostic hysteroscopy performed on a 30-year-old woman who
is trying to conceive, we decide not to remove an accidental,
small (<1.5 cm), submucous myoma. How could we confi-
dently answer the patient then about the risks that such a le-
sion could impair her fertility? Could we absolutely exclude
that the myoma would become bigger before or duringFertility and Sterility Vol.-, No.-,- 2007 1
ociety for Reproductive Medicine, Published by Elsevier Inc.
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ARTICLE IN PRESSpregnancy, thus posing greater risk for complications either
during gestation or during an operative procedure? And yet,
let us consider a small submucous myoma in an asymptom-
atic 40-year-old woman who is undergoing diagnostic hys-
teroscopy after an ultrasonography that is suspicious for
intrauterine growth. How could we reassure such a patient
about the nature of the mass or, most important, about the
future occurrence of any lesion-related symptom?
Using our current knowledge and presenting what we con-
sidered the best available evidence, we performed a thorough
analysis aimed at demonstrating that a wait-and-see approach
is no longer acceptable in women of reproductive age with
small submucous myomas, even if they are asymptomatic, es-
pecially if the lesion may be easily and safely removed in an
outpatient setting during the diagnostic workup, with mini-
mal patient discomfort.T
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DESTINY OF MYOMAS
It is (or should be) widely accepted that even a 0.5-cm mass
invading the uterine cavity may exert a more detrimental ef-
fect than a 3-cm lesion that is located in the uterine serosa.
We will try here to explain that. The destiny of a myoma pri-
marily depends upon the combination of its location, size,
shape, and number. This is mainly due to the special features
of the uterine cavity. Its form is that of an isosceles triangle
with incurved sides. The length of the cavity in a woman of
reproductive age is about 3 cm, with the breadth between
the fallopian tubes’ os being 1.7 cm, and <1 cm at the center
of the cavity. The volume of the uterine cavity in its physical
condition (with the walls collapsed) shows an average value
of 1 mL, whereas in pregnancy, it can exceed 10 L (19, 20).
A so-called intramural myoma is not a permanent prag-
matic entity. Most myomas arise right from the inner myome-
trial fibers of the uterine walls and show an intramural
growth. Thus, they can be undetectable at laparoscopy and/
or hysteroscopy, at%1.5 cm in size. Therefore, a purely in-
tramural myoma represents a temporary status, and its growth
is dependent on the existing hormonal conditions of the
woman. Once the myoma starts to grow inside the myome-
trium, it can displace the adjacent muscle fibers (by produc-
ing dislocation, compression, and stretching, but not rupture),
moving toward either the mucosa or the serosa. In the latter
case, it may become detectable either in the uterine or the ab-
dominal cavity.
Purely subserosal myomas usually have a longer existence,
because they may grow inside the abdomen and reach a con-
siderable size (even 10 cm in diameter, or more) before
becoming symptomatic.
Whether they are intramural and submucous or purely sub-
mucous, the destinies of myomas in a woman of reproductive
age are different. Indeed, life spans and biological behaviors
of such lesions are rather different. However, in both cases,
the earlier that symptoms appear, the quicker will be recogni-
tion and treatment.2 Bettocchi et al. Destiny of myomas
SCO 5.0 DTD  fns22808  28 SeF
Because myomas usually are spherical in shape, it is easy
to calculate by simple mathematics both their volumes and
surfaces (Figs. 1 and 2), as follows: ½
volume ¼ 4=3 p r3 and surface ¼ 4 p r2; where p
¼ 3:14 and r ¼ ray:
We would like to focus the reader’s attention on the follow-
ing two simple observations. First, linear growth in the diam-
eter of a myoma corresponds to squared growth in its surface
and to cubic growth in its volume. And second, a submucous
myoma with a diameter of 2 cm, demonstrating a volume of
3.57 cm3 and a surface of 11.34 cm2, would exceed the vol-
ume and the surface of a normal uterine cavity.E
D
P
R
OHormonal Influence on Myomas ½As has been ½well established in the literature, myomas are es-
trogen-dependent tumors (21). In women of reproductive
age, one could logically expect myomas to change in size.
In this respect, and as soon as there exists for them the posi-
tive stimuli of estrogens, even small myomas (1 or 2 cm) have
a high growth potential and may result in a lesion that is more
difficult to treat. We are not aware of any evidence of differ-
ing growth potential according to the myoma’s position (e.g.,
whether they are subserosal, intramural, or submucous).
Likewise, there is no definitive answer that can be given a pa-
tient who wonders whether an asymptomatic myoma will
ever cause symptoms in the future. Such an answer becomes
even more uncertain when the question involves pregnancy-
related complications, because hormonal variations become
more evident in such a case.Risk of Malignancy
Even though the risk of malignancy is rare, even the most ex-
perienced operator cannot exclude malignancy or premalig-
nant lesions (i.e., atypical polypoid adenomyoma) from the
histological analysis (22), especially when the morphologic
appearance of a lesion is obscure (e.g., polypoid contour)
(23). Furthermore, the lack of a histological analysis may
lead to a dangerous diagnostic delay in detecting mesenchymal
tumors, which usually show aggressive biological behavior.Myomas and Infertility
Uterine myomas also may be associated with female infertil-
ity that is caused by several incompletely clarified pathoge-
netic mechanisms (24–34). Their negative effects on
fertility appear mainly to be dictated by their location and
size (11, 35), with submucous myomas having more detri-
mental effects than intramural and subserosal ones (25, 28,
32, 34).
The percentage of women undergoing hysteroscopic myo-
mectomy for infertility ranges from 11.6% to 32% (4, 37),
with a reported postsurgical pregnancy rate varying from
16.7% to 76.9% (11, 28, 31, 32, 36–48).Vol.-, No.-,- 2007
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FIGURE 1
Relation between myoma½Q24 diameter and surface. Linear growth in the diameter of a myoma corresponds to
squared growth in its surface.
Bettocchi. Destiny of myomas. Fertil Steril 2007.
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However, the effects of hysteroscopic resectoscopic myo-
mectomy on infertility still are unclear (10, 11). Indeed, as-
sessing the real impact of such endoscopic technique on
subsequent fertility appears to be hampered by difficulties
in controlling for multiple infertility factors, by the varying
number of submucous myomas resected, as well as by the
presence of concomitant intramural fibroids (37, 49–51).
At present, it has yet to be ascertained whether small my-
omas that minimally distort the uterine cavity reduce fertility
potential. Dietterich and colleagues (30) have reported that
small myomas, which do not modify the morphology of the
uterine cavity, appear not to affect conception outcomes,
even in older women.
However, it is likely that as a submucous myoma gets bigger
or invades further into the uterine layers, it will exert a more det-
rimental effect on fertility and will be more difficult to remove.
Nevertheless, a definite response to this issue may be given only
after appropriate prospective randomized studies have been
conducted and the genetic mechanisms at the basis of myoma
development and growth have been completely clarified.
In the meanwhile, we can state only that fertility issues are
a sensitive area, in which every treatment option has to be ex-
tensively discussed with the subfertile couple, with the latter
contributing essentially to the decision making process.Fertility and Sterility
SCO 5.0 DTD  fns22808  28 SeHowever, if the woman has a pathologic medical background
(e.g., history of recurrent miscarriage or early pregnancy loss),
the removal of these lesions should always be recommended.Myomas and Assisted Reproduction Techniques
The advent of assisted reproductive techniques (ART) and in
particular of IVF has offered a useful tool for elucidating the
impact of myomas on embryo implantation. However, be-
cause there still is no definite consensus on whether myomas
affect the outcome, they should be removed before any at-
tempt. Their location, followed by their size, is considered
to be the main factor determining this impact (52).
Four meta-analyses (31, 33, 53, 54) have aimed to assess
the impact of fibroids on IVF cycles.
Pritts (31) reported significantly lower pregnancy rates
(risk ratio, ½0.32), implantation rates (risk ratio, 0.28), and de-
livery rates (risk ratio, 0.75) in patients with submucosal my-
omas and abnormal uterine cavities, in comparison with
infertile control women without myomas. Results from Don-
nez ½and Jadoul (33) confirmed that only submucous myomas
have a negative impact on embryo implantation.
Conversely, Benecke et al. (53) also reported a negative
impact of intramural myomas. Recently, Somigliana et al.3
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FIGURE 2
Relation between myoma diameter and volume. Linear growth in the diameter of a myoma corresponds to cubic
growth in its volume.
Bettocchi. Destiny of myomas. Fertil Steril 2007.
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icantly lower pregnancy and delivery rates for patients with
submucosal myomas (respective odds ratios, 0.3 and 0.3)
and with intramural myomas (respective odds ratios, 0.8
and 0.7).
The impact of hysteroscopic myomectomy on IVF out-
come has been less extensively investigated. Among the three
studies that evaluated the impact of previous myomectomy
on IVF cycles (50, 55, 56), only two (50, 56) have included
patients who were operated on for submucosal myomas.
A meta-analysis of those two studies reported that hystero-
scopic myomectomy does not appear to negatively affect the
chance of pregnancy in IVF cycles (54). However, such pos-
itive results may be in doubt, because they were based on only
two retrospective studies, both of which were characterized
by a limited number of patients.
To our knowledge, there have been no prospective studies
comparing removal vs. nonremoval of submucous myomas
of <1.5 cm diameter in women undergoing ART.
However, also considering the potential risk of failure, we
believe that patients undergoing ART, especially those with
unexplained infertility or with a history of recurrent implan-
tation failures, need the best conditions before any treatment
cycle. Further, in the case of infertile patients with a history of4 Bettocchi et al. Destiny of myomas
SCO 5.0 DTD  fns22808  28 Serecurrent implantation failures, a ‘‘special emphasis on cor-
rectable causes’’, including myomas, has been suggested
(57). The reasons for treatment are quite profound. Indeed,
even if a submucous myoma is of small size, it may impair
embryo implantation potential by causing endometrial
changes, by altering myometrial vascularization and contrac-
tility, or simply by producing a mechanical compression.
In conclusion, we have presented the most apparent rea-
sons for why submucous myomas, even if they are small
and asymptomatic, should be treated in an office setting in
women of reproductive age. We admit that much of the
data referred to in this study are derived from an indirect ap-
proach, looking at the effect of fibroids on either causing
symptoms or affecting reproduction.
Small myomas, being hormone-dependent benign tumors,
have a high potential to grow and either become symptomatic
or cause complications during natural or assisted conception
and pregnancy. The clinician should always be aware of the
biological effect of the hormonal changes and/or of high cir-
culating levels of estrogens during a woman’s reproductive
life. In the menstrual cycle itself, the induced ovarian hyper-
stimulation during ART, as well as pregnancy, in most cases
will enlarge myomas (58). In such cases, one could logically
expect enlargement of a small and possibly asymptomatic
myoma that is accidentally discovered in a diagnosticVol.-, No.-,- 2007
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ARTICLE IN PRESSworkup. If so, the expected side effects and complications
mentioned in this article would be much more difficult to
treat later.
The evidence, so far, is not enough to justify a policy of not
treating. Therefore, at present, the clinician’s choice has to be
influenced by the above-mentioned parameters. Neverthe-
less, every situation and patient must to be judged separately;
that is, management options must be biased toward the least
risk of impairing fertility or of causing complications during
pregnancy.
The use of large-diameter instruments such as resecto-
scopes, even in the presence of such small lesions, is not rec-
ommended because it requires cervical dilatation; local or
general anesthesia; and an operating room with dedicated
personnel, with correspondingly elevated health care costs.
However, office hysteroscopy appears to be an excellent
method for the treatment of such lesions, because it has be-
come easy to learn and perform. Moreover, with the aid of
modern technology, it is accurate and offers the additional
benefit of cost savings, shorter recovery, and minimal patient
discomfort.
Nevertheless, currently, the effectiveness of office myo-
mectomy has been demonstrated only in a few studies, which
were characterized by potential methodological weaknesses,
including the lack of a control group of women and a rela-
tively short-term follow-up (14, 59, 60). Larger prospective
comparative studies are needed to better evaluate this prom-
ising approach in terms of symptom response, complications,
and cost savings. C Q21
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ARTICLE IN PRESS1 The destiny of myomas: should we treat small
submucous myomas in women of reproductive
age?
S. Bettocchi, C. Siristatidis, G. Pontrelli, A. Di Spiezio
Sardo, O. Ceci, and L. Selvaggi
Bari, Greece and Naples, Italy
A wait-and-see approach is no longer acceptable in
women of reproductive age when it comes to small
submucous myomas, even if they are asymptomatic.
This is especially the case if the lesion may be easily
and safely removed in an outpatient setting by using
hysteroscopy.U
N
C
O
R
R
E
C
T
E
D
P
R
O
O
F
Fertility and Sterility
SCO 5.0 DTD  fns22808  28 September 2007  12:29 pm  ce 12
i
p
p
c
t
R
1
2
3
4
5
6
7
8
d
R
T
t
m
i
g
a
h
s
n
t
i
w
T
a
l
d
b
s
r
w
i
o
w
t
p
.
r
d
s
u
u
t
t
p
o
o
o
b
a
h
R
1
125Letters to the Editormaging techniques, as we recently supported in 2 studies on
reoperative evaluation of submucous myomas [7,8]. Ap-
ropriate integration of sonography (diagnosis) and endos-
opy (treatment) should enable our patients to benefit from
he best possible minimal surgery required by their disease.
Francesco P.G. Leone, MD
Enrico Ferrazzi, MD
Milan, Italy
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esponse
o the Editor:
First of all, we thank Dr. Leone and Prof. Ferrazzi for
heir interest regarding our article [1]. Their insightful com-
ents are worthy of our response to better clarify some
ssues.
It is unquestionable that ultrasound has revolutionized
ynecology in that it allows us to see what we palpate, but
lso what we cannot palpate. Particularly, in recent years, it
as been well-established that 3-dimensional (3D) ultra-
ound is an accurate and reproducible method for the diag-
osis of congenital uterine anomalies. The superiority of 3D
echnique over conventional 2-dimensional (2D) ultrasound
s in its ability to visualize the coronal plane of the uterus
ith both the internal and external uterine fundal contours.
he 3D technique allows not only for description of thenomaly but also measurements to be made (i.e., septum
ength, length of uterine cavity) [2].
However, with the same intellectual honesty, it cannot be
enied that, currently, hysteroscopy has also made it possi-
le to palpate (treat) under direct view (so it is not a blind
urgery) those intrauterine structures that can only be indi-
ectly seen at 2D or 3D ultrasonography.
Indeed, the development of smaller diameter scopes
ith working channels and continuous flow systems has
ntroduced the concept of a single procedure in which the
perative part is perfectly integrated with the diagnostic
orkup (see-and-treat hysteroscopy) [3,4]. According to
his philosophy, in our study we have investigated “ the
ossibility of performing metroplasty in an office setting
. . without any prior laparoscopic information.” Our
esults have demonstrated if a double uterine cavity is
iagnosed at hysteroscopy, we have the opportunity, in-
truments, technique, and criteria to differentiate double
teri and to safely treat only those suggestive of being
terine septa, independent of an earlier assessment of the
rue anatomy of the uterus.
However, we agree with Dr. Leone and Prof. Ferrazzi
hat, if available, 3D transvaginal sonography and post-
rocessing technologies could avoid unnecessary hyster-
scopies and laparoscopies. Unfortunately such technol-
gies:
1) are still not available in many centers and, in the
majority of cases, a uterine anomaly continues to be
only suggested by 2D transvaginal sonography and
then confirmed at hysteroscopy/laparoscopy or inci-
dentally found at endoscopic view.
2) if available, are not always located in the same am-
bulatory center where the hysteroscopic procedure is
performed.
3) at least in Italy, when the patient comes to a center, an
appointment is made for a single procedure. It is very
difficult to perform an additional examination if it is
not scheduled prior.
In conclusion, the current study did not aim at dem-
nstrating that hysteroscopy could replace ultrasound (or
etter, 3D ultrasound) but that, if 3D ultrasound is not
vailable, one could diagnose correctly a septum with
ysteroscopy.
Stefano Bettocchi, MD
Attilio Di Spiezio Sardo, MD
Luigi Nappi, MD
Bari, Naples, and Foggia, Italy
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TECHNIQUES AND INSTRUMENTATION
Hysteroscopy: a technique for all? Analysis of 5,000
outpatient hysteroscopies
Attilio Di Spiezio Sardo, M.D., Alexander Taylor, M.R.C.O.G., M.D., Panos Tsirkas, M.D.,
George Mastrogamvrakis, M.D., Malini Sharma, B.Sc., M.R.C.O.G., and
Adam Magos, B.Sc., M.D., F.R.C.O.G.
Minimally Invasive Therapy Unit and Endoscopy Training Centre, University Department of Obstetrics and Gynaecology, Royal
Free Hospital, London, United Kingdom
Objective: 1) To investigate the relationship between operator experience and the success of outpatient hystero-
scopy; and 2) to determine if the introduction of normal saline and the use of narrow-caliber hysteroscopes and
vaginoscopic approach are associated with a lower failure rate.
Design: Retrospective study.
Setting: Teaching-hospital based outpatient hysteroscopy clinic.
Patient(s): Five thousand consecutive women undergoing outpatient hysteroscopy between October 1988 and
June 2003.
Intervention(s): The hysteroscopies were carried out both by experienced operators and by trainees. Procedures
were performed using 4-mm and 2.9-mm telescopes with 5-mm and 3.5-mm diagnostic sheaths, respectively. Be-
tween October 1988 and 1996, the uterine cavity was distended with CO2 (CO2 period), whereas normal saline was
preferred after 1997 (1997–2003: saline period). Traditional technique of hysteroscope insertion and vaginoscopic
approach were used depending on operator preference and experience and patient characteristics.
Main Outcome Measure(s): Success, failure, and complication rates.
Result(s): The hysteroscopies were successfully performed in nearly 95% of cases by 362 operators (mean 13.8
hysteroscopies per operator) with different levels of expertise. Failure and complication rates were 5.2% and 5.4%,
respectively, without any significant difference between CO2 and saline periods. Vasovagal attacks and shoulder
pain were significantly higher during the CO2 period. The success of outpatient hysteroscopy was negatively af-
fected by postmenopausal status, nulliparity, need for cervical dilatation or local anaesthesia, traditional technique
of hysteroscope insertion, and use of a 5-mm hysteroscope.
Conclusion(s): A high level of expertise is not a prerequisite to performing hysteroscopy on an outpatient basis.
Recent advances in technique and instrumentation facilitate this approach and might encourage greater adoption by
the wider gynecology community. (Fertil Steril 2008;89:438–43. 2008 by American Society for Reproductive
Medicine.)
Key Words: Complication, experience, failure, outpatient hysteroscopy, success, vaginoscopyHysteroscopy can be regarded as the gold standard for
the evaluation of the uterine cavity in cases of abnormal uter-
ine bleeding, infertility, recurrent pregnancy loss, and sus-
pected intrauterine out-growth (1, 2). It has replaced
conventional cervical dilatation and curettage under general
anesthesia, which has been shown to be diagnostically rela-
tively inaccurate (3–6), for the investigation of abnormal
uterine bleeding.
Hysteroscopy can be performed in the office setting (outpa-
tient hysteroscopy) or as a day-case procedure, under general
Received January 4, 2007; revised and accepted February 27, 2007.
Reprint requests: Attilio Di Spiezio Sardo, M.D., Via Vecchia San Gennaro
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438anesthesia (inpatient hysteroscopy). Outpatient hysteroscopy
has been shown to be as accurate as inpatient hysteroscopy.
But compared with a traditional inpatient procedure, it has
the advantage of reduced anesthetic risks, enhanced time-
cost effectiveness, and patient preference (3, 7–8).
We believe the success of outpatient diagnostic hystero-
scopy is based on three fundamental criteria: instrument qual-
ity, characteristics of the distension medium, and the ability
and experience of the operators (9).
Recent technical advances, such as the introduction of
small-diameter rigid and flexible hysteroscopes, have made
it possible to perform hysteroscopy in the outpatient setting
(10–13). Moreover the introduction of an atraumatic inser-
tion technique (‘‘no touch’’ technique or vaginoscopic0015-0282/08/$34.00
Published by Elsevier Inc. doi:10.1016/j.fertnstert.2007.02.056
approach) has further minimized the patient’s pain and
discomfort (11, 14–19).
Carbon dioxide (CO2) and normal saline are the most com-
monly used distension medium for diagnostic hysteroscopy.
Although CO2 gas is generally well tolerated, uterine disten-
sion with normal saline has been shown to be more comfort-
able for the patient, to be more cost-effective, and to provide
superior hysteroscopic views in cases of intrauterine bleeding
(4, 13, 17, 20–22).
However, despite the high sensitivity and specificity, tech-
nical improvements, high patient acceptability, the low fail-
ure and complication rates, it has been estimated that only
15% of gynecologists in the United States routinely perform
office hysteroscopy (23) and that only 36% of the members of
the American Association of Gynecological Laparoscopists
do so (24). Reasons given for this include a perceived paucity
of patients who would benefit from the procedure, a duplica-
tion of procedures for patients who need surgery in the oper-
ating room, the expense of the capital equipment, poor
reimbursements, and the perception that a high level of exper-
tise is needed to perform the procedure (23). The scientific lit-
erature contributes to propagate the latter, because most
studies on feasibility and safety of outpatient hysteroscopy
state in the text that ‘‘all of the examinations were performed
by one or a few experienced operators.’’
We report the outcome and findings in 5,000 consecutive
patients who underwent the examination in a teaching hospi-
tal–based outpatient hysteroscopy clinic. By definition,
therefore, the hysteroscopies were carried out both by expe-
rienced operators and by trainees. Our analysis focused on: 1)
the relationship between operator experience and the success
of the procedure; and 2) determining if the introduction of
normal saline and the use of narrow-caliber hysteroscopes
and the no touch technique are associated with a lower failure
rate.
MATERIALS AND METHODS
We conducted a retrospective review of 5,000 patients who
underwent outpatient hysteroscopy between October 1988
and June 2003. The hysteroscopies were done at the John
Radcliffe Hospital, Oxford (October 1988 to May 1990),
and The Royal Free Hospital, London (June 1990 to June
2003). The study was approved by our Institutional Review
Board, and all patients had given their informed consent for
the hysteroscopy.
The most common indication for the procedure was abnor-
mal uterine bleeding (84.7% of cases), and other reasons
were subfertility (7.2%), check hysteroscopy after hystero-
scopic surgery (3.5%), and lost intrauterine contraceptive
device (1%) (Table 1). The women were defined as premen-
opausal, perimenopausal, and postmenopausal according to
the following criteria: premenopausal—all women<45 years
old with regular and/or irregular menstrual cycles; perimeno-
pausal—women >45 years old with regular and/or irregularFertility and Sterilitymenstrual cycles; and postmenopausal—women at least
1 year after the last menses or those who were taking estrogen
replacement therapy.
Between October 1988 and April 1998 hysteroscopy was
performed using a standard 4-mm telescope with a 30
fore-oblique lens and a 5-mm diagnostic sheath. After April
1998, hysteroscopy was performed using both the 4-mm tele-
scope and the newer 2.9-mm optic with a 30 fore-oblique
lens and a 3.5-mm diagnostic sheath (all instruments manu-
factured by Storz, Tuttlingen, Germany). Illumination was
provided by a high-intensity cold light source via a fiber-optic
lead. All the procedures were monitored using a video
camera and a monitor.
Between October 1988 and 1996, the uterine cavity was gen-
erally distended with CO2 (CO2 period) via an electronic Hamou
hysteroflator (Storz) adjusted to a flow rate of 45 mL/min and
a pressure not exceeding 100 mm Hg. Following the results of
our study in 1996 (13), we changed the distension medium to
normal saline (1997–2003: saline period) infused at a pressure
of 100 to150 mm Hg by a pressure bag.
TABLE 1
Patient characteristics.
Number of cases 5,000
Age, yrs (range) 44.2 (17–87)
Parity, mean 1.59
Nulliparous (%) 1,448 (29.8)
Menopausal status (%)
Premenopausal 3,426 (68.5)
Perimenopausal 679 (13.6)
Postmenopausal 895 (17.8)
Current use of gynecologic
medication (%)
1376 (27.5)
Hormonal 931 (18.6)
Nonhormonal 402 (8.0)
Both 43 (0.9)
None 3597 (72.3)
Previous uterine surgery (%) 859 (17.1)
Cesarean section 304 (6.1)
Myomectomy 170 (3.4)
Endometrial ablation 159 (3.2)
Cervical surgery 101 (2.0)
Others 125 (2.5)
Primary indication for hysteroscopy (%)
Abnormal uterine bleedinga 4216 (84.7)
Subfertilityb 360 (7.2)
Control after
hysteroscopic surgery
174 (3.5)
Lost IUCD 48 (1.0)
Note: IUCD ¼ intrauterine contraceptive device.
a Includes menorrhagia, intermenstrual bleeding, post-
coital bleeding, and postmenopausal bleeding.
b Includes infertility and recurrent miscarriage.
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Patients were placed in the lithotomy position and an anti-
septic solution was used to wash the vaginal cavity and the
cervix. A bimanual examination was then performed to as-
sess the size and position of the uterus. Diagnostic hystero-
scopy was then performed using two different techniques:
Traditional technique: A Sims speculum was inserted into the
vagina to visualize the cervix, and a vulsellum was then ap-
plied to the anterior lip of uterine cervix to create counter-
traction to facilitate the insertion of the hysteroscope.
No-touch technique: This was introduced in our clinic in 1999
and avoids the use of a speculum and a tenaculum. The hys-
teroscope is first introduced into the introitus of the vagina.
The vagina is then distended with the saline distension me-
dium. This facilitates visualization of the anatomy. The
hysteroscope is then directed towards the cervix, the cervi-
cal canal, and then into the uterine cavity (14, 15, 19).
From 1988 to 1999, all hysteroscopies were performed
with the traditional technique. After 1999, hysteroscopies
were performed with either technique depending on operator
preference and experience and patient characteristics.
Whichever technique was used, the hysteroscope was guided
through the endocervical canal and and into the uterine cavity
under direct vision. The cavity was then systematically exam-
ined, starting at the fundus and tubal ostia and finishing in the
endocervical canal, which was examined in more detail dur-
ing withdrawal of the hysteroscope. Cervical dilatation up to
Hegar 4–6 and/or intracervical local anesthesia were carried
out only when required. If this became necessary with the no
touch technique, the hysteroscopy was continued using the
traditional approach.
Endometrial biopsies were performed based on symptoms
or abnormal hysteroscopic findings. Most biopsies were done
using a small metal curette (1988 to 1996) or with a Pipelle de
Cornier (1996 onwards; Laboratoire CCD, Paris, France). If
a target biopsy was required, it was done using either 5-Fr bi-
opsy forceps with an operative hysteroscope or a small metal
curette. Minor surgical procedures were performed via 7-mm
and 5-mm operative sheaths for 4-mm and 2.9-mm hystero-
scopes, respectively, using flexible scissors or grasping for-
ceps (all of the equipment manufactured by Storz). Minor
surgical procedures involving the cervix (e.g., removal of
IUD, cervical polypectomy) were performed with conven-
tional instruments.
All hysteroscopies were defined as attempted or not at-
tempted; the latter included cases where there was a contrain-
dication or the patient chose to cancel the procedure.
Hysteroscopies which were attempted were classified as suc-
cessful (complete or incomplete) or failed according to the
following criteria: complete—the entire uterine cavity in-
cluding both tubal ostia were visualized; incomplete—the en-
tire uterine cavity could not be examined (e.g., part of cavity
was obscured by blood clots, fibroids, or other focal lesions,
technical problems with the instruments, lack of distension);
and failed—examination of the uterine cavity was not possi-
ble (e.g., because of pain, vasovagal attack, cervical stenosis,440 Di Spiezio Sardo et al. Hysteroscopy: a technique forextreme anxiety, heavy bleeding). Failed hysteroscopies were
referred for investigation under general anaesthesia or for
other investigations.
The hysteroscopic view, defined as the quality of the pan-
oramic overview inside the uterine cavity, was defined as
good or poor according to the following criteria: good–the
view was of a high quality, allowing for a rapid assessment
of the shape of the uterine cavity, the endometrium, and
any focal lesions; poor–the view of the uterine cavity was
of low quality, allowing for only slow identification of struc-
tural abnormalities.
Data collection was performed by four people (A.D.S.,
G.M., V.P., and P.T.) using a dedicated Access database
(Microsoft, Redmond, WA). Data analysis was done using
Access, Excel (Microsoft), and SPSS 9.0 (SPSS, Chicago,
IL). Statistical significance was assessed using c2 and Fisher
exact tests. All tests were two sided, and P<.05 was consid-
ered to be statistically significant.
RESULTS
The baseline characteristics of the 5,000 women are summa-
rized in Table 1. Most women were multiparous and premen-
opausal and complained of abnormal uterine bleeding. The
outcomes are shown in Table 2. In 98.2% of cases a hystero-
scopy was attempted and in 89.7% completed. The hystero-
scopic view was judged as good in 92.7% of successful
hysteroscopies. The main reasons for canceling the hystero-
scopy were high blood pressure before the procedure
(18 cases), patient choice (16 cases), and severe anxiety
(15 cases).
The hysteroscopies were performed by 362 different oper-
ators, the average number of hysteroscopies per operator was
13.8. A small percentage of operators (7.7%) performed>20
hysteroscopies (Table 3). The majority of hysteroscopies
(72%) were performed by operators with lower experience
(<50 hysteroscopies/operator).
The main reasons for failed hysteroscopies are shown in
Figure 1.
Two thousand seven hundred fifty-four hysteroscopies
were attempted in the CO2 period (group A) and 2,156 in
the saline period (group B).
TABLE 2
Technical outcome of 5,000 outpatient
hysteroscopies.
Attempted Not attempted
Total 4,910 (98.2%) 90 (1.8%)
Complete 4,487 (89.7%) —
Incomplete 163 (3.3%) —
Failed 260 (5.2%) —
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One hundred thirty-five failed hysteroscopies (135/2,754:
4.9%) occurred in group A, and the other 125 (125/2,156:
5.7%) occurred in group B. No significant difference in fail-
ure rate was detected between the two groups (c2 ¼ 1.94;
P¼n.s.).
Failure of hysteroscopy was mainly influenced by post-
menopausal status (7.6% vs. 4.8%; c2 ¼ 11.0; P<.001), nul-
liparity (6.2% vs. 4.8%; c2 ¼ 4.4; P<.05), need for cervical
dilatation (6.6% vs. 3.5%; c2 ¼ 24.9; P<.001) or local anes-
thesia (7.4% vs. 3.0%; c2 ¼ 49.4; P<.001), traditional tech-
nique of hysteroscope insertion (5.5% vs. 0.9%; c2 ¼ 33.8;
P<.001), and use of a 4-mm optic (4.9% vs. 2.7%; c2 ¼
7.3; P<.01).
The most frequent complications during hysteroscopy pro-
cedure are shown in Figure 2.
The overall rate of complications was 5.4% (266/4,910).
One hundred fifty-one complications (151/2,754: 5.48%) oc-
curred in group A and 115 (115/2,156: 5.3%) in group B. No
significant difference in complication rates was detected be-
tween the two groups (c2¼ 0.05; P¼n.s.). Complications led
to failed hysteroscopy in 54.8% of cases (146/266). Vasova-
gal attacks (c2 ¼ 13.49; P<.001) and shoulder pain (c2 ¼
9.57; P<.01) were significantly higher in group A.
TABLE 3
Operator experience.
Number of hysteroscopies
performed Operators (%)
<20 334 (92.2)
20–50 20 (5.5)
>50 8 (2.2)
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FIGURE 1
Reasons for failed hysteroscopy.
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mainly influenced by nulliparity (c2¼ 4.14; P<.05), need for
cervical dilatation (c2 ¼ 27.64, P<.05) or local anaesthesia
(c2 ¼ 42.51; P<.05), traditional technique of hysteroscope
insertion (c2 ¼ 21.47; P<.05), and use of a 4-mm optic
(c2 ¼ 4.33; P<.05).
The 4-mm and 2.9-mm scopes were used in 84.7% and
15.3% of cases, respectively.
The traditional (group C) and the vaginoscopic technique
(group D) for insertion of the hysteroscope were used in
81.9% and 18.1% of cases, respectively.
A lower percentage of failed hysteroscopies was detected
in group D with either the 4-mm or the 2.9-mm scope, in
comparison with group C (2.9 mm: 4.4% vs. 1%; c2 ¼ 9.0;
P<.01; 4 mm: 5.1% vs. 0.5%; c2 ¼ 16.5; P<.001).
Five hundred forty-eight minor procedures were per-
formed during hysteroscopy. The operative sheath with hys-
teroscopic flexible instruments (grasping, scissors, biopsy
forceps) was used in 182 (33.2%) cases, for target biopsies
(n¼ 56), polypectomies (n¼ 83), removal of intrauterine de-
vices (n ¼ 30), adhesiolysis (n ¼ 5), and other minor proce-
dures (n ¼ 8).
Vaginal instrumentation (tenaculum, Kocher, biopsy for-
ceps) after hysteroscopic examination of uterine cavity was
used in 366 cases (76.8%) for biopsies (n ¼ 4), polypecto-
mies (n ¼ 316), removal of intrauterine device (n ¼ 39),
adhesiolysis (n ¼ 6), and other minor procedures (n ¼ 1).
DISCUSSION
To the best of our knowledge, this is the first report in inter-
national literature of a large series of outpatient hysteroscop-
ies in which the procedures were performed by a large
number of operators with different levels of expertise.
In 1996, Nagele et al. (2) analyzed the outcome of the first
2,500 hysteroscopies performed in our department, with the
main aim of demonstrating the feasibility and acceptability
of outpatient diagnostic hysteroscopy.
Our descriptive analysis of 5,000 hysteroscopies (includ-
ing the 2,500 reported by Nagele et al.) fills a gap in the ex-
isting literature. Previously in the published studies,
hysteroscopies were performed by one or a few experienced
operators. The present data demonstrate that a high level of
expertise is not a prerequisite to performing hysteroscopy
on an outpatient basis.
In the present series, 362 operators with different levels of
expertise successfully performed hysteroscopies in nearly
95% of cases. This success rate is in accordance with other
large series performed by one or a few experienced operators
(11, 14, 20, 25).
A limitation of the present study is the difficulty in evalu-
ating the level of expertise of the operator. However, because
most of the operators had performed fewer than 20441
FIGURE 2
Complications during outpatient hysteroscopy. *P< .01 vs. after 1997; **P< .001 vs. after 1997.
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sized that they were likely to be doctors in training.
Our clinical experience suggests that if the first ten hyster-
oscopies performed by a trainee are closely supervised by an
experienced operator it is possible to avoid any serious com-
plication without lowering the success rate.
Recently, Campo et al. (25) investigated the relative impor-
tance of a surgeon’s experience in a prospective multicenter
randomized controlled trial. They discovered that experi-
enced surgeons had better outcomes only when 5.0-mm con-
ventional instruments were used. This was not the case when
hysteroscopies were performed with minihysteroscopes
(3.5 mm).
The present data also confirm this. The failure rate was sig-
nificantly higher when using the 5-mm hysteroscope, sug-
gesting that a narrow hysteroscope can overcome anatomic
challenges and operator limitations.
The second objective of our analysis was to determine if
the introduction of normal saline, smaller hysteroscopes,
and the vaginoscopic approach have lowered the failure rate.
In 1996, Nagele et al. (13) compared patient acceptability
and the clinical feasibility of the two most-used distension
media (CO2 and normal saline) in 157 patients undergoing
outpatient hysteroscopy. Their results showed that procedure
times were significantly longer for CO2 (because of the
occurrence of bubbles during the procedure) and that abdom-
inal and shoulder tip pain was significantly higher. After the
results of that study, all of the outpatient hysteroscopies in our442 Di Spiezio Sardo et al. Hysteroscopy: a technique for adepartment have been performed using normal saline as the
distension medium.
After 1996, other studies have confirmed that normal sa-
line is more acceptable to patients (17, 22), is quicker to
perform (22), and offers advantages in terms of good visual-
ization of uterine cavity in the presence of blood clots, mu-
cus, and debris and increasing confidence in diagnosis (21).
Our descriptive analysis did not show a significantly higher
number of complications and failed hysteroscopies between
the CO2 and saline periods, suggesting that factors other
than distension medium could exert a primary role in deter-
mining the success or failure of outpatient hysteroscopy.
However, two severe complications—vasovagal attack and
shoulder pain—were significantly higher in the CO2 period.
Taking into account that these complications globally repre-
sent 22% of all of the complications reported in the present
analysis, we believe that the use of normal saline has largely
contributed to making the procedure safer and more accept-
able to patients.
These results are in keeping with Agostini et al (26) who
have recently evaluated the risk of vasovagal syndrome in
2079 women undergoing outpatient hysteroscopy. They
showed that it is significantly higher with the use of CO2, re-
gardless of the indication for hysteroscopy, parity, and
menopausal status of the patient.
Recent technical and instrumental improvements have sig-
nificantly increased the feasibility and acceptability of hys-
teroscopy. The use of new thin telescopes (minitelescopes)ll? Vol. 89, No. 2, February 2008
1–2 mm lower in caliber compared with conventional 4-mm
ones improves the acceptability of the examination (11, 27);
indeed, a 1- to 2-mm reduction in the telescope diameter and
consequently in the total hysteroscope size (minihystero-
scopes) reduces the section area of the instrument by about
50%–75%. This could well explain why minihysteroscopes
are less painful than conventional ones (11, 28). Furthermore,
in recent years, new techniques for the introduction of the
hysteroscope into the external uterine orifice have been de-
veloped to reduce the patient’s pain and discomfort.
The vaginoscopic approach is a nontraumatic technique, in
which the hysteroscope is introduced into the vagina without
a speculum and tenaculum (14, 15). The vagina is distended
by the distension medium (normal saline) at the same pres-
sure (60–80 mm Hg) used for the subsequent distension of
uterine cavity (17). This approach has permitted complete
elimination of any kind of premedication, analgesia, or anes-
thesia, making the procedure faster and complication free
(11, 14). A recent review (16) has shown that diagnostic min-
ihysteroscopy with vaginoscopic approach is accurate with-
out significant discomfort or risk.
In a prospective randomized controlled study performed in
our unit, Sharma et al. (29) demonstrated that vaginoscopic
hysteroscopy is significantly faster to perform than the tradi-
tional technique. Although there was no difference in pain
scores between the two techniques, local anesthetic require-
ments were least in those who underwent vaginoscopic hys-
teroscopy with a narrow-bore hysteroscope.
Data from our retrospective analysis confirmed that the use
of minihysteroscopes and vaginoscopic approach is associ-
ated with significantly lower failure rates.
CONCLUSIONS
Outpatient hysteroscopy represents a simple and safe ap-
proach for intrauterine evaluation. The present large series
shows that a high level of expertise is not a prerequisite. In
addition, recent advances in technique and instrumentation
facilitate this approach and, we believe, should encourage
its higher adoption by the wider gynecology community.
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CHAPTER V 
 
NEW FRONTIERS OF SEE & TREAT HYSTEROSCOPY (2006- 
2008) 
 
In 2002 Bettocchi proposed the scheme (Fig.1) of treatment indications for office 
procedures performed using modern hysteroscopes before and after introduction of bipolar 
instrumentation. Today, thanks to further technological advancement and increased 
operator experience, some other uterine, cervical and vaginal pathologies or conditions 
may be treated in an office setting. This represents the “new frontier of  office operative 
hysteroscopy” (Fig.2). 
 
Fig.1 
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  Fig.2 
 
? TREATMENT OF VAGINAL POLYPS 
 
Vaginal polyps represent an unusual, often underdiagnosed cause of abnormal 
uterine bleeding, mostly after sexual intercourse. Vaginoscopic approach is imperative to 
obtain an appropriate vaginal distension and to identify such lesions. Then these polyps 
can be easily removed by means of 5 Fr Versapoint twizzle electrode inserted through the 
operative channel of semirigid or rigid office continuous flow hysteroscopes. Recently, M. 
Guida, Attilio Di Spiezio and coll described  a case of vaginal polyp (M. Guida,  A. Di 
Spiezio Sardo, C. Mignogna , S. Bettocchi , C. Nappi. Vaginal fibro-epithelial polyp 
as cause of postmenopausal bleeding: office hysteroscopic treatment. Gynecol 
Surg 2008; 5: 69–70) . Moreover, Attilio Di Spiezio e coll, published another study, 
reporting an exceptional case of vaginal endometriosis (A. Di Spiezio Sardo, P. Di Iorio, 
M. Guida, M. Pellicano, S. Bettocchi, C. Nappi. Vaginoscopy to identify vaginal 
endometriosis. JMIG 2008, artiche in press) 
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outpatient setting by operative vaginoscopy in 
? SECTION OF LONGITUDINAL VAGINAL SEPTUM  
 
Recently (A. Di Spiezio Sardo, S. 
Bettocchi ,S.  Bramante, M. Guida, G. 
Bifulco, C. Nappi. Office vaginoscopic 
treatment of an isolated longitudinal 
vaginal septum: a case report. JMIG 2007; 
14(4):512-5) we have treated an isolated 
longitudinal vaginal septum (Fig. 3) in an 
a 27-year-old virgin woman complaining of 
leucorrhoea and recurrent vaginal infections.  At vaginal inspection, through the unbroken 
hymeneal membrane, a partial longitudinal vaginal septum in the upper half of the vagina 
was detected. The two hemivaginas were not obstructed. To ascertain whether the cervix 
was single or double, we performed a small incision on the esocervical  surface with the tip 
of the bipolar electrode. As this mark was detectable from either side of the septum, we 
could confirm the presence of a single cervix. We then performed the resection of the 
septum by Versapoint Twizzle electrode, starting at its midpoint and progressively 
proceeding towards the vaginal apex.  
The electric energy (VC3 50W) applied during the resection provided complete 
haemostasis. 
The patient experienced only a mild pain during the resection of the upper portion of 
the septum because of the proximity of the vaginal wall which is well-known to be rich in 
sensorial neural terminations. However, analgesics were not required during nor 
immediately following the procedure.  
 
Fig. 3 
? DIAGNOSIS AND TREATMENT OF SUPERFICIAL ADENOMYOSIS 
 
Although office hysteroscopy cannot definitely diagnose or 
exclude adenomyosis (Fig.4), as its field of observation is limited 
to the endometrial surface, certain investigators (A. Di Spiezio 
Sardo, M. Guida,  S. Bettocchi,  L. Nappi, F. Sorrentino,  G. 
Bifulco, C. Nappi. Role of hysteroscopy in evaluating chronic 
Fig. 4 
pelvic pain. Fertil Steril 2008; 90(4): 1191-6) have described some hysteroscopic 
findings which are suggestive of such pathology: an irregular endometrium with superficial 
openings, hypervascularization, strawberry pattern or cystic haemorrhagic lesions.  In 
addition to the direct visualization of the uterine cavity and the possibility of obtaining 
histological specimens under visual control, hysteroscopy also offers the possibility to 
empty cystic haemorrhagic lesions by means of mechanical instruments or by Versapoint 
twizzle electrode. 
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vaporization of the residual endometrium, in order to be 
 
? ABLATION OF CERVICAL STUMP 
  
Office operative hysteroscopy may represent a therapeutic option in the case of 
cyclical or continuous bleeding in patients who have undergone subtotal hysterectomy. 
Giovanni Pontrelli, Attilio Di Spiezio Sardo and coll, reported the successful treatment of a 
40-year-old woman with ongoing cyclical vaginal bleeding lasting 10 days after 
laparoscopic subtotal hysterectomy. Hysteroscopic vaporization of the endometrial stripe 
in the cervical stump was performed in an office setting, using a 5-mm Bettocchi double-
channel operative hysteroscope armed with a bipolar electrode. (G. Pontrelli, S. Landi, C. 
Siristatidis, A. Di Spiezio Sardo, O. Ceci, S. Bettocchi. Endometrial vaporization of 
the cervical stump employing an office hysteroscope and bipolar technology. JMIG 
2007; 14: 767–769) 
Spring electrode (Fig.5), which provides a deeper 
and larger vaporization and coagulation (Fig.6) of the 
tissues may be used to 
vaporize residual endometrial 
islands present within the 
cervical stump. This procedure 
could require the use of 
conscious sedation, as the 
effective, has to reach the first 2-3 mm of the myometrium 
Fig. 5 
Fig.6 
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 OFFICE PREPARATION OF PARTIALLY INTRAMURAL MYOMAS: OPPIUM 
Resectoscopic removal of myomas 
with 
fice in order to facilitate the subsequent 
? REPOSITIONING OF MISPLACED INTRAUTERINE DEVICE 
ometimes, an intrauterine device may be  misplaced in the isthmic area, mainly 
due to
?
 
prevalent intramural extension is 
advisable to be performed only by highly 
experienced surgeons as it is technically 
difficult with a slow learning curve and it is 
associated with an higher risk of 
complications. Recently, we have developed 
a technique to prepare such myomas in of
resectoscopic procedure under general anaesthesia. It is called O.P.P.I.uM: Office 
Preparation of Partially Intramural Myomas.(Fig. 7) The endometrial mucosa which covers 
the myoma, is incised by means of scissors or 5 Fr bipolar electrodes along its reflection 
line on the uterine wall, up to the precise identification of  the cleavage surface between 
the myoma and pseudo-capsula, thus facilitating the protrusion of the intramural portion of 
myoma into the cavity during subsequent menstrual cycles. This action may in turn 
facilitate the subsequent total removal of the lesion via resectoscopy, as the surgeon will 
deal with a lesion with prevalent intracavitary development, working more safely and 
quickly (S. Bettocchi, A. Di Spiezio Sardo, M. Guida, E. Greco, L. Nappi, G. Pontrelli, 
C. Nappi. Office Preparation of Partially Intramural Myomas (OPPIuM): A Pilot Study: 
Golden Hysteroscope Award for the Best Hysteroscopy paper, 37th AAGL meeting, 
Las Vegas, 30 October-1 November 2008) 
 
Fig 7 
 
S
 incorrect positioning;  in such instances, we can re-position it, by grasping it with 
forceps or simply by pushing the device’s distal extremity with the tip of the hysteroscope. 
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? EMPTYING OF HEMATOMETRA 
Hematometra is an accumulation of blood in the uterus. It is usually the result of 
tometra 
 EMPTYING OF UTERINE CYSTIC NEOFORMATIONS  
terine cystic neoformations are rare but they should always be investigated in order to 
 
developmental anomalies or may be secondary to cervical or vaginal obstruction . 
Recently we have described the outpatient hysteroscopic empting of a huge hema
in a 13-years-old virgin patient affected by mosaic Turner’s syndrome. Hysteroscopy was 
performed by means of a 5-mm continuous-flow operative office hysteroscope with a 2.9 
mm rod lens optic (Bettocchi office hysteroscope “size 5”, Karl Storz , Tuttlingen, 
Germany). The vaginoscopic approach (without speculum or tenaculum) was used to 
preserve the integrity of the hymen. Neither analgesia nor local anaesthesia were 
administered to the patient. Distension of the uterine cavity was obtained using normal 
saline solution and the intrauterine pressure was automatically controlled by an electronic 
irrigation and suction device (Endomat, Karl Storz, Tuttlingen, Germany). The intrauterine 
pressure was set at 45 mm Hg, being the balance of irrigation flow around 200 mLthe 
uterine cavity determining a poor endoscopic vision. At this moment the vacuum pressure 
was increased up to 0.4 bar making the emptying of uterine cavity quick and easy. Nearly 
300 cc of blood were aspirated in five minutes. The uterine cavity appeared 
morphologically normal. At ultrasound follow up examination performed two days later the 
complete resolution of the hematometra was observed. The success of the procedure was 
confirmed by the resolution of clinical symptoms ( A. Di Spiezio Sardo, C. Di Carlo, MC 
Salerno, S. Sparice, G. Bifulco, M. Guida, C. Nappi. Use of office hysteroscopy to 
empty a very large hematometra in a young virgin patient with mosaic Turner’s 
Syndrome. Fertil. Steril 2007; 87: 417. e1-3) 
 
?
 
U
rule out a malignant lesion. The differential diagnosis of the uterine cystic mass include 
congenital malformation, leiomyomata cystic degeneration, adenocystic tumor, 
adenomyosis, echinococcus cyst and intramyometrial hydrosalpinges. The diagnostic 
work-up of these lesions include transvaginal ultrasonography, magnetic resonance 
imaging (MRI) and blood tests and it is essential to avoid any over or under-treatment. 
Office hysteroscopy might represent an helpful tool both for its diagnostic and therapeutic 
properties. Recently, Attilio Di Spiezio Sardo e coll,  reported the hysteroscopic emptying 
of a cystic- degenerated leiomyoma with a 5- Fr flexible needle inserted through the 
operative channel of a 5mm continuous- flow operative office hysteroscope in an 
outpatient setting. This needle is normally used in gynecology to instill intrauterine local 
anesthesia under a hysteroscopic view. The authors adapted it to drain a fluid- filled lesion, 
identifying a further application of this instrument ( A. Di Spiezio Sardo, M. Guida,  G. 
Bifulco, S. Frangini, M. Borriello, C. Nappi. Outpatient hysteroscopic emptying of a 
submucosal uterine cystic lesion. JSLS. 2007; 11:136- 137)    
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  DIAGNOSIS OF CERVICAL METAPLASIA OF ENDOMETRIUM 
ysteroscopy can be useful also in infertile  patients affected by  Cystic Fibosis. Indeed, 
 REMOVAL OF UTEROVAGINAL PACKING  
ttilio Di Spiezio Sardo and coll, have 
reporte
nt setting and a ing a repeated 
?
 
H
Roberto Piccoli, Attilio Di Spiezio Sardo and coll, have recentely described  the case of an 
infertile female patient with cystic fibrosis who was diagnosed with endocervical 
metaplasia of the endometrium at diagnostic hysteroscopy and successfully treated with 
an oral estroprogestinic formulation. This report suggest a novel histological alteration 
possibly involved in affecting fertility in women with cystic fibrosis. (R. Piccoli, A. Di 
Spiezio Sardo, L. Insabato, G. Acunzo, M. Guida, C. Nappi. Endocervical 
metaplasma of the endometrium in a patient with cystic fibrosis: a case report. 
Fertil. Steril. 2006; 85: 750 e 13-6) 
 
?
 
A
d on the successful hysteroscopic  removal of 
uterovaginal packing, inserted during caesarean 
sections  following uterine haemorrhage resistant to 
medical therapy. The packing could not be removed 
vaginally with sponge forceps as it had adhered to 
the uterine cavity. A hysteroscopic approach 
enabled identification and cutting with 5Fr scissors of 
the stitches fixing the packing to the uterine walls  
(Fig 8), allowing straightforward removal in an outpatie
laparotomy ( S. Bettocchi, A. Di Spiezio Sardo, L. Pinto, M. Guida, M. Antonietta 
Fig. 8 
void
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Castaldi, O. Ceci, C. Nappi. Outpatient hysteroscopic removal of gauze packing 
adherent to the uterine cavity: report of 2 cases. JMIG 2008, article in press) 
In conclusion, provided we have the appropriate equipment, some basic rules  
should always be followed in order to perform a safe and effective office operative 
hysteroscopy: 
 
1)   To correctly identify and respect the indications and to apply the proper technique 
for each pathology detected  
2)  To maintain uterine muscle integrity at all times by avoiding touching, scratching 
or cutting the muscle fibres 
3)  To maintain a constant intrauterine pressure (lower than 70mmHg) and a clear 
intrauterine view during the overall procedure         
4) To work with the active area of the instrument (either mechanical or 
electrosurgical) very close to the tip of the hysteroscope, thus avoiding loss of 
depth of view.  
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Vaginal fibro-epithelial polyp as cause of postmenopausal
bleeding: office hysteroscopic treatment
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Abstract We report on the case of a 72-year-old woman
who underwent office hysteroscopy following an episode of
postmenopausal bleeding. A vaginal fibro-epithelial polyp
was diagnosed and removed by means of a 5 Fr bipolar
electrode inserted through the operating channel of a 5 mm
continuous flow office hysteroscope.
Keywords Hysteroscopy . Office . Vaginal polyp
Fibro-epithelial polyp
Introduction
When an organic cause of postmenopausal bleeding is
suspected, a uterine or cervical lesion is usually searched
for. Vaginal lesions represent an unusual, often under-
estimated, cause of postmenopausal bleeding. Among
vaginal lesions, the fibro-epithelial polyp (FP) represents a rare
benign growth that should not be mistaken for a malignant
growth, especially embryonal rhabdomyosarcoma [1].
Case
We report on the case of a 72-year-old woman who
underwent office hysteroscopy following an episode of
postmenopausal bleeding. The study was eventually ap-
proved by our Institutional Review Board.
Hysteroscopy was performed by a vaginoscopic ap-
proach (without speculum and tenaculum) using a 5 mm
continuous flow office hysteroscope (Bettocchi Office
Hysteroscope size 5; Karl Storz, Germany) with a 30°
grade optic and an incorporated 5 Fr working channel.
Normal saline solution was used for vaginal and uterine
distension.
After a thorough inspection of the vagina, a polypoid
lesion was detected in the proximal portion of the vagina
near to the posterior cervical lip. The lesion was reddish,
1 cm in size, and with the appearance of a small
“cauliflower” (Fig. 1). The uterine cavity and the
endocervical canal showed no abnormalities.
The vaginal lesion was resected by means of a 5 Fr
Twizzle bipolar electrode (Gynecare; Ethicon, NJ, USA)
inserted through the operating channel of the hysteroscope.
The electrode was connected through a cable with a
versatile electrosurgical system dedicated to hysteroscopy
[Versapoint Bipolar Electrosurgical System (Gynecare;
Ethicon)]. No analgesic was required during or immediate-
ly after the procedure. The histological diagnosis was FP.
At 6 months’ follow-up the patient did not complain of any
vaginal bleeding.
Discussion
FP is an uncommon hamartomatous or benign neoplastic
polypoid mass of the vagina, evoking a level of interest in
Gynecol Surg (2008) 5:69–70
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pathologists disproportionate to its frequency or signifi-
cance. The mean age at diagnosis is approximately 40 years,
with an age range varying from that of the newborn child to
77 years. The lesions are usually asymptomatic and are
discovered incidentally, during pelvic examination, on the
lateral wall of the lower third of the vagina [2].
Rarely, they can be associated with abnormal uterine
bleeding, mostly after sexual intercourse. No report of FP
as a cause of postmenopausal bleeding is available in the
international literature.
The classical surgical resection of such lesions consists
of excision by scissors after the application of a Kelly or
Kocher forcep to prevent any blood loss. The availability of
smaller diameter hysteroscopes with working channels and
continuous flow systems, and the advent of bipolar
electrosurgical technology, makes it possible to diagnose
and eventually treat such benign vaginal lesions in the
outpatient setting and also to diagnose and treat postmen-
opausal patients who might otherwise require general or
local anesthesia [3, 4]. A vaginoscopic approach is
imperative to obtain an appropriate vaginal distension and
to identify any lesion in the vaginal cavity [5, 6].
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macroscopic appearance of the
vaginal fibro-epithelial polyp
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Images in Endoscopy
Vaginoscopy to Identify Vaginal Endometriosis
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Fig. 1. Hysteroscopic view of polypoid vaginal endometriosis (VE) in the
posterior vaginal fornix (V). C5Cervix.
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Fig. 2. A chocolate-like fluid starts to spill out from polypoid vaginal endo-
metriosis (VE). V5 posterior vaginal fornix; C5 cervix.
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RThe endometriotic implants that penetrate the retroperito-neal space for a distance of 5 mm or more are defined as
deeply invasive endometriosis and typically involve the
Douglas pouch (retrocervical endometriosis) and the rectova-
ginal septum. Vaginal endometriosis is usually considered
a secondary implantation of endometriotic foci infiltrating
pouch of Douglas or mostly rectovaginal septum.
We report on a 42-year-old woman referred to our depart-
ment presenting with severe dyspareunia. Vaginal examina-U
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96tion only revealed multiple, soft irregularities in the
posterior fornix.
To better visualize the deeper vagina, vaginoscopy was
performed in the office, with a 4-mm continuous-flow office
hysteroscope (Bettocchi Office Hysteroscope size 4; Karl
Storz GmbH & Co., Tuttlingen, Germany) with a 30-degree–
grade optic and an incorporated 5Fr working channel. Normal
saline solution was used for vaginal distension. Vaginal pres-
sure was maintained at a constant 30 to 40 mm Hg with an
electronic pump for irrigation and aspiration (Endomat;
Karl Storz GmbH&Co.). There was no need to close the vul-
var labia with the fingers because the weight of the liquid is
usually sufficient to distend the vagina.
Vaginoscopy showed the presence of polypoid, pedun-
culated, brownish lesions of a size of 0.5 to 1 cm in the
posterior vaginal fornix (Fig. 1), which were drained
(Fig. 2) with a 5Fr bipolar electrode. Five-French scissors20 August 2008  6:29 pm  ce
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115and grasping forceps with teeth were respectively used to
cut and grasp some pieces of such lesions to be sent for
histological examination.
Pathologic analysis of such specimens confirmed the
clinical suspicion of endometriosis. The patient underwent
laparoscopy, which showed a small nodular lesion of the rec-
tovaginal septum that was completely excised.U
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FLA 5.0 DTD  JMIG1110_proof It might be of paramount importance to inspect the vagina
thoroughly in those women who complain of dyspareunia.
Indeed the diagnosis of vaginal endometriosis may represent
a great diagnostic challenge as very difficult to be assessed by
physical examination. Operative vaginoscopy allows
identification of vaginal lesions and obtaining specimens
for histologic diagnosis.E
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Journal of Minimally Invasive Gynecology (2007) 14, 512–515ffice vaginoscopic treatment of an isolated longitudinal
aginal septum: A case report
ttilio Di Spiezio Sardo, MD, Stefano Bettocchi, MD, Silvia Bramante, MD,
aurizio Guida, MD, Giuseppe Bifulco, MD, and Carmine Nappi, MD
rom the Department of Gynecology and Obstetrics and Pathophysiology of Human Reproduction, University of Naples
Federico II,” Naples (Drs. Di Spiezio Sardo, Bramante, Guida, Bifulco, and Nappi); and the Department of General
nd Specialistic Surgical Sciences, Section of Obstetrics and Gynecology, University of Bari, Bari (Dr. Bettocchi), Italy.Abstract. This case report describes a new treatment of an isolated longitudinal vaginal septum (LVS)
by office operative vaginoscopy with a 4-mm rigid hysteroscope in a 27-year-old virgin who reported
leukorrhea and recurrent vaginal infections. This technique might represent an effective treatment of an
LVS, mostly in patients with an intact hymen. This could allow the inclusion of vaginal lesions among
the indications for office endoscopic procedures performed using operative hysteroscopes.
© 2007 AAGL. All rights reserved.
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Office hysteroscopy;
Rigid hysteroscope;
Longitudinal vaginal
septum;
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aCongenital anomalies of the vagina, cervix, and uterus
müllerian anomalies) arise from abnormal development
uring embryogenesis and are characterized by diversity in
natomic features, clinical presentation, and reproductive
erformance. They have been estimated to occur in 1% to
% of women1 and categorized by using various classific
ion systems. A simple classification for müllerian duct
nomalies was suggested by Buttram and Gibbons in 1979.
n 1988, the American Fertility Society proposed a re-
ised classification, categorizing müllerian duct abnor-
alities into seven classes.2
The cause of most müllerian anomalies remains unclear,
ut they could potentially be due to a failure of the fusion of
he müllerian ducts and/or reabsorption of the septum. The
The authors have no commercial, proprietary, or financial interest in the
roducts or companies described in this article.
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553-4650/$ -see front matter © 2007 AAGL. All rights reserved.
oi:10.1016/j.jmig.2007.03.001irection in which fusion of the müllerian ducts occurs, the
rocess by which this is regulated, and whether the fusion
ccurs in a continuous manner are still unknown.
Longitudinal vaginal septum (LVS) is frequently associ-
ted with some uterine anomalies, especially with complete
r partial high septum and didelphys uterus, while it is an
solated malformation less frequently.3
It is thought to develop as a consequence either of failure
f fusion of the lateral müllerian ducts or of incomplete
esorption of the vaginal septum, which may (complete) or
ay not (partial) extend throughout the full length of the
agina and may or may not be obstructive. The vaginal
avities on both sides of the septum are often asymmetric,
nd this finding may contribute to the under-diagnosis of
his malformation.
Longitudinal vaginal septum is frequently asymptomatic
nd detected incidentally during routine gynecologic exam-
nation, hysteroscopy, or delivery. Sometimes, it may cause
yspareunia, menstruation complaints, serious hemorrhage
ue to its rupture during intercourse, or hygienic prob-
ems (inability to insert a tampon or persistent bleeding
fter its insertion) thus requiring surgical treatment. Fur-
hermore, in patients who desire a child, vaginal septum
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513Di Spiezio Sardo et al Office vaginoscopic treatment of isolated LVSesection might improve access to the cervix and avoid
he risk of dystocia at delivery.
Resection of an LVS can be performed using the classic
urgical procedure, consisting of excision by scissor after
he application of 2 Kelly or Kocher forceps to prevent any
lood loss. This traditional surgical method is successful in
ost patients, but it requires anesthesia and meticulous
ttention to dissection, suturing, and hemostasis to avoid
njuries to bladder or rectum, subsequent bleeding, and
carring. Furthermore, traditional excision of the septum
equires hymenotomy to be performed when an intact hy-
en is present.4
Another modality of treatment is represented by resecto-
copy5– 6 with fluid as distension medium. This techniq
n addition to offering a higher magnification of the septum,
rovides a fibrous tissue distended by the intravaginal pres-
ure, thus making easy its dissection along a safe line, away
rom the urethra or rectum. In this poorly vascularized
issue, the electric energy applied during the resection pro-
uces complete occlusion of the small vessels.
Though this technique may be of potential value to a
irgin by preserving the integrity of the hymen, the wide
iameter of the resectoscope and the restricted field of
peration in the virgin complicate the operation, often re-
uiring general anesthesia.
In recent years, with the development of smaller-diame-
er scopes with working channels and continuous-flow sys-
ems and the advent of bipolar electrosurgical technology, it
as been possible to treat several uterine and cervical pa-
hologies, as well as those patients who might otherwise
equire general or local anesthesia (i.e., women with intact
ymens, postmenopausal women), as outpatient procedures.
his new philosophy (“see-and-treat hysteroscopy”) re-
uces the distinction between a diagnostic and an operative
rocedure with a substantial decrease in health and social
osts.6
In the case report, we describe the treatment of an iso-
ated LVS in a patient with an intact hymen by office
perative vaginoscopy using a 4-mm rigid hysteroscope.
ase report
A 27-year-old woman with an intact hymen was referred
o the Department of Gynecology and Obstetrics and Patho-
hysiology of Human Reproduction of the University of
aples “Federico II” for leukorrhea and recurrent vaginal
nfections. She reported menarche at age 13, and she denied
ysmenorrhea or menstrual irregularities.
The study protocol was approved by our institutional
eview board. A vaginal swab was done, but during the
rocedure the operator detected the presence of an unex-
ected and undefined lesion inside the vaginal cavity. A
ransabdominal ultrasound was negative for uterine, cervi-
al, and vaginal pathologies, but the reliability of the result
as hampered by the high body mass index (28 kg/m2) of hhe patient. The vaginal swab resulted positive for gram-
ositive infection.
A vaginoscopy was planned after 1 week of antibiotic
herapy and was performed using a 4-mm continuous-flow
ffice hysteroscope (Bettocchi Office Hysteroscope size 4;
arl Storz GmbH & Co., Tuttlingen, Germany) with a
0-degree optic and an incorporated 5F working channel.
he oval profile and the small caliber of the hysteroscope
acilitated the passage through a 7- to 8-mm hymeneal
rifice.
No pharmacologic preparations or local anesthetics were
dministered before the examination. Normal saline was used
or vaginal and uterine distension. Vaginal and intrauterine
ressures were maintained at a constant 30 to 40 mm Hg using
n electronic pump for irrigation and aspiration (Endomat;
arl Storz GmbH & Co.). There was no need to close the
ulvar labia using the fingers because the weight of the liquid
as sufficient to distend the vagina and provide a correct
isualization of the portio.7
The electrosurgical instrument was the Versapoint Bipo-
ar Electrosurgical System (Gynecare, Ethicon, Inc., Som-
rville, NJ), consisting of a dedicated bipolar electrosurgical
enerator and a 5F Twizzle electrode, which provides a
recise and controlled vaporization (resembling cutting).
e used the mildest vapor-cutting mode (VC3) that pro-
ides the lowest energy flowing into the tissue, with a power
f 50 W.
At vaginal inspection through the unbroken hymeneal
embrane, a partial LVS in the upper half of the vagina was
etected (Figure 1). This septum did not reach compl
he vaginal apex in its middle portion, thus making the 2
emivaginas communicating at this level. Through this
igure 1 Vaginoscopic view of longitudinal vaginal septum
LVS) from the point right after the hymen orifice. RH  right
emivagina; LH  left hemivagina.
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VS.
To ascertain if the cervix was single or double, we
erformed a small incision on the exocervical surface with
he tip of the bipolar electrode; and as this mark could be
etectable from each side of the septum, we could confirm
he presence of a single cervix.
Then we began the resection of the septum by the
wizzle electrode, starting in its middle portion and pro-
eeding progressively toward the vaginal apex. The electric
nergy (vapor-cutting mode, VC3) applied during the re-
ection provided complete hemostasis. Successively, the
terine cavity and endometrial surface were inspected, and
he tubal ostia were identified. The hysteroscope was then
ulled back toward the internal uterine orifice to obtain a
anoramic view of the whole cavity. We did not observe
ny anomalies of the uterus. The endocervical canal was
nspected during the withdrawal of the hysteroscope, and
n endocervical polyp measuring less than 0.5 cm was
emoved by a 5F grasping forceps (Karl Storz GmbH
Co.).
At the 3-month follow-up visit, the patient’s symptoms
ere significantly improved, and a vaginal swab had a
egative result. Vaginoscopy showed a normal vagina with
small scar in its middle portion, without wound retraction
r stenosis.
iscussion
Currently, office hysteroscopy allows for an easy, pre-
ise, and cost-effective evaluation of the uterine cavity,
ervical canal, and vagina.
However, it has been estimated that only 15% of gyne-
ologists in the United States routinely perform office hys-
eroscopy. Reasons given include, among others, a duplica-
ion of procedures for patients who need surgery in the
perating room and the expense of the capital equipment
ith relatively poor reimbursements from third-party pay-
rs.8
Indeed, diagnostic and operative hysteroscopy have long
een considered separate entities, as they required different
nstruments and approaches, thus resulting in a large num-
er of procedures being performed in the operating room,
ith significantly higher patient morbidity and health care
osts.
Since the introduction at the beginning of the 1990s of
ew scopes with a diameter range between 1.2 and 3 mm,
t has been possible to produce an operative hysteroscopic
ystem with a diameter equal or less than 5 mm that allows
he introduction of operative instruments. This made it pos-
ible to diagnose and treat most benign endouterine and
ndocervical pathologies simultaneously in a single proce-
ure without analgesia or anaesthesia.7 Mechanical opera-
ive instruments have long been the only way to apply the
ee-and-treat procedure in an outpatient setting. The advent Tf bipolar technology, with the introduction of several types
f 5F electrodes, increased the number of conditions treated
y office operative hysteroscopy, reserving the use of the
esectoscope and the operating room to a few particular
ases.9
While a large number of papers describing office hyster-
scopic treatment of cervical and uterine pathologies are
vailable in English-language literature, no study reporting
he vaginoscopic treatment of vaginal septum or other vag-
nal lesions in an outpatient setting was found using a
EDLINE literature search with “vaginal lesions,” “vagi-
al septum,” “hysteroscopy,” and “vaginoscopy” as key-
ords.
Several reports describe the hysteroscopic treatment of
n LVS5– 6 using a resectoscope and under general anest
ia. A few reports of foreign bodies, vaginal tumors, or
aginal adhesions removed by operative vaginoscopy are
vailable in the English-language literature, but all the de-
cribed procedures have been performed under general
nesthesia.
To the best of our knowledge, this case report dem-
nstrates the first successful treatment of a woman with
n LVS by office operative vaginoscopy with a rigid
-mm hysteroscope. The vaginoscopy was fast (it re-
uired no more than 10 minutes), safe, bloodless, and
early painless with a high level of patient satisfaction
oth for her hymen remaining intact and successful out-
atient treatment of her lesion with no analgesia or an-
sthesia. The absence of recovery time and an immediate
eturn to normal activities completed the success of the
rocedure.
The patient experienced mild pain only during the resec-
ion of the upper portion of the septum because of the
roximity of the vaginal wall, which is well known to be
ich in sensorial neural terminations. However, no anal-
esic was required during and immediately after the
rocedure.
Sometimes the presence of a thick vaginal septum
ould make it difficult to identify a single or double
ervix, therefore, we suggest the surgeon make a small
ncision on the esocervical surface with the tip of the
ipolar electrode and then try to detect this mark from
ach side of the septum. Furthermore, as LVS is often
ssociated with other müllerian anomalies, endoscopic
nspection of both the endocervical canal and uterine
avity always has to be performed.
onclusion
Whenever a new technique simplifies the treatment of a
esion without any serious complications, it deserves to be
onsidered when such a lesion is detected. Office operative
ysteroscopy has already demonstrated itself to be safe and
ffective in treating most uterine and cervical pathologies.
he reported successful treatment of an isolated vaginal
ss
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515Di Spiezio Sardo et al Office vaginoscopic treatment of isolated LVSeptum by operative vaginoscopy, if confirmed by larger
eries, could allow the inclusion of vaginal septa and other
aginal lesions in the list of treatment indications for office
rocedures performed using operative hysteroscopes.9
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Role of hysteroscopy in evaluating chronic pelvic pain
Attilio Di Spiezio Sardo, M.D.,a Maurizio Guida, M.D.,a Stefano Bettocchi, M.D.,b Luigi Nappi, M.D.,c
Filomena Sorrentino, M.D.,a Giuseppe Bifulco, M.D.,a and Carmine Nappi, M.D.a
a Department of Gynaecology and Obstetrics and Department of Pathophysiology of Human Reproduction, University of Naples
‘‘Federico II,’’ Naples; b Department of General and Specialistic Surgical Sciences, Section of Obstetrics and Gynaecology,
University of Bari, Bari; and c Department of Surgical Sciences, Unit of Obstetrics and Gynaecology, University of Foggia,
Foggia, Italy
Objective: To provide a survey of various gynecological conditions causing chronic pelvic pain (CPP) that might
be diagnosed by hysteroscopy.
Design: Review article.
Setting: Departments of obstetrics and gynecology and of pathophysiology of human reproduction at a university
in Italy.
Patient(s): Women affected by CPP.
Intervention(s): Hysteroscopy.
Main Outcome Measure(s): Effectiveness in diagnosing intrauterine pathologies that cause CPP.
Result(s): Hysteroscopy is highly effective in diagnosing various gynecological causes of CPP, including adeno-
myosis, chronic endometritis, M€ullerian anomalies, retained fetal bones, endocervical ossification, and intrauterine
abnormalities. Furthermore, hysteroscopy may play a primary role in the resolution of some of these conditions.
Conclusion(s): Because it can be executed safely without anesthesia or an operating room, office hysteroscopy
may be indicated, together with the other noninvasive procedures such as transvaginal ultrasonography, as
a first-level investigation in women who are affected by CPP. (Fertil Steril 2007;-:-–-.2007 by American
Society for Reproductive Medicine.)
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mon indication for referral to gynecology clinics, accounting
for 10%–40% of all gynecological visits and 50% of all diag-
nostic laparoscopies (1).
There is no universally accepted definition of CPP.
However, according to the guidelines of the Society of Obste-
tricians and Gynaecologists of Canada, CPP can be defined as
nonmalignant pain that is perceived in structures related to
the pelvis; it must have been continuous or recurrent for
R6 months (2).
Often, the etiology of CPP is not discernible. Many disor-
ders of the reproductive tract, gastrointestinal system, urolog-
ical organs, musculoskeletal system, and psychoneurological
system may be associated with CPP in women. The most im-
portant gynecological causes of CPP include endometriosis,
adenomyosis, chronic pelvic inflammatory disease, pelvic
congestion syndrome, and intrauterine or cervical patholo-April 12, 2007; revised and accepted July 23, 2007.
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110gies (contraceptive device, leiomyomata, endometrial or cer-
vical polyps, cervical stenosis, or chronic endometritis) (3)
Gynecological causes of CPP usually are detected by the
patient’s history, physical examination, transvaginal sonogra-
phy (TVS), and laparoscopy (4, 5).
A thorough patient history may identify the cause of pain,
as well as the factors that may exacerbate or alleviate it, its
relationship to the menstrual cycle, and its different locations.
The physician also should elicit a history of previous pelvic
or abdominal surgery, previous pelvic infections, and other
significant gynecologic disorders. The physical examination
should include a comprehensive, multiorgan evaluation that
concentrates on the lower abdominal and pelvic regions.
Noninvasive procedures such as TVS and magnetic reso-
nance imaging (MRI) may provide important information,
because they investigate both intrauterine and extrauterine
environments, without significant patient risk or discomfort.
In particular, TVS often is used as the first-line diagnostic
tool in the evaluation of CPP, because it is relatively inexpen-
sive and does not use ionizing radiation (6).
Okaro et al. (7) created the ultrasound term soft marker
to indicate pelvic pathology in women with CPP, the softFertility and Sterility Vol.-, No.-,- 2007 1
ociety for Reproductive Medicine, Published by Elsevier Inc.
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marker being the presence of immobile ovaries and/or
specific tenderness and/or loculated pelvic fluid at TVS.
They found such soft markers to indicate significant pelvic
pathology, with a positive likelihood ratio of 1.9.
Magnetic resonance imaging commonly is considered
when TVS is nondiagnostic or equivocal. Although MRI
may be the best overall test for clearly evaluating abdomi-
nal and pelvic anatomy, it has some limitations: it is
relatively expensive, images may be degraded by metal im-
plants in the body, and there are some contraindications to
having the test (e.g., ferromagnetic aneurysm clips or
pacemakers) (6).
Some invasive procedures, such as laparoscopy, are major
components in evaluating CPP, and many physicians believe
that a workup is incomplete without this procedure. At pres-
ent, gynecologists liberally use laparoscopy or microlaparo-
scopy under general anesthesia as the gold standard for the
assessment of women with CPP. Laparoscopic observation
of abdomen and pelvis will identify potential sources of
CPP in most women. The most common findings at laparos-
copy are pelvic endometriosis and adhesions (3). However, in
%40% of women with CPP, laparoscopy fails to identify any
obvious cause for the pain (7, 8).
There are a number of reasons that laparoscopy may fail to
identify an organic cause of pain: the condition may not be
visible at laparoscopy (i.e., adenomyosis, intrauterine pathol-
ogies, and so on), or an inexperienced surgeon may not rec-
ognize the disease, as with some forms of endometriosis
(9). This results in an underdiagnosis of some gynecologic
causes of CPP and, consequently, in an inappropriate referral
of the woman and an inadequate treatment of the pain.
At this point, the following question spontaneously arises:
can hysteroscopy provide significant information concerning
the causes of CPP? In other words, can hysteroscopy
diagnose some causes of CPP that otherwise may be hard
to diagnose or that may not be detected when using TVS
and/or laparoscopy?
Although some clinicians already use hysteroscopy in the
evaluation of CPP, other investigators refute its usefulness.
In the international literature, data are lacking on the prev-
alence of hysteroscopic findings in unselected women with
CPP, with the exception of those reported by Nezhat et al. (4).
Those investigators have conducted a study on 499 women
who are affected by CPP and are undergoing diagnostic lap-
aroscopy, plus hysteroscopy to identify the potential causes
of pain. Their work has shown that hysteroscopy is effective
not only when laparoscopy fails but also in patients in whom
laparoscopy is performed successfully. Indeed, indepen-
dently of the pathophysiology of CPP, the investigators
showed that approximately one third of patients with abnor-
malities diagnosed at laparoscopy had concomitant intrauter-
ine pathology. Leiomyomas and cervical stenosis were the
most common hysteroscopic diagnoses and were considered
to be potential sources of CPP.2 Di Spiezio Sardo et al. Hysteroscopy and chronic pelvic
FLA 5.0 DTD  fns22675  17 AThe aim of our analysis is to provide a survey of various
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ADENOMYOSIS
Adenomyosis is a common, benign gynecological disorder
that is characterized by the heterotopic presence of endome-
trial glands and stroma within the myometrium, surrounded
by smooth muscle proliferation.
It traditionally has been diagnosed by the pathologist on
hysterectomy specimens or by means of invasive techniques,
such as laparoscopic uterine biopsies.
However, the recent development of high-quality, noninva-
sive techniques (TVS and MRI) has renewed interest in diag-
nosing adenomyosis before any treatment (10).
Adenomyosis particularly is amenable to MRI diagnosis,
with accuracy rates of %99% (11–13). Compared with
MRI, TVS is less sensitive for diagnosing such pathology,
with sensitivity of 86%, specificity of 50%, and positive pre-
dictive value of 86% (11, 14).
Hysteroscopy has been demonstrated to be an important
additional procedure for the evaluation of uterine pathology,
even in the case of adenomyosis, because it offers the main
advantage of direct visualization of the uterine cavity and
the possibility of obtaining histological specimens under
visual control (10, 15).
Recently, Molinas and Campo (16) proposed office
hysteroscopy and TVS as first-line diagnostic tools in case
of suspicion of adenomyosis.
Notwithstanding the fact ½that diagnostic hysteroscopy of
the cavity cannot definitively diagnose or exclude adenomyo-
sis, because its field of observation is limited to the endome-
trial surface, some investigators have described some
hysteroscopic findings that are suggestive for such pathology:
an irregular endometrium with endometrial defects (superfi-
cial openings), hypervascularization, a strawberry pattern,
or cystic hemorrhagic lesions (10, 16, 17).
In particular, an irregular endometrial vascular distribution
has been detected in more than half of patients (16). Ota and
Tanaka (18) used morphological analysis of the endometrium
to demonstrate that the mean surface area, total surface area,
and total number of capillaries increased in the adenomyosis
group, both in the proliferative and secretory phases. These
findings strongly support the concept that endometrium
is functionally abnormal in patients with adenomyosis.
However, it should be emphasized that the superficial vascu-
larization can be inspected correctly only by reducing the in-
tracavitary pressure at the time of hysteroscopic examination.
In addition to the direct visualization of the uterine cavity,
the hysteroscopic approach offers the possibility of obtaining
histological specimens under visual control, allowing more
accurate information to be obtained and correlations betweenpain Vol.-, No.-,- 2007
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ARTICLE IN PRESSimages and histopathology to be made. During hysteroscopy,
target biopsies of the endometrium and underlying myome-
trium can be obtained, either with the mechanical-punch
technique or with electrical-loop resection. Furthermore,
the visual control before, during, and after the loop resection
also may demonstrate typical signs for adenomyosis.
McCausland (19) first described the technique of myome-
trial biopsy through the hysteroscope with loop resection and
reported a prevalence of adenomyosis of 66% in patients with
abnormal uterine bleeding. That work also demonstrated
a correlation between the depth of the lesion and the severity
of the menorrhagia.
Furthermore, in a comparative study, Darwish et al. (20)
demonstrated the superiority of loop resection over punch
biopsy with rigid biopsy forceps.
At the moment, there is no consensus on the diagnosis of
adenomyosis by hysteroscopic resectoscopic biopsy with
respect to handling, orientation of the resected pieces, and
depth of penetration (21); however, adenomyosis may be
highly suspected when the following signs are found: [1] ir-
regular subendometrial myometrium (whorled, fibrotic, and
so on), [2] absence of typical myometrial architecture during
the resection, and [3] intramural endometriomas (19, 20).T
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CHRONIC ENDOMETRITIS
Chronic endometritis is a subtle condition that is difficult to
identify with noninvasive examinations. Indeed, it is not
detectable by TVS and MRI and can be suspected only in pa-
tients who have complications such as adhesions, pyometra,
or hydrometra. It may cause abnormal uterine bleeding,
although in most cases it is asymptomatic or is accompanied
by mild disturbances such as spotting and undefined CPP. A
recent study has demonstrated that>70% of cases of chronic
endometritis result from non-gonococcal, non-chlamydial
infections, with common bacteria and mycoplasma repre-
senting the most frequent etiologic agents (22).
No general agreement exists in the literature about the
diagnostic usefulness of hysteroscopy in the detection of
chronic endometritis (23, 24).
Recently, Cicinelli et al. (25) described diagnostic criteria
for chronic endometritis at fluid hysteroscopy with low
pressure. Fluid hysteroscopy is more efficacious than is
CO2 hysteroscopy for detection of this entity; indeed, saline
has no effect on endometrial microcirculation and provides
smoother distension and continuous washing of the uterine
cavity, allowing endometrial ingrowths to float.
The diagnostic criteria for chronic endometritis at fluid
hysteroscopy are the following: stromal edema, focal or
diffuse hyperemia, and endometrial micropolyps (<1 mm
in size).
Stromal edema, mostly when combined with hyperemia, is
a sign of inflammation that can be detected easily at fluid
hysteroscopy, because the endometrial mucosa, although itFertility and Sterility
FLA 5.0 DTD  fns22675  17 AO
F
is in the proliferative phase, appears pale, whitish, and nonho-
mogeneously thick; in some cases it may fold, thus simulat-
ing a polyp.
Micropolyps, in particular, represent a very reliable sign of
inflammation. They are small, vascularized ingrowths that
are covered by endometrium and characterized by an accu-
mulation of inflammatory cells (lymphocytes, plasma cells,
or eosinophilic granulocytes) and edema in stroma; they
probably are an expression of an active and strong endome-
trial reaction and of massive release of interleukine ½and local
growth factors (26, 27).
The combination of hyperemia, edema, and micropolyps
has a diagnostic accuracy of 93.4%, confirming hysteroscopy
to be a reliable and useful technique for investigating chronic
endometritis (25).E
D
P
R
O
M€ULLERIAN ANOMALIES
Even if M€ullerian anomalies usually are associated with in-
fertility and abnormal uterine bleeding, it should be empha-
sized that some of them may cause CPP (28). Hysteroscopy
together with laparoscopy may contribute to the diagnosis
of such anomalies. Steinkampt et al ½. (29) recently reported
the case of a non-communicating accessory uterine cavity
as a cause of pelvic pain. Hysteroscopy together ½with TVS
was useful for detecting the cavity.
Recently, Nawroth ½et al. (30) described a significantly
higher incidence of endometriosis in patients with a septate
uterus, suggesting that in such cases, a combined hystero-
scopy and laparoscopy should be performed. If this associa-
tion is confirmed in further, larger studies, additional CPP
may support the decision to operate. Indeed, clinical experi-
ence suggests that hysteroscopic resection of the uterine sep-
tum (even without laparoscopic treatment of endometriosis)
often is followed by a significant improvement in, or com-
plete resolution of, severe dysmenorrhea.INTRAUTERINE BONE STRUCTURES
The presence of intrauterine bone structures is a rare
condition (31–35) that mostly is caused by retained fetal
bone fragments, as a complication of induced abortion, spon-
taneous intrauterine fetal death, and missed abortion (36, 37).
In some cases, it may be caused by metaplasia of mature en-
dometrial stromal cells, in response to chronic inflammation
or trauma (38, 39). It is interesting to note that the presence of
retained fetal bones may be more common in cases of uterine
anomalies (34, 40).
This situation may cause CPP, infertility, abnormal uterine
bleeding, vaginal discharge, and passage of bony fragments
in menstrual blood (31, 41).
Transvaginal sonography usually represents the first-line
diagnostic tool. Retained bone fragments are displaced on
an ultrasound as bright echogenic areas with posterior
shadowing. Hysteroscopy has been demonstrated to be3
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ARTICLE IN PRESSeffective for confirming the diagnosis and achieving the
successful removal of fetal bones (35, 42–44), either with
a resectoscope or with grasping forceps inserted through
the operative channel of a hysteroscope (34, 40, 45).Q17
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Endocervical ossification is an osseous metaplasia in the cer-
vical canal, usually complicating chronic endocervicitis (46–
48). The mechanism through which endocervicitis leads to
endocervical ossification is still unclear; however, it has
been hypothesized that the release of the increased amount
of intracytoplasmic calcium after the death of the cervical
cells may trigger further deposition of calcium and formation
of macroscopic bone structures (46). These patients may have
CPP, infertility, hypermenorrhea, and dysmenorrhea. The
diagnosis is based on TVS and hysteroscopy, which is useful
for confirming the diagnosis as well as for treating the pathol-
ogy. During hysteroscopy, the presence of white-colored
endocervical fragments with a sponge-like aspect and hard
consistency at contact with the tip of the hysteroscope sup-
ports the diagnosis of endocervical ossification and chronic
endocervicitis (46).T
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INTRAUTERINE ABNORMALITIES
Some uterine abnormalities may cause CPP. These include
cervical stenosis, intrauterine adhesions, polyps, and submu-
cosal myomas (49). In case of cervical stenosis and adhe-
sions, pelvic pain usually is caused by the occurrence of
different sizes of hematometras, with consequent increase
of the intrauterine pressure.
Large polyps and submucosal myomas may cause pain,
especially when the uterus tries, by means of contractions,
to expel them.
Some of these intrauterine lesions (i.e., polyps, submucosal
myomas, hematometra) may be easily diagnosed with TVS,
whereas other abnormalities may only be suspected or not
diagnosed (i.e., intrauterine adhesions, cervical stenosis).
At present, office hysteroscopy commonly is regarded as
the gold-standard technique in any situation in which a ma-
jor or minor intrauterine or cervical anomaly is suspected or
has to be ruled out (50). Furthermore, several investigators
have demonstrated that most intrauterine and cervical le-
sions also may be successfully treated by hysteroscopy in
the outpatient setting, during the diagnostic workup (see
and treat) (51–53).Q18
Q19
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The term office setting refers to the performance of hystero-
scopy, either diagnostic or operative, on an outpatient basis,
while the patient is not in the operating room. Improvements
in office hysteroscopy, both in technology and technique,
such as the use of saline solution as distension medium
(54), the availability of high-resolution mini-endoscopes4 Di Spiezio Sardo et al. Hysteroscopy and chronic pelvic
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(55), and the atraumatic insertion of the instruments (56),
have led to the development of its current form. It is, there-
fore, now recommended as a first-line diagnostic tool for
the evaluation of abnormal uterine bleeding (57) and infertil-
ity (58), because it is associated with minimal patient discom-
fort, excellent visualization, and very low complication and
failure rates (58).
Moreover, as an operative tool, the new-generation office
hysteroscope has the advantages of including an operative
channel ofR5 Fr, which enables the simultaneous diagnosis
and treatment (see and treat) of various uterine and cervical
pathologies in an outpatient setting (56–60).
Office hysteroscopy ½can be considered to be a valid diag-
nostic instrument for numerous pathological conditions caus-
ing CPP that can be hard to diagnose by, or that may not be
diagnosed by, noninvasive techniques (TVS or MRI) or
even by laparoscopy (i.e., chronic endometritis, intrauterine
pathologies, M€ullerian anomalies, superficial adenomyosis)
(16, 51–53, 61, 62). Furthermore, it should be emphasized
that a negative laparoscopy does not mean that there is no dis-
ease or that a woman has no physical basis for her pain (3).
Moreover, office hysteroscopy may play a primary role in
the resolution of many causes of CPP, such as M€ullerian
anomalies (28, 62, 63), intrauterine bone structures (34, 35,
40, 42–45), endocervical ossification (46), and intrauterine
abnormalities (51, 52, 62).
For these reasons, although laparoscopy still represents the
gold standard for the assessment of women with CPP, hys-
teroscopy may be considered a useful technique, mostly
when the cause of CPP remains a diagnostic dilemma (4, 7).
Nowadays, the validity of hysteroscopy has been well
demonstrated. However, unfortunately, most gynecologists
still are unable to take advantage of the many potentialities
of this technique or do not perform hysteroscopic procedures
in the office setting.
Because it can be executed safely without anesthesia and
has high patient compliance, office hysteroscopy may be in-
dicated, together with the other noninvasive procedures such
as TVS, as a first-level investigation in women affected by
CPP. This could reduce the number of unnecessary laparosco-
pies that are performed in women with CPP.REFERENCES
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Journal of Minimally Invasive Gynecology (2007) 14, 767–769ndometrial vaporization of the cervical stump employing
n office hysteroscope and bipolar technology
iovanni Pontrelli, MD, Stefano Landi, MD, Charalampos Siristatidis, MD,
ttilio Di Spiezio Sardo, MD, Oronzo Ceci, MD, and Stefano Bettocchi, PhD
rom the Department of Obstetrics, Gynaecology and Neonatology–II Unit of Obstetrics and Gynaecology, University of
ari, Bari, Italy (Drs. Pontrelli, Ceci, and Bettocchi); the Department of Obstetrics and Gynaecology, Ospedale Sacro
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aples “Federico II”, Naples, Italy (Dr. Di Spiezio Sardo), and the 3rd Department of Obstetrics and Gynaecology, “Attikon”
ospital, University of Athens, Athens, Greece (Dr. Siristatidis).Abstract. We report the successful treatment of a 40-year-old woman with ongoing cyclical vaginal
bleeding lasting 10 days after laparoscopic subtotal hysterectomy. Hysteroscopic vaporization of the
endometrial stripe in the cervical stump was performed in an office setting, using a 5-mm Bettocchi
double-channel operative hysteroscope armed with a bipolar electrode.
© 2007 AAGL. All rights reserved.
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uSubtotal hysterectomy continues to represent a justifiable
lternative to total hysterectomy for benign gynecologic
onditions, being associated with a reduced rate of compli-
ations (i.e., damage to surrounding pelvic organs, vaginal
rolapse, hematomas, blood loss, wound infections), a
horter operative time, and more rapid recovery.1,2 How-
ver, the theoretical advantage of subtotal versus total
ysterectomy in terms of better preservation of sexual
atisfaction in young patients, because of less disturbance
f the cervical and upper vaginal innervation,3 was not
onfirmed by recent more robust evidence.4 The main
linical arguments against subtotal hysterectomy are the
isk for development of cancer in the cervical stump and
he possibility of abnormal bleeding related to the pres-
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oi:10.1016/j.jmig.2007.06.006nce of even small islands of residual endometrial tissue
n the cervical stump.2
Nevertheless, the risk for development of a neoplasia in
he cervical stump should no longer be considered a reason
or preferring total to subtotal hysterectomy because the
ikelihood is low (less than 1%),5 and cervical screening has
lready been shown to be effective in the follow-up of these
atients.6 On the other hand, the incidence of cyclical or
ontinuous bleeding after subtotal hysterectomy ranges be-
ween 1% and 31.4% in different series1,7 and negatively
ffects the quality of life of those women who could expect
o stop menstruating after such major surgery, as well as
otentially complicating the use of hormone replacement
herapy.2 To minimize this complication, during surgery
iathermy is usually applied to the top of the endocervical
anal with the aim of destroying any cycling endometrium.8
his modality, however, has not been proven to prevent
uture bleeding episodes.7 Thakar et al1 proposed that for-
al reverse conization, including the cervical epithelium
ogether with the transformation zone, as well as any resid-
al endometrium, could minimize this complication during
laparotomic subtotal hysterectomy.
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768 Journal of Minimally Invasive Gynecology, Vol 14, No 6, November/December 2007In the presence of intermittent or continuous bleeding
fter the procedure, laparotomic, laparoscopic, or vaginal
rachelectomy with or without laser treatment or medica-
ions (progestins or combined hormone replacement ther-
py) are currently performed. Although successful in most
ases, such surgical options require the use of general an-
sthesia and are associated with significant morbidity, apart
rom their high cost.9 In this report, we propose an alterna-
ive option for the treatment of abnormal bleeding after
ubtotal hysterectomy, with a 5-mm hysteroscope and 5F
ipolar electrodes.
ase report
A 40-year-old multiparous woman was referred to our
epartment for persistent cyclical vaginal bleeding of 10
ays duration, arising nearly 2 months after laparoscopic
ubtotal hysterectomy. The latter had been performed for
enorrhagia in the presence of a uterus with multiple my-
mas, the largest of which was 6 cm in diameter. Her
istory was unremarkable for malignancy or significant
edical conditions. She had undergone a resectoscopic
yomectomy at age 38 for menorrhagia without any sig-
ificant improvement of her symptoms. Laparoscopic sub-
otal hysterectomy was therefore preferred because the pa-
ient was still experiencing heavy bleeding, but she
aintained that the whole uterus not be removed, for fear of
possible decline in the quality of her sexual activity.
iathermy to the top of the endocervical canal was per-
ormed at the end of the laparoscopic procedure.
Two months later, the patient started to experience per-
istent cyclical bleeding from the cervical stump and there-
ore underwent vaporization of the remaining endometrial
issue by means of a 5-mm hysteroscope and a bipolar
lectrode. Prior institutional review board approval and in-
ormed consent from the patient were obtained.
Transvaginal ultrasonography performed before the pro-
edure excluded a hematoma over the apex of the cervical
tump or pelvic diseases. Hysteroscopy was performed by
.P. with a 5-mm continuous-flow operative office hystero-
cope with a 2.9-mm rod lens (Bettocchi Office Hystero-
cope; Karl Storz, Tuttlingen, Germany). The vaginoscopic
pproach (without speculum and tenaculum) was used, and
istension of the endocervical canal was obtained with nor-
al saline solution. Pressure within the cavity was automat-
cally controlled by an electronic irrigation and suction
evice (Endomat; Karl Storz); the pressure was set at 45
m Hg, being the balance of an irrigation flow around 200
L/min and a vacuum of 0.2 bar. The electrosurgical in-
trument used for the vaporization of the residual endome-
rium was the VersaPoint Bipolar Electrosurgical System
Gynecare, Ethicon Inc., Somerville, NJ), consisting of a
edicated bipolar electrosurgical generator and a 5F spring
lectrode inserted through the 5F operative channel of the
ysteroscope (Figure 1). The mildest vapor cutting mode pVC3) with a power of 50 W was used to minimize the
nergy flowing into the tissue and to reduce the generation
f bubbles. Conscious sedation was achieved by adminis-
ering midazolam 10 mg and fentanyl 100 g intravenously.
2-mm endometrial stripe was identified in the proximal
ortion of the cervical stump. The procedure was performed
ith the patient in Trendelenburg position to keep the bowel
way from the fundus of the cervical stump.
The overall procedure was quick (operative time: 12
inutes), bloodless, and free from intraoperative or postop-
rative complications. The patient’s immediate return (2
ours after) to normal activities bear witness to the success
f the procedure.
At 2-month follow-up, the patient’s symptoms were sig-
ificantly improved. She reported only 1 episode of spotting
asting for 3 days, nearly 1 month after the procedure. At the
- and 12-month follow-up appointments, she did not com-
lain of any bleeding. Transvaginal ultrasonography per-
ormed at the 12-month visit did not detect any occult
ccumulation of blood or pelvic abnormalities.
iscussion
To the best of our knowledge, this is the first report of
uccessful treatment of abnormal bleeding from the cervical
tump with an office hysteroscope and bipolar technology.
he patient had undergone laparoscopic subtotal hysterec-
omy followed by diathermy of the top of the endocervical
anal. However, the procedure was ineffective because the
igure 1 A spring electrode inserted through the 5F operative
hannel of the hysteroscope is used to vaporize a 2-mm endome-
rial stripe identified in the proximal portion of the cervical stump.atient experienced persistent cyclical vaginal bleeding 2
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769Pontrelli et al Cervical stump-related bleeding and hysteroscopic vaporizationonths after the procedure. This was probably related to the
blind” nature of laparoscopic diathermy, which cannot
nsure complete destruction of the residual endometrial
slands located in the cervical stump.
Several reports have already demonstrated that the
ersaPoint system can be safely used to treat benign intra-
terine and cervical lesions.10 On the basis of these previous
tudies and our clinical experience, we decided to apply our
ee-and-treat philosophy to treat this problem of cervical
tump–related abnormal bleeding.
The main difference as compared with our previously
eported experience10 was the use of conscious sedation.
he use of the latter was based on the idea that to be
ffective, vaporization of the residual endometrium had to
each the first 2 to 3 mm of the myometrium and that such
n approach was expected to be painful for the patient. The
pring electrode was preferred to the Twizzle and Ball ones,
ecause it provides a deeper and wider vaporization/coag-
lation of the tissues. The procedure was quick, bloodless,
nd free from intraoperative or postoperative complications.
n additional cases, intraoperative ultrasound guidance
ight be recommended to ascertain that the apex of the
ndometrial echo is treated as completely as possible while
aintaining a safe distance from the bowel or bladder.
The high magnification of the endoscopic view ensured a
orrect identification of the residual endometrium and its
omplete vaporization (Figure 2). The correct power setting
f the VersaPoint, together with the use of an electronic
rrigation and suction device, restricted bubbles in the en-
ocervical canal and ensured a clear, satisfactory view
hroughout the procedure.
The effectiveness of the procedure was demonstrated by
he absence of any bleeding at the follow-up appointments
nd by the negative transvaginal ultrasound findings at the
2-month visit. The patient was very satisfied both with the
uccessful treatment of her condition and the immediate
eturn to normal activities. In additional cases, even if
ymptom free, an ultrasound scan performed at 6 and 12
onths is strongly recommended to make certain there is no
etrograde accumulation of blood or fluid. In fact, the index
echnique could cause sclerosis of the distal endocervical
anal, and any trapped bleeding occurring proximal to a
tenotic endocervix could result in an accumulation of blood
hat might or might not provoke symptoms as a hematome-
ra.
Larger prospective randomized trials comparing our in-
ovative approach to standard surgical approaches are
eeded to test its feasibility and effectiveness. If such stud-
es confirm our promising results, our technique may in the
uture replace both more-invasive surgical approaches andess–cost-effective medical approaches to the treatment of
leeding of the cervical stump after subtotal hysterectomy.
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Précis 
Office Preparation of Partially Intramural Myomas (OPPIuM) is an novel hysteroscopic technique 
which leads to the conversion of submucous myomas with intramural development into totally or 
prevalent intracavitary ones in nearly 90% of cases, thus facilitating subsequent resectoscopic 
myomectomy. 
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Abstract  
Objective: To assess the safety and efficacy of a novel hysteroscopic technique for the Office 
Preparation of Partially Intramural Myomas (OPPIuM) for the subsequent resectoscopic 
myomectomy. 
Design: Pilot study. 
Setting: University of  Bari, Naples and Foggia. 
Patients: Thirty-one fertile women (ages 30-48 yrs) diagnosed at office hysteroscopy as having 
symptomatic submucous myomas > 1.5cm with intramural development (G1 and G2) scheduled for 
resectoscopic surgery. 
Interventions: OPPIuM technique consists of an incision of endometrial mucosa covering the 
myoma by means of scissors of 5Fr bipolar electrodes along its reflection line on the uterine wall, 
up to the precise identification of cleavage surface between the myoma and pseudo-capsula. This 
action may trigger the protrusion of the intramural portion of myoma into the cavity during the 
following menstrual cycles thus facilitating the subsequent total removal of the lesion via 
resectoscopic surgery. All patients underwent a follow-up in-patient hysteroscopy after two 
menstrual cycles before resectoscopic surgery was performed. 
Measurements & Main Results: OPPIuM technique was successfully performed in all cases. The 
mean diameter of successfully prepared myoma was 3.1±1.0 cm. At follow-up hysteroscopy the 
conversion of such myomas with intramural development into totally or prevalent intracavitary 
lesions was observed in 87% (27/31) of cases. In two out of three cases of failure the diameter of 
the myoma was > 4 cm. One patient was excluded from the study because of the occurrence of 
spontaneous total expulsion of the myoma at the following menstrual cycle. 
Conclusions: Our preliminary findings seem to support the safety and effectiveness of this novel 
technique by reporting the conversion of myomas with intramural development > 1.5 cm into totally 
or prevalent intracavitary ones in nearly 90% of cases. This action may allow surgeons to perform 
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resectoscopic surgery more safely and quickly as dealing with prevalent intracavitary lesions. 
However further studies are mandatory to validate its use in daily practice. 
 
Key words: OPPIuM, intramural myomas, hysteroscopy, resectoscopic myomectomy, submucous 
myomas. 
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Introduction 
 
With ongoing developments in the field of hysteroscopy during the last fifteen years, hysteroscopic 
surgery is becoming safer and less invasive for the patient. Improved technology has enabled us to 
perform many operative procedures in an office setting without significant patient discomfort and 
with potentially significant cost savings. Indeed, today hysteroscopy is considered the gold standard 
not only for visualizing the cervical canal and the uterine cavity, but also for treating a number of 
benign uterine pathologies including polyps, sinechiae and myomas (1-2). 
 At the present time, submucous myomas < 1.5 cm with total (G0) or mostly (>50%) intracavitary 
development (G1) may be successfully treated in outpatient setting with 5Fr mechanical and bipolar  
instruments. The procedure has been already described elsewhere by our group. (3). On the 
contrary, when dealing with moymas greater than 1.5 cm or with those characterized by prevalent 
(> 50%) intramural development (G2), it seems reasonable to plan a resectoscopic myomectomy 
possibly preceded by a 3 months of Gonadotropin Releasing Hormone analogue (GnRHa) 
treatment.   
Resectoscopic myomectomy for G0 and G1 myomas is not a complex procedure, being feasible 
even for surgeons with average hysteroscopic experience. On the contrary resectoscopic 
myomectomy for G2 myomas is a difficult procedure to be performed only by surgeons skilled in 
hysteroscopy. Indeed it is associated with a significant risk of complications which is proportional 
to the degree of intramural development of the myoma. Furthermore, the larger is the myoma and 
its intramural development, the more likely is the need for splitting the procedure into different 
surgical steps (4). 
A wide number of techniques have been proposed for the treatment of partially intramural myomas 
via resectoscopy. Among those, the “cold knife myomectomy” developed by Mazzon (5) and the 
“enucleation in toto” described by Litta (6) seem to comply most with the necessary requirements 
of safety and efficacy. 
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Therefore, proceeding from those techniques, we have recently developed a novel procedure to 
prepare submucous myomas > 1.5cm with partially intramural development (G1 and G2) in 
outpatient setting with miniature hysteroscopes (Office Preparation of Prevalent Intramural 
Myomas: OPPIuM) in order to facilitate the subsequent resectoscopic removal under general 
anaesthesia.  
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Materials and Methods 
 
Patients 
This study prospectively enrolled thirty-one women of reproductive age (range 30-48 yrs) 
hysteroscopically diagnosed with submucous myoma and referred to any of the three participating 
University hospitals (Bari, Naples and Rome) from January 2007 to January 2008. To be eligible 
for inclusion, patients with an hysteroscopic diagnosis of a single submucous, partially intramural 
(G1 or G2) myoma >1.5 cm, must have had symptoms (abnormal uterine bleeding, pain, infertility) 
for which they had been scheduled for treatment via resectoscopy. Women sonographically 
diagnosed as having a free myometrium margin < 0.8 cm, those with multiple or asymptomatic 
lesions, or with other uterine or adnexal pathologies as well as those affected by any major systemic 
disorders were excluded. All centers received research ethics approval for this study, and subjects 
gave their informed consent. 
Baseline data recorded at inclusion included age, race, BMI, reproductive history, infertility work-
up, educational status (surrogate for socioeconomic status), symptoms, transvaginal ultrasound 
(TVS) characterization of the lesion and the free myometrium margin, and hysteroscopic grading of 
the lesion (G0, G1, G2 type) according to the European Society of Hysteroscopy classification (7). 
 
Interventions 
a) Transvaginal  ultrasound scanning 
Preoperative transvaginal ultrasound scanning (TVS) was performed in all patients to provide 
accurate informations concerning the characteristics of the submucousal myoma to be operated on 
and to exclude other coexistent uterine or adnexal pathologies. Ultrasonographic measurements 
were performed by a trained physician using a 5.0- to 9.0-MHz multi-frequency transvaginal probe 
(Voluson 730 Expert; General Electrics Medical Systems, Paris, France) during the first half of the 
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menstrual cycle. The size of the myoma was defined by the mean of the three diameters as 
measured on both the longitudinal (length and anteroposterior diameters) and transverse (transverse 
diameter) planes. The location (anterior, fundus, or posterior wall) and type (I, intramural extension 
less than 50%; II, intramural extension equal to or greater than 50%) of the submucous myomas as 
well as the diameters of the entire uterus (lenght, thickness and width) were also measured. In 
addition, the thickness of the myometrium remaining between the deep edge of the myoma and the 
serous peritoneum (free myometrial margin) was measured by TVS and a safety margin of at least 
0.8 cm was set.  
 
b) Office Hysteroscopy 
An office hysteroscopy was performed during the early proliferative phase of the menstrual cycle. 
All the procedures were performed by three skilled hysteroscopist (one per each center: A.D.S., 
L.N, and S.B.) by means of a 4mm continuous-flow office hysteroscope (Bettocchi Office 
Hysteroscope, Karl Storz, Tuttlingen, Germany) with a 2.9 mm rod lens optic. The vaginoscopic 
approach, without speculum and tenaculum was used and no analgesia or anesthesia was 
administered to the patient. Distension of the uterine cavity was obtained using saline solution and 
the intrauterine pressure was automatically controlled by an irrigation-suction electronic device 
(Endomat, Karl Storz, Tuttlingen, Germany) set at 45 mm Hg, being the balance of an irrigation 
flow around 200 mL/min and a vacuum of 0.2 bars. The location, size, and grading of the 
submucous myoma according to the European Society of Hysteroscopy classification (7) were 
recorded. 
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c) OPPIuM  
The OPPIuM technique was performed at the time of the office hysteroscopy. The endometrial 
mucosa covering the myoma was incised by means of 5Fr scissors or bipolar Versapoint Twizzle 
electrode (Gynecare; Ethycon Inc., NJ, USA) along its reflection line on the uterine wall, up to the 
precise identification of the cleavage surface between the myoma and pseudo-capsula (Fig.1). This 
action was aimed at facilitating the protrusion of the intramural portion of myoma into the cavity 
during the following menstrual cycles. No hormonal therapy was administered to the patient either 
before or after the procedure.  
The OPPIuM procedure was considered successfully completed as soon as the cleavage surface 
between the myoma and the pseuso-capsula was clearly visualized for the intracavitary extension of 
the myoma.   
 
4) VAS score 
A visual analogic scale (VAS) score on a 100-mm scale was used to assess the intensity of pain 
experienced during and after the procedure (on which 0 indicated absence of pain and 100 the worst 
pain possible). The patients were asked to quantify pain three times, at the introduction of the scope 
into the cavity (VAS1), at the time of incision of the pseudocapsule (VAS2) and 30 minutes after 
the procedure (VAS3).  
 
5) Follow-up diagnostic hysteroscopy  
Follow-up data were obtained from a second diagnostic hysteroscopy performed in the early 
proliferative phase after two menstrual cycles. Although the procedure was carried out in in-patient 
setting and under general anaesthesia, the same hysteroscope and set-up (pressure, flow, suction) 
used for the office procedure were selected and the hysteroscopic grading of the submucous myoma 
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was re-assessed in order to evaluate the protrusion of the possible intramural portion of the myoma 
into the uterine cavity. 
 
6) Resectoscopic myomectomy 
Immediately after the follow-up diagnostic hysteroscopy, the resectoscopic excision of the myoma 
was carried out with the classical technique of slicing using a 27Fr bipolar resectoscope  (Gynecare; 
Ethycon Inc., NJ, USA). The technique consisted of repeated and progressive passages of the 
cutting loop, carried out with the standard technique (loop carried beyond the neoformation, with 
cutting only taking place during the backward or return movement of the loop). Excision began 
from the top of the myoma, progressing in a uniform way towards the base. When dealing with the 
base of the myoma, care was taken to limit the surgical traumatism to the area of the implant, thus 
avoiding the damage of the surrounding structures. As soon as the excision of the myoma was 
finished, the base of the implant was cleaned out until smooth and regular; the operation being 
considered finished when the fasciculate structure of the myometrium was visualized. Operating 
time was calculated from the introduction of the resectoscope into the uterine cavity to the visual 
reassessment of myoma resection completion. Fluid balance was recorded throughout the entire 
procedure by measuring the inflow and outflow fluid from the continuous flow resectoscope. 
Patients were fully counselled regarding the risks of operative hysteroscopy prior to the intervention 
and any complication occurring either during or after the procedure was recorded. 
 
Data analysis 
Statistical analysis was performed using the SPSS 9.0 (SPSS Inc.; Chicago, IL, USA). The Shapiro-
Wilk’s test was performed to evaluate data distribution of all variables. VAS scores and mean 
diameters of the myomas showed a normal distribution and a Student’s t-test for paired samples was 
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used to compare such values. Data were expressed as mean ± standard deviation (SD) unless stated 
otherwise. Statistical significance was set at p <0.05. 
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Results 
The mean age of the enrolled women was 41 years (range 30-48 years). Fifteen patients (48.3%) 
were nulliparous and 20 patients (64.5%) had a history of pelvic operations including 6 (19.3%) 
caesarean sections and 14 (45.1%) pelvic surgeries. Indications for treatment were abnormal uterine 
bleeding (n= 20) and/or infertility (n= 10) and/or pain (n= 8). By ultrasound examination all 
detected myomas were single and submucous, being 7/31 (22.5%) located on the anterior wall, 
12/31 (38.7%) on the posterior wall and the remaining 12/31 (38.7%) on the uterine fundus. Fifteen 
(48.3%) out of the thirty-one myomas to be treated were hysteroscopically classified as being G1, 
whilst the remaining 16 (51.7%) were graded as G2 (Table 1). 
The mean diameter of the myomas as measured by ultrasound was 3.1±1.0 cm (Table 1). No 
statistically significant differences were observed between the mean diameters of G1 and G2 
myomas (2.76±0.98 vs 3.3±0.89  p>0.05). 
OPPIuM technique was successfully performed in all cases being the procedure considered 
completed when the cleavage surface between the myoma and the pseuso-capsula was clearly 
visualized for the intracavitary extension of the myoma. 
The mean VAS2 score was slightly, but not significantly increased in comparison with VAS1 
score (33.0± 13.1 mm  vs 31.7± 12.2 mm). The mean VAS3 score (19.7±9.6mm) was significantly 
lower than VAS1 and VAS2 (P< 0.05).  
At follow-up hysteroscopy the conversion of myomas with partially intramural development 
into totally (G0) or prevalent (G1) intracavitary lesions was globally observed in 87% (27/31) of 
cases (Table 1). For G1 myomas the conversion into G0 lesions was observed in all cases (100%). 
However, in one patient diagnosed as having a 1.8 mm, anteriorly located, G1 submucous myoma 
the spontaneous total expulsion of the myoma occurred at the following menstrual cycle as 
demonstrated either by follow-up hysteroscopy and intraoperative ultrasound. The office 
preparation of G2 myomas succeeded in 13/16 (81.2%) cases, resulting in 10 G1 (76.9%) and 3 G0 
(23.1%) lesions, respectively. In three cases of failure the myomas, originally classified as G2, were 
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still graded as G2 at follow up hysteroscopy. In two of those cases myoma size was > 4 cm (Table 
2). 
 Resectoscopic myomectomy was successfully performed in a single surgical procedure in all 
cases in which OPPIiuM technique succeeded. The mean operating time was 23.7± 8.8min. No 
intra-operative complications were reported (Table 1). All patients were discharged within 24 hours 
of hospital stay. 
In all the cases of failure, as soon as we realized the lesions to persist as G2 myomas, we 
preferred to approach them by means of a monopolar resectoscope (Karl Storz, Tuttlingen, 
Germany) which may fit cold loops for enucleating the intramural portion of myoma. However, in 
two cases the resectoscopic myomectomy required a second surgical step to avoid fluid overload 
syndrome. 
 
.  
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Discussion 
The development of small diameter (4-5mm) continuous flow hysteroscopes equipped with an 
operative channel enabled the treatment of many intrauterine pathologies in an “office setting” 
without cervical dilatation and consequently without anesthesia or analgesia and using saline 
solution as distention media (1-2,8). 
Indeed, submucous myomas with a mean diameter < 1.5 cm may be treated in office setting if 
totally intracavitary (G0) or with an intramural part < 50% (G1) (3), while actually gold standard 
treatment for myomas bigger than 1.5 cm or with an intramural part greater than 50% (G2) is 
resectoscopy eventually after 3 months therapy with GnRH analogues  
Nevertheless, hysteroscopic resection of myomas with intramural extension is advisable for 
expert operating surgeons as it is technically difficult with a slow learning curve and it is associated 
with an higher risk of complications (9). Indeed, hysteroscopic myomectomy is associated with a 
significantly higher rate of complications than other hysteroscopic procedures, being fluid overload 
and uterine perforation the most frequent complications occurring during surgery. Other 
intraoperative complications include bleeding, cervical trauma and air embolism, while late 
complications include postoperative intrauterine adhesions and uterine rupture during pregnancy 
(4).  
Several techniques have been proposed for the treatment of such submucous myomas, most of 
them sharing the objective to turn a partially intramural myoma into a totally or prevalent 
intracavitary lesion, thus avoiding a deep cut into the myometrium (4) 
 In the past, several authors have proposed a progressive resectoscopic excision of the only 
intracavitary component of those myomas with extensive intramural involvement (10), but the 
constant intracavitary expulsion and the subsequent volumetric increase of the residual intramural 
component of the myoma, leading to the persistence of the initial symptomatology, made such a 
treatment fall into disuse.  
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Nowadays the complete excision of a partially intramural myoma can be performed in different 
ways by using either one-step or two-step techniques. The two-step technique, developed by 
Donnez (11) and Loffer (12), seems to be very effective and safe; however it requires an extended 
GnRHa treatment and repeated hysteroscopies, which can cause greater distress in patients.  
Among one-step techniques, cold loop myomectomy and enucleation in toto are widely accepted 
as being safe and effective techniques. The cold loop myomectomy, developed by Mazzon (5),  is 
characterized by a sequence of three different operating steps: 1) Excision of the intracavitary 
component of the fibroid, which is carried out with the usual technique of slicing;  2)  Enucleation 
of the intramural component of the fibroid, which starts once the cleavage plane is identified and 
provides the use of a suitable blunt dissection cold loop. During the entire phase of enucleation, 
electric energy is not used, as the loop is only used in a mechanical way;  3) Excision of the 
intramural component by slicing, which begins at the end of the enucleation phase, as soon as the 
intramural part of the fibroid is totally dislocated inside the uterine cavity. At present, the cold loop 
myomectomy seems to represent the best option as it allows a safe and complete removal of such 
myomas in just one surgical procedure, while respecting the surrounding healthy myometrium. 
However the use of such technique requires adequate training, high experience and the availability 
of cold loops, which are manufactured by a single company (Storz, Germany) and may fit only the 
monopolar resectoscope.  
The enucleation in toto, developed by Litta et al. (6) provides that an elliptic incision of the 
endometrial mucosa that covers the fibroid is performed with a 90 degree Collins electrode at the 
level of its reflection on the uterine wall until the cleavage zone of the fibroid is reached. The effect 
of such action is that the fibroid protrudes into the cavity, thus facilitating its removal by traditional 
slicing.  
Proceeding from those techniques, we have recently developed a novel technique to prepare 
submucous myomas > 1.5cm with partially intramural development in outpatient setting with 
miniature hysteroscopes in order to facilitate the subsequent resectoscopic removal under general 
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anaesthesia. Such technique is simple to be performed in that it may be carried out either by means 
of mechanical instruments (5Fr scissors) or bipolar electrodes whether available. It provides that the 
endometrial mucosa covering the myoma is incised by means of 5Fr scissors or bipolar Versapoint 
Twizzle electrode along its reflection line on the uterine wall, up to the precise identification of the 
cleavage surface between the myoma and pseudo-capsula. This action is aimed at facilitating the 
protrusion of the intramural portion of myoma into the cavity during the following menstrual 
cycles. Indeed, as elsewhere demonstrated (6), the elliptic incision of endometrial mucosa covering 
the intact myoma (i.e. without the removal of the intracavitary portion) permits the expulsion forces 
of the uterine wall to maintain their maximum value until expulsion starts. 
In our series, OPPIuM technique demonstrated to be effective as it resulted in the conversion of 
myomas with intramural development into totally or prevalent intracavitary ones in nearly 90% of 
cases. This action allowed surgeons to perform resectoscopic surgery in less than 30 minutes on 
average, with reduced risks related to a prolonged anaesthesia. Furthermore, as dealing with 
prevalent intracavitary lesions, surgeons were able to remove those lesions in a single surgical step 
without any intraoperative complications. 
The rationale assuring that intrauterine lesions may be treated in outpatient setting without any 
analgesia or anaesthesia lays in the anatomical characteristics of uterus. Indeed, uterine sensitive 
innervation starts from the myometrium out while fibrotic tissue and endometrium are not 
innervated (1). One of the main concerns arising when we ideated OPPIuM technique was the fear 
to inflict pain to patients when going too deep within the myometrium. However in our preliminary 
data, the mean VAS score at the time of incision of the pseudocapsule was not significantly 
increased in comparison with that describing the pain experienced by the patients at the time of the 
introduction of the scope into the cavity. According to our preliminary clinical experience the 
correct identification of the all anatomical layers represents the main prerequisite for the success of 
the procedure. Indeed, whether after the incision of the endometrial mucosa the pseudocapsula is 
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correctly identified, the deep stimulation of myometrial innervation can be avoided, thus further 
minimizing patients’ discomfort. 
In all failed cases, submucous myomas had a prevalent intramural extension; in addition, two of 
those had a mean diameter > 4 cm. Such data seem to support the hypothesis that a greater (> 4 cm) 
myoma size in the presence of prevalent intramural development may negatively affect the 
likelihood of success of the procedure.  
Apparently, such hypothesis is in disagreement with Litta et al (6) who showed that when a 
myoma with more than 50% intramural involvement is incised, the expulsion force increases, 
reaching its maximum value when during surgery the intramural part reaches 50%. 
However the small sample size does not allow to draw any definitive conclusion and larger 
studies are mandatory to address this issue. 
  
Conclusion 
Our findings seem to support the safety and effectiveness of this novel technique by reporting 
the conversion of myomas with intramural development into totally or prevalent intracavitary ones 
in nearly 90% of cases. This action may allow surgeon to perform resectoscopic surgery more 
safely and quickly as dealing with prevalent intracavitary lesions. 
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Table 1. Main characteristics of treated myomas and outcomes of OPPIuM technique and 
resectoscopic surgery 
 
 TVS Characterization Hysteroscopic Grading Resectoscopic Data 
 Size 
(mean diameter) 
Location Office 
hysteroscopy 
(before OPPiUM) 
Follow-up 
hysteroscopy 
(after OPPiUM) 
One-step 
procedure 
Operating 
time 
(min) 
Intraoperative
complications 
1° 1,8 A G1 - - - - 
2 1,7 A G1 G0 YES 12 - 
3 1,8 L G2 G0 YES 13 - 
4* 4,7 F G2 G2 NO 74§ - 
5 3,1 F G1 G0 YES 25 - 
6 3,3 F G2 G1 YES 33 - 
7 4 F G2 G1 YES 40 - 
8 3,1 P G1 G0 YES 18 - 
9 3,2 P G2 G1 YES 26 - 
10 3,2 L G1 G0 YES 17 - 
11 3,1 A G1 G0 YES 24 - 
12 3,8 F G1 G0 YES 23 - 
13* 4,4 F G2 G2 NO 65§ - 
14 3,7 P G2 G1 YES 26 - 
15 3,3 A G2 G1 YES 30 - 
16 2 P G2 G1 YES 16 - 
17 1,9 P G1 G0 YES 14 - 
18 1,6 L G1 G0 YES 12 - 
19 2,2 F G2 G0 YES 15 - 
20 4 F G2 G1 YES 44 - 
21 4,9 A G1 G0 YES 32 - 
22 2,9 P G2 G0 YES 22 - 
23 4,4 L G2 G1 YES 37 - 
24 1,6 A G1 G0 YES 12 - 
25 3 F G1 G0 YES 22 - 
26 3,1 A G1 G0 YES 24 - 
27 3,7 P G1 G0 YES 28 - 
28 2,7 F G2 G1 YES 30 - 
29* 3,1 P G2 G2 YES 36 - 
30 1,8 P G1 G0 YES 16 - 
31 4,2 L G2 G1 YES 29 - 
368 
369 
370 
371 
372 
373 
374 
375 
376 
377 
 
A: anterior wall; P: posterior wall; F: uterine fundus; L: lateral walls. Myomas are classified in G0, 
G1 and G2 type according to the European Society of Hysteroscopy classification (G0 myoma is 
completely within the uterine cavity; a G1 myoma has its larger part (> 50%) in the uterine cavity; 
and a G2 myoma has its larger part (> 50%) in the myometrium 
 
°  Spontaneous total expulsion of the myoma 
* Failed OPPIuM technique 
§  Sum of operating times of two surgical procedures 
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Legend of figures 
 
Figure 1. OPPIuM technique: a) Incision of endometrial mucosa which covers the myoma by 
means of 5 Fr bipolar electrode  b) Identification of  the cleavage surface between the myoma and 
pseudo-capsula. 
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CASE REPORTS
0
dUse of office hysteroscopy to empty a very large
hematometra in a young virgin patient with mosaic
Turner’s syndrome
Attilio Di Spiezio Sardo, M.D.,a Costantino Di Carlo, M.D.,a Maria Carolina Salerno, M.D.,b
Stefania Sparice, M.D.,a Giuseppe Bifulco, M.D.,a Maurizio Guida, M.D.,a and
Carmine Nappi, M.D.a
a Department of Gynaecology, Obstetrics and Pathophysiology of Human Reproduction, and b Department of Paediatrics,
University of Naples “Federico II,” Naples, Italy
Objective: To describe the successful management of a hematometra using a 5-mm continuous flow operative
office hysteroscope.
Design: Case report.
Setting: University of Naples “Federico II.”
Patient(s): A 13-year-old virgin patient affected by mosaic Turner’s syndrome (45 X; 46 XX) was referred to the
emergency room of the Department of Obstetrics and Gynecology after an episode of severe pelvic pain with
metrorrhagia. A large hematometra was detected by transabdominal ultrasound scanning.
Intervention(s): Vaginoscopic hysteroscopy performed in outpatient setting.
Main Outcome Measure(s): Complete resolution of the hematometra and related clinical symptoms.
Result(s): Vaginoscopic approach avoided general anesthesia and preserved the integrity of her hymen. A
chocolate-like fluid started to spill out from the uterine cavity as soon as the tip of hysteroscope passed through
the internal uterine ostium. A transabdominal ultrasound performed 2 days later showed resolution of the
hematometra. Success of the procedure was confirmed by the resolution of all clinical symptoms.
Conclusion(s) In selected cases, with intact outflow tract, outpatient vaginoscopic hysteroscopy might represent
the therapeutic technique of choice in case of hematometra, even in the case of virgin patients. (Fertil Steril
2007;87:417.e1–3. ©2007 by American Society for Reproductive Medicine.)
Key Words: Hematometra, hysteroscopy, Turner’s syndrome, vaginoscopic approacha
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murner’s syndrome is the most common sex chromosome
bnormality in female patients, occurring in about 50 per
00,000 live-born girls. In about 50% of cases, karyotype
nalysis reveals the complete loss of one X chromosome
45X), whereas the remaining patients display a multitude of
hromosomal abnormalities, including partial absence of one
chromosome or mosaicism (1). The degree of mosaicism
ay not predict the severity of the phenotype. The main
enital abnormalities associated with Turner’s syndrome are
onadal dysgenesis and uterine and fallopian tube infanti-
ism. Nearly 15% of these girls have spontaneous menstrual
eriods (1).
No previous case of hematometra in patients with
urner’s syndrome has been reported in the international
iterature. This report describes a 13-year-old virgin patient
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ASE REPORT
13-year-old virgin patient was referred to the emergency
oom of the Department of Obstetrics and Gynaecology after
n episode of severe pelvic pain with metrorrhagia. The
atient provided an informed consent to perform the study.
he study was eventually approved by our Institutional Re-
iew Board.
At the age of 5 years, after genetic study performed for
rowth retardation, the patient was diagnosed with mosaic
urner’s syndrome (45 X; 46 XX). Since the age of 6 years,
he was successfully treated with the growth hormone at the
osage of 0.38 mg/kg/week (Saizen, Serono, Rome, Italy).
pontaneous breast development and pubic hair growth oc-
urred at the age of 10 years. Puberty progressed normally,
esulting in a spontaneous menarche at 12.75 years of age, 3
onths before her admission to the Department of Obstetricsnd Gynaecology. According to her mother, her first men-
417.e1Fertility and Sterility Vol. 87, No. 2, February 2007
ety for Reproductive Medicine, Published by Elsevier Inc.
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2007trual episode was regular in terms of duration and amount,
ithout pelvic discomfort. Approximately 1 month later, she
tarted to complain of pelvic cramps, which required anal-
esic treatment. The patient reported no other episodes of
enstrual-like bleeding until the episode of metrorrhagia,
hich required admission to this Department. A physical
xamination revealed discomfort with diffused tenderness of
he lower abdomen. Transabdominal ultrasound scanning
howed an anteverted uterus with a greater than normal
olume (Longitudinal diameter (LD): 82 mm, Antero-pos-
ero diameter (APD): 48 mm, Transverse diameter (TD): 63
m) and an acute angle of flexion. The cavity was totally
lled up by a transonic layer. The ovaries were not visible
Fig. 1).
Hysteroscopy was performed by A.D.S. with a 5-mm
ontinuous flow operative office hysteroscope with a 2.9-mm
od lens (Bettocchi office hysteroscope: Karl Storz, Tuttlin-
en, Germany). The vaginoscopic approach (without specu-
um and tenaculum) was used to preserve the integrity of the
ymen. Neither analgesia nor local anesthetics were admin-
stered to the patient. Distension of the uterine cavity was
btained using normal saline solution and the intrauterine
ressure was automatically controlled by an electronic irri-
ation and suction device (Endomat; Karl Storz). The intra-
terine pressure was set at 45 mm Hg, the irrigation flowed
t about 200 mL/min, and a vacuum was set at 0.2 bar.
ndoscopic vaginal and cervical explorations were normal.
FIGURE 1
Transabdominal ultrasound scanning showing an ant
APD: 48 mm, TD: 63 mm) and an acute angle of flex
transonic layer (hematomethra).
Di Spiezo Sardo. Hematometra, Turner’s Syndrome, and hysteroscopy. Fertil Sterils soon as the tip of the hysteroscope passed through the m
417.e2 Di Spiezio Sardo et al. Hematometra, Turner’s syndromnternal uterine ostium (IUO), which was moderately ste-
otic, a chocolate like fluid started to spill out from the
terine cavity resulting in poor endoscopic vision. At this
oment the vacuum pressure was increased to 0.4 bar,
aking emptying of uterine cavity easier and faster. Approx-
mately 300 mL of blood were aspirated in 5 minutes.
An ultrasound performed 2 days later showed complete
esolution of the hematometra. The success of the procedure
as confirmed by the resolution of the clinical symptoms.
uring the next 2 months the patient experienced normal,
egular, painless menstrual cycles.
ISCUSSION
ailure of the female genital tract to develop may result in
enital outflow tract obstructions. Because of the absence of
n outlet for menstrual flow, menstrual blood accumulates in
he vagina (hematocolpos) and uterus (hematometra) with
he onset of menstruation (2). The most common symptoms
ssociated with the presence of an hematometra are lower
bdominal pain radiating to the lower back, discomfort, and
ense of fullness in the pelvis. A suprapubic tender mass
ften is palpable as a result of uterine enlargement and
pward displacement. Urinary retention or constipation can
ccur because of compression of the distended uterus (3).
This case report demonstrates a successful management of
n hematometra in a 13-year-old virgin patient affected by
ted uterus with an increased volume (LD: 82 mm,
The cavity appears to be totally filled by a
.ever
ion.osaic Turner’s syndrome using a standard rigid 5-mm
e, and hysteroscopy Vol. 87, No. 2, February 2007
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Fontinuous flow operative office hysteroscope in an uncom-
on situation. Apart from moderate stenosis of IUO and an
nteverted uterus with a remarkable reduction of the flexion
ngle, there were no other significant pathological intrauter-
ne findings (e.g., sinechiae, isthmic or cervical occluding
esions). Our main ethiopathogenetic hypothesis was that
uch a reduced uterine flexion angle, associated with a mod-
rate stenosis of IUO, could have caused an acquired ob-
truction to her menstrual flow, resulting in the progressive
evelopment of a large hematometra.
A MEDLINE literature search using Turner syndrome,
ematometra, and genital abnormalities as key words failed
o identify other reported cases of an hematometra in a
atient with Turner’s syndrome. Whether the syndrome
ight have contributed to the genesis of the hematometra is
hus questionable.
In 2001, the vaginoscopic approach to hysteroscopy was
ntroduced in our clinic. The vaginoscopic approach is a
ontraumatic procedure, in which the scope is introduced
nto the vagina without speculum and tenaculum (4, 5), the
agina being distended by distension medium (normal sa-
ine) at a pressure of 60–80 mm Hg, which is the same
ressure used for the subsequent distension of the uterine
avity. This approach has permitted complete elimination of
remedication, analgesia, or anesthesia, making the proce-
ure rapid and without complications. Furthermore, hyster-
scopy can be performed in outpatient setting in patients
ho otherwise might require general anesthesia, such as
lder women with somewhat stenotic vaginas and virgin
atients (5). In our patient, the vaginoscopic approach al-
owed us to avoid general anesthesia and to preserve the
ntegrity of her hymen.
The instruments used for vaginoscopy in children include
ysteroscope, cystoscope, urethroscope, otoscope, panendo-
cope, and even a nasal speculum. Among the hysteroscopes,
he flexible ones are not only easy to use but also convenient,
afe, and effective. In the current case a standard 5-mm rigid
ysteroscope was used as is normal in the outpatient setting.
ertility and Sterilityhe small caliber and the irrigating fluid used to balloon the
agina allowed for the successful performance of the hys-
eroscopy while retaining the integrity of the hymen in the
oung girl. The use of Endomat made the procedure quick
nd easy with a clear endoscopic view during most of the
rocedure. However, although electronic irrigation and suc-
ion device was not available in our case, we recommend
onnecting the hysteroscopic outflow channel to a cannula
nd set for surgical aspiration (Bioservice Medical Devices,
ioservice S.p.A., Italy).
Because we believed that a moderate stenosis of the IUO
ight have contributed to the pathogenesis of the hematome-
ra, we decided to enlarge the IUO by moving the hystero-
cope gently from side-to-side and also by opening the two
ranches of a 5-Fr grasping forceps inserted through the
ysteroscopic operative channel. The overall procedure was
eferred to by the young patient as moderately uncomfort-
ble, with a moment of pain when the tip of the hysteroscope
assed through the IUO. However, no analgesic was re-
uired during and immediately after the procedure.
In conclusion, in selected cases, with intact outflow tract,
utpatient vaginoscopic hysteroscopy could represent the
herapeutic technique of choice in case of hematometra, even
n case of virgin children, because it is safe, convenient,
ffective, and easy to perform.
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Outpatient Hysteroscopic Emptying of a Submucosal
Uterine Cystic Lesion
Attilio Di Spiezio Sardo, MD, Maurizio Guida, MD, Giuseppe Bifulco, MD, Sergio Frangini, MD,
Maddalena Borriello, MD, Carmine Nappi, MD
ABSTRACT
Background: Uterine cystic neoformations are rare, but
they should always be investigated to differentiate a be-
nign from a malignant pathology. Transvaginal ultra-
sonography, MRI, and blood tests are the main investiga-
tions for diagnosing these lesions, avoiding over- or
undertreatment. Hysteroscopy might represent a helpful
tool both for its diagnostic and therapeutic properties.
Methods: We report the hysteroscopic emptying of a
cystic-degenerated leiomyoma with a 5-Fr flexible needle
inserted through the operative channel of a 5-mm contin-
uous-flow operative office hysteroscope in an outpatient
setting.
Results: The cystic lesion was successfully emptied. The
hystopathological result of the target biopsies performed
on the cystic wall was cystic degeneration of a leiomyoma.
Conclusion: This needle is normally used in gynecology
to instill intrauterine local anesthesia under a hystero-
scopic view. We adapted it to drain a fluid-filled lesion,
identifying a further application of this instrument.
Key Words: Flexible needle, Hysteroscopy, Leiomyoma,
Uterine cyst.
INTRODUCTION
Cystic neoformations of the female reproductive system
are very common in the ovarian tissue, while rare in the
other organs.
The differential diagnosis of the uterine cystic mass in-
cludes congenital malformation, leiomyomata cystic de-
generation, adenocystic tumor, adenomyosis, echinococ-
cus cyst, and intramyometrial hydrosalpinges.1–4
We report the successful hysteroscopic emptying of a
cystic-degenerated leiomyoma with a 5-Fr flexible needle
(Karl Storz, Tuttlingen, Germany) in an outpatient setting.
CASE REPORT
A 39-year-old female, para 4, was admitted to our depart-
ment after complaining of severe lower abdominal pain
for the last year. On physical and gynecological examina-
tions, no pathological finding was detected. Transvaginal
sonography (TS) revealed an intramural anechogenic le-
sion in the uterine fundus 18.2 x 19.6mm in size sur-
rounded by a hyperechogenic ring (Figure 1). This cystic
mass was suspected to be a gestational sac, but serum
HCG dosage was negative.
Tumor markers were within the normal range. An outpa-
tient diagnostic hysteroscopy was performed. The uterine
cavity was regular with the exception of an atypical area
of vascularization, corresponding to the cystic mass de-
tected on TS.
The patient was discharged with a diagnosis of suspicious
adenomyosis and was advised to document her pain ep-
isodes in a diary. She was scheduled for a repeat TS and
CA125 dosage after 3 months. Mefenamic acid was pre-
scribed for further episodes of pain.
However, the patient was referred to the emergency room of
our department nearly one month later following a severe
episode of dysmenorrhea. Repeat TS revealed that the cystic
mass had become submucosal. A repeat outpatient hyster-
oscopy was performed using a 5-mm continuous-flow op-
erative office hysteroscope with a 2.9-mm rod lens (Bettoc-
chi office hysteroscope, Karl Storz, Tuttlingen, Germany).
The vaginoscopic approach (without speculum and tenacu-
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CASE REPORT
lum) was used to improve the patient’s compliance. Saline
solution was used as the distending medium. Neither anal-
gesia nor local anesthesia was administrated to the patient.
A translucent lesion apparently blood filled was detected
at the uterine fundus. Because the cystic wall was thin, the
cyst was emptied by using a flexible needle (1.7 mm and
80 cm length; Karl Storz, Tuttlingen, Germany) introduced
through the 5-Fr operative channel (Figure 2). Nearly 5
mL of hematic fluid were drained. Several target biopsies
were performed on the cystic wall. The hystopathological
result was cystic degeneration of leiomyoma. A TS per-
formed one month later showed that the anechogenic
image in the uterus had completely disappeared. At the
3-month follow-up visit, the patient’s symptomatology
was remarkably improved.
DISCUSSION
Every uterine cystic mass should always be investigated to
differentiate a benign from a malignant pathology.5 Trans-
vaginal ultrasonography, MRI, and blood tests (ie, HCG
and tumor markers) are the main investigations for diag-
nosing these lesions, avoiding over- or undertreatment.6–8
Hysteroscopy can be a helpful tool both for its diagnostic
and therapeutic properties. Moreover, the possibility of per-
forming target biopsies allows a hystopathological diagnosis.
CONCLSION
In this report, we have described the possibility of emp-
tying a blood-filled uterine submucosal lesion in an out-
patient setting by using a flexible needle inserted through
the 5-Fr operative channel of a 5-mm continuous-flow
operative office hysteroscope.
The index needle is normally used in gynecology to instill
intrauterine local anaesthesia under a hysteroscopic view.
We adapted it to drain a fluid-filled lesion, identifying a
further application for this instrument.
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Figure 1. Intramural anechogenic lesion (18.2 x 19.6 mm) in the
uterine fundus surrounded by a hyperechogenic ring.
Figure 2. Distal tip of the 5-Fr flexible needle (Karl Storz,
Tuttlingen, Germany).
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dEndocervical metaplasia of the endometrium in a
patient with cystic fibrosis: a case report
Roberto Piccoli, M.D.,a Attilio Di Spiezio Sardo, M.D.a, Luigi Insabato, M.D.,b
Giuseppe Acunzo, M.D.,a Maurizio Guida, M.D.,a and Carmine Nappi, M.D.a
a Department of Gynecology and Obstetrics, and Pathophysiology of Human Reproduction and b Department of Biomorphic and
Functional Sciences, Pathological Anatomy Section, University of Naples “Federico II,” Naples, Italy
Objective: To report the case of an infertile female patient with cystic fibrosis who was diagnosed with
endocervical metaplasia of the endometrium at diagnostic hysteroscopy and successfully treated with an oral
estroprogestinic formulation.
Design: Case report.
Setting: University hospital.
Patient(s): A 27-year-old infertile female patient with cystic fibrosis.
Intervention(s): Hysteroscopy with multiple random biopsies was performed at the time of the first visit and after
a 10-month cycle with an oral estroprogestinic formulation.
Main Outcome Measure(s): Hysteroscopic evaluation with target biopsy; histological examinations of endome-
trial specimens.
Result(s): Our patient benefited from a 10-month cycle with an oral estroprogestinic formulation. At the control
visit we noticed a significant improvement in the hysteroscopic appearance of her endometrium, and the
histological examination confirmed the complete reversion of the metaplastic alterations previously observed.
Conclusion(s): The present report suggests a novel histological alteration possibly involved in affecting fertility
in women with cystic fibrosis. In addition, the positive response to the estroprogestinic treatment observed in our
patient poses new questions regarding the relationship between ovarian hormones and cystic fibrosis transmem-
brane conductance regulator protein regulation, offering interesting perspectives for a hormonal therapy in the
treatment of subfertility in women with cystic fibrosis. (Fertil Steril 2006;85:750e13–6. ©2006 by American
Society for Reproductive Medicine.)
Key Words: Infertility, cystic fibrosis, endocervical metaplasia, endometrium, hysteroscopyp
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oystic fibrosis (CF) is the most frequent lethal autosomal
ecessive disease among Caucasians (1). It is characterized
y defective production of the cystic fibrosis transmembrane
onductance regulator (CFTR) protein (2) (a complex chan-
el regulating the passage of chloride and, indirectly, sodium
nd water across luminal cell membranes), which results in
hickened and desiccated secretions throughout most of the
xocrine glands and tissues, including the reproductive tract.
Because the life expectancy for individuals with CF has
ramatically improved over the past 50 years, the issues of
ertility and reproductive health have become increasingly
mportant. Up to 98% of men are infertile due to the con-
enital bilateral absence of the vas deferens with consequent
bstructive azoospermia. The effects of CF on female fertil-
ty are less clear. Unlike in men, reproductive tract anoma-
ies have not been described in women affected by CF, nor
as any evidence been presented of a “global” reduction in
F female fertility. It is generally reported that subfertility
ight be attributable to the reduction in cervical mucus
ater content due to the defective expression of CFTR
eceived January 12, 2005; revised and accepted July 22, 2005.
eprint requests: Attilio Di Spiezio Sardo, M.D., University of Naples
“Federico II,” Department of Gynecology and Obstetrics, and Patho-
physiology of Human Reproduction, Via Pansini 5, Naples, Italy (FAX:p39-0817462905; E-mail: cdispie@tin.it).
015-0282/06/$32.00
oi:10.1016/j.fertnstert.2005.07.1336 Copyright ©2006 American Societrotein in the cervix of CF patients. This might result in a
hick, tenacious mucus plug interfering with sperm motility
nd penetration (3, 4). In addition, menstrual irregularities,
vulatory disturbances, and amenorrhea are quite common
ndings in female CF patients (5–7).
Nevertheless, recent reports have interestingly demonstrated
hat CF patients, although undernourished and suffering from
hest disease and/or irregular menstrual patterns, can still
onceive and successfully carry out their pregnancies (8, 9).
To our knowledge, this is the first reported case in the
nternational literature of a female patient with CF who was
iagnosed with endocervical metaplasia of the endometrium
t diagnostic hysteroscopy performed for abnormal men-
trual pattern and infertility.
ASE REPORT
n January 2004, a 27-year-old woman with CF was referred
o the hysteroscopy clinic of University Hospital “Federico
I” of Naples for menstrual pattern abnormalities and infer-
ility. Our patient provided informed consent for the perfor-
ance of this study. The study was eventually approved by
ur institutional review board.
Since the age of 5 years, the patient had suffered fromrogressive respiratory and gastrointestinal complaints,
750.e13Fertility and Sterility Vol. 85, No. 3, March 2006
y for Reproductive Medicine, Published by Elsevier Inc.
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ehich had led to the diagnosis of CF at the age of 16 (sweat
lectrolytes: Na  152 mEq/L, Cl  144 mEq/L).
Since then, steatorrhea due to pancreatic insufficiency and
alabsorption had been thoroughly controlled by means of
edical therapy, as demonstrated by the stability of her body
ass index at approximately 19 kg/m2. The patient’s recur-
ent, chronic lung colonization with Pseudomonas aerugi-
osa required cyclic antibiotics and the use of bronchodila-
ors, which had effectively preserved her pulmonary function
Shwachman score: 85).
At the age of 14 years the patient had reached menarche,
lbeit with slightly delayed development of the secondary
exual characteristics. Menstrual periods had initially been
egular, as customary at 30 days intervals and with 4 to 5
ays of flow. However, from the age of approximately 25
ears, the patient started to suffer from oligomenorrhea and
enorrhagia, and such symptoms were accompanied by
acial acne and hirsutism.
Endocrine evaluation and ultrasonographic imaging of the
varies revealed findings consistent with chronic anovula-
ion. Pelvic examination showed that the vulva and vagina
ere normal, whereas the cervix appeared totally covered by
FIGURE 1
Section showing tissue fragments of endometrial cav
magnification, 40.Piccolo. Cystic fibrosis and endometrium. Fertil Steril 2006.
750.e14 Piccolo et al. Cystic fibrosis and endometriumpproximately 15 cm3 of thick mucus coming out from the
ervical os. The uterine fundus and adnexa were normal.
At colposcopic evaluation the ectocervical epithelium ap-
eared erythroplastic, lined by cylindrical epithelium almost
otally hidden by the thick mucus layer. The evaluation of
he endocervical channel was also hampered by the presence
f adherent mucus. As a result, the patient was scheduled for
utpatient hysteroscopy.
Once the tenacious, mucous cap occluding the cervical os
as removed, hysteroscopy revealed a cervical channel of
ortuous, irregular appearance. The endocervical epithelium
as totally covered by thickened mucus. Two biopsies were
andomly executed in the endocervical canal. Whitish, mu-
ous thickenings were widely diffused throughout the uter-
ne cavity, obstructing tubal ostia and making any complete
valuation of the cavity unfeasible. The vascularization was
ugmented and irregular, with some large-caliber vessels
merging. The lining of the uterine cavity was repeatedly
nd randomly biopsied.
Histological findings revealed metaplastic endocervical
pithelium on endometrial fragments (Fig. 1), whereas
ined by cervical columnar epithelium. Originality lVol. 85, No. 3, March 2006
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Fhronic, acute, and focally erosive cervicitis was found on
he cervical specimen.
To improve her cycle irregularities, a combined estropro-
estinic formulation containing cyproterone (2 mg) and ethi-
ylestradiol (0.035 mg Diane; Schering, Milan, Italy), to be
aken once daily for 21 days per month, was prescribed to the
atient. The patient was clinically and hysteroscopically
e-evaluated after a 10-month period of therapy.
Hysteroscopy showed a significantly improved appear-
nce of both the cervical channel and the uterine cavity. The
ervical channel still appeared tortuous, but the surface was
egular. Residual mucous thickenings were noticeable on the
osterior uterine wall only, whereas the fundus and the
nterior wall were lined with endometrium of normal ap-
earance. Histological examination of endometrial speci-
ens obtained under hysteroscopic view revealed early se-
retive endometrium and thick stroma, with no residual
etaplastic aspects.
The patient discontinued the contraceptive pill in Decem-
er 2004. Endocrine evaluation and ultrasonographic imag-
ng of the ovaries performed in January 2005 revealed find-
ngs consistent with ovulatory cycles. The patient is currently
rying to conceive without any pharmacologic aid. A further
iagnostic hysteroscopy with target multiple biopsies was
erformed in March 2005. Such examination confirmed a
ubstantially improved appearance of her endometrium and a
omplete reversion of the metaplastic alterations that were
reviously observed.
ISCUSSION
omen with CF are considered less fertile than those not
ffected by CF (3). The reasons for this observation are still
nclear.
Traditionally, the main cause of the reduced fertility rate
bserved in women with CF has been suggested to be the
bnormal expression of the CFTR in the cervical epithe-
ium, leading to the formation of a tenacious, imperme-
ble mucus, which in turn acts as a barrier to sperm motility
nd penetration (3, 4).
More recently, several lines of evidence have proved that
he cause of hypofertility in women with CF is much more
omplex than what was previously believed, because the
FTR has been shown to be of physiological significance in
everal reproductive events (10).
Cystic fibrosis transmembrane conductance regulator has
een found throughout the female reproductive tract of both
nimal and human tissues, where it seems to be involved in
he secretory activities of the lining epithelia (10, 11).
It has been shown that distribution and expression of
FTR is highly variable, according to the phase of the
enstrual cycle (with estrogens enhancing and P down-egulating its expression) (12) and the specific site of the t
ertility and Sterilityeproductive tract (oviduct, endometrium, cervix, or vagina).
uch hormone-dependent, tissue-specific regulation of CFTR
xpression provides a physiological basis for the cyclic,
egional changes in female reproductive fluid volume and
omposition, which are consistent with the variable actions
layed by the fluid at the different levels of the reproductive
ract and in the different phases of the menstrual cycle, to
ermit successful reproductive events in the individual sec-
ions of the reproductive tract (10, 13).
This suggests that, in CF, abnormal CFTR expression
ight lead to biochemical abnormalities in reproductive tract
uid of possible importance to fertility, in addition to any
echanical obstruction to sperm migration from increased
iscosity and associated ultrastructural changes of CF cervi-
al mucus.
Multiple ovarian cysts, associated with a polycystic ovary-
ike hormonal pattern and an increased incidence of anovu-
ation, have also been reported as additional causes of hy-
ofertility in women with CF (5–7). Poor nutritional status
ue to malabsorption and steatorrhea, impaired insulin sen-
itivity (due to the progressive replacement of the islet of
angerhans with fibrous and fatty tissue), as well as psycho-
ogical stress commonly observed in chronically ill patients,
ave all been considered potential factors responsible for
uch endocrine abnormalities (6).
Furthermore, involvement of cytokines or a disturbed
ypothalamic–pituitary–ovarian axis cannot be excluded as
auses for reduced fertility in women with CF. Indeed,
FTR messenger RNA expression has been recently found
n the region of rat hypothalamus containing high concen-
rations of GnRH and estrogen-rich neurons, which are likely
o be involved in sexual maturation and reproduction (14).
We believe this is the first report in the English literature
ndicating such a particular histological endometrial abnor-
ality in a CF patient as a potential cause of the patient’s
ypofertility, together with other well-known factors of
nfertility, including thick cervical mucus and polycystic
varies.
Our patient benefited from the blockage of ovarian steroi-
ogenesis induced by a 10-month cycle with an estroproges-
inic formulation. During the control visit we noticed a
ignificant improvement in her clinical symptomatology
acne, hirsutism, and menstrual irregularities) and the hys-
eroscopic appearance of her endometrium. In addition, we
oticed a complete histological reversion of the metaplastic
lterations previously observed.
The present report introduces a new etiopathogenetic hy-
othesis in the understanding of the mechanisms involved in
etermining hypofertility and infertility in young female CF
atients. The study suggests a novel histological alteration
ossibly affecting fertility in CF women. The viscosity, as
ell as the electrolyte composition of the endometrial mucus
ecreted by the metaplastic endocervical glands, might alter
he physiological uterine environment required for the re-
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1ional reproductive processes, such as sperm transport and
apacitation, as well as embryo transport, development, and
mplantation.
Because this histological alteration was accompanied by
ther well-recognized factors of infertility in our patient, it is
ifficult to evaluate the real impact of this endometrial
hange on her hypofertility and infertility.
Finally, the positive response to the estroprogestinic treat-
ent observed in our patient poses new questions regarding
he relationship between ovarian hormones and CFTR reg-
lation, either in normal or in CF patients, offering interest-
ng future perspectives for a hormonal therapy in the treat-
ent of subfertility in women with CF.
We are now evaluating the real incidence and impact of
his histological abnormality in hypofertile and infertile
oung female CF patients.
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Case report
Hysteroscopic Removal of Gauze Packing Inadvertently Sutured
to the Uterine Cavity: Report of 2 Cases
Stefano Bettocchi, Attilio Di Spiezio Sardo,*, Lauro Pinto, Maurizio Guida,
Maria Antonietta Castaldi, Oronzo Ceci, and Carmine Nappi
From the Department of General and Specialistic Surgical Sciences, Section of Obstetrics and Gynecology, University of Bari, Italy (Bettocchi, Pinto, and
Ceci); and Department of Gynecology and Obstetrics, and Pathophysiology of Human Reproduction, University of Naples "Federico II," Italy (Di Spiezio
Sardo, Guida, Castaldi, and Nappi).
ABSTRACT We report on 2 cases of successful hysteroscopic removal of uterovaginal packing, inserted during cesarean sections after uter-The authors have
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Oine hemorrhage resistant to medical therapy. The packing, in both cases, could not be removed vaginally with sponge forceps asit had adhered to the uterine cavity. A hysteroscopic approach enabled identification and cutting with 5F scissors of the stitches
fixing the packing to the uterine walls, allowing straightforward removal in an outpatient setting and avoiding a repeated
laparotomy. Some useful techniques to handle such a situation are described. Journal of Minimally Invasive Gynecology
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Management options for postpartum hemorrhage (PPH)
include oxytocics, prostaglandins, genital tract exploration,
ligation or angiographic embolization of uterine/internal iliac
arteries, and hysterectomy.
After excluding uterine rupture, genital tract lacerations,
and retained placental tissue, efforts are directed toward con-
tracting the uterus by bimanual compression and oxytocics. If
these are not successful either, surgical techniques are recom-
mended. At this stage, alternative options to control bleeding
would be tamponade balloons, such as Foley [21], Bakri bal-
loon [23], and Sengstaken-Blakemore tube [22,23], or utero-
vaginal packing, which is easy and quick to perform even by
the novice [1,2]. The uterovaginal packing may be inserted in
women who have delivered either abdominally or vaginally,
the success of the procedure being strictly related to the tech-
nique used [3]. Indeed, a high level of success in bleeding
control was reported by using the unrolled packing material
and evenly distributing it in all areas of the uterine cavityU
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Dthrough repeated insertion efforts [3]. After uterine packing
is completed, vaginal packing is usually also carried out.
The 2 main complications of uterovaginal packing are
infections of the packing [4,5] and difficulties encountered
during removal, often caused by awkward surgical maneu-
vers [1,6,7]. Uterovaginal packing is usually removed 12 to
24 hours after positioning, with sponge forceps, by gently
drawing the visible end toward the perineum with downward
and forward movement and care must be taken withdrawing
knotted strips [8]. If removal is painful, sometimes uterovagi-
nal packing must be removed in a surgical setting, under
anesthetic, or both [9]. In addition, sometimes it is impossible
to remove the packing vaginally especially after cesarean
section, because the packing may remain entrapped within
the stitches of the suture. Whenever this occurs, a new lapa-
rotomy is usually performed to safely remove the packing.
We report on 2 successful outpatient hysteroscopic re-
movals of uterovaginal packing, inserted during cesarean
sections and entrapped within uterine stitches.
Case 1
A 38-year-old woman, primigravida, underwent an elec-
tive cesarean section performed for breech presentation. Dur-
ing surgery, a severe primary hemorrhage led the operator to
opt for uterine packing after several failed attempts to con-
tract the uterus by bimanual compression and administration21 October 2008  12:52 am  ce
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of oxytocics and prostaglandins. Packing was placed from
the fundus through the cervix up to the vagina and provided
good control of the hemorrhage. The hysterotomy incision
was then sutured with polyglactin 1. The patient underwent
antibiotic therapy and was scheduled for vaginal removal
of the packing 24 hours later. The gynecologist was not
able to remove the packing as it seemed to adhere to the
uterine walls. Before performing a repeated laparotomy, the
gynecologist contacted the hysteroscopic department for
advice, as it was suspected that the packing was entrapped
in the hysterotomy suture. Hysteroscopy was performed in
an office setting using the vaginoscopic approach without
speculum or tenaculum, without analgesia or anesthesia.
The procedure was performed using the 4-mm continuous-
flow operative office hysteroscope with a 2.9-mm rod lens
(Bettocchi office hysteroscope size 4, Karl Storz, Tuttlingen,
Germany).
Distention of the uterine cavity was achieved using nor-
mal saline solution and intrauterine pressure was automati-
cally controlled by an electronic irrigation and suction
device (Endomat, Karl Storz). Intrauterine pressure was
initially set at 45 mm Hg, this being the balance of irrigation
flow approximately 200 mL/min and a vacuum of 0.2 bars.
Then it was increased to improve endoscopic view. The vag-
inal extremity of the packing was kept in tension manually by
the operator to mobilize the packing within the uterine cavity
and to allow identification of the stitches holding the gauze to
the uterine wall. Endoscopically it was possible to determine
that the packing was anteriorly entrapped in the hysterotomy
suture. Two stitches in particular were identified and easily
cut by means of 5F sharp scissors (Fig. 1). Subsequent
removal of the packing from the uterine cavity was straight-
forward.
Case 2
A 37-year-old woman, primigravida, underwent an elec-
tive cesarean section performed for central placenta previa.
During surgery, a primary hemorrhage, intractable despiteU
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Fig. 1. Sharp 5F scissors cutting 1 of 2 stitches fixing packing to uterine wall.
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administration of oxytocics and prostaglandins, led the oper-
ator to opt for tight uterovaginal packing, placed through the
hysterotomy incision and then through the whole uterus and
cervix up to the vagina, using 3 U of povidone-iodine–soaked
gauze, which successfully controlled uterine bleeding. Then
the hysterotomy incision was sutured with polyglactin 1 and
further hemostatic sutures were also provided in correspon-
dence with the right uterine artery. The patient underwent an-
tibiotic therapy and was scheduled for vaginal removal of the
packing 24 hours later. The packing seemed to adhere to the
uterine walls and, as a result, the gynecologist was not able to
remove it. Before performing a new laparotomy, the gynecol-
ogist contacted the hysteroscopic department seeking advice,
as it was suspected that the packing was entrapped in the uter-
ine sutures. Hysteroscopy was performed in an office setting
using the same instrumentation and setting as in the first case.
The operator first decided to cut the packing in half with
a Versapoint Twizzle Electrode ( QGynecare) to improve endo-
scopic vision of the uterine cavity. After that, the endoscopic
view showed that the packing was entrapped in the hemo-
static suture of the right uterine artery. Taking into account
the potential for intractable bleeding that could result after
cutting the hemostatic stitch, the operator decided to cut
the packing with 5F sharp scissors leaving a small piece
(,1 cm) in situ, thus avoiding loosening of the suture. After
30 days a repeated office hysteroscopy was performed, the
stitch was easily cut with 5F scissors, and the residual gauze
was safely removed from the uterine cavity.Techniques
To improve the endoscopic view and facilitate the identi-
fication of those stitches to be cut, some special techniques
can be used.201
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208Increasing Intrauterine Pressure
The cervical leakage of fluid distention medium as a result
of the packing extruding throughout the cervix did not allow
satisfactory distention with the values of flow (200 mL/min),
suction (0.2 bar), and pressure (120 mm Hg) commonly used
in office setting to avoid patient discomfort. Thus, the intra-
uterine pressure was increased by closing suction and in-
creasing flow and pressure of irrigation up to 250 mL/min
and 150 mm Hg, respectively.
209
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221Handling of Vaginal Extremity of Gauze Packing
In the first case, the vaginal extremity of the packing was
kept in tension manually and pulled to 1 side by the operator
and the hysteroscope advanced progressively in the space
between the opposite uterine wall and the packing itself.
The operation was then repeated on the opposite side. This
action allowed the mobilization of the packing within the
uterine cavity and the exact identification of the stitches
fixing the gauze to the anterior uterine wall.21 October 2008  12:52 am  ce
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Cutting of the Gauze Packing
In the second case the operator decided to halve the pack-
ing to improve the intrauterine view. Taking into account the
hard consistency of the packing, a 5F bipolar electrode was
preferred instead of sharp scissors. Subsequently, the endo-
scopic view showed the packing entrapped in the hemostatic
suture of the right uterine artery.
Color Searching
After entering the uterine cavity, in both cases, the endo-
scopic view showed that the predominant color was white, as
the gauze packing occupied the whole cavity, simulating an
enormous submucous myoma. Therefore, the operator needs
to be quick and have precise control of movements to identify
the blue of the stitches within the white.
Discussion
Acute PPH is nowadays the main cause of maternal death
in developing countries, whereas in developed countries it is
the third most common reason, after embolism and hyperten-
sive emergency [10]. Current hemorrhage management, on
the premise that prevention assessed by continued observa-
tion is the gold standard in managing this complex obstetric
emergency [11–14], shows different possibilities such as
medical, paramedical, parasurgical, and surgical procedures.
When a pharmacologic approach and bimanual compression
cannot stop the bleeding, uterovaginal packing may represent
a valid alternative before opting for surgical techniques. Fur-
thermore, uterovaginal packing may be used to gain time to
stabilize the patient while arranging for a surgical procedure.
In some of these situations, packing alone proved successful,
thereby obviating the need for surgery [7].
Uterovaginal packing for PPH was often used before the
1960s. Its use subsequently declined because of fear of infec-
tion and concealed hemorrhage [6]. Today, newer and safer
options are available and were in use since the 1990s,
especially in the United States [15]. Placement of a uterine
balloon tamponade (Foley [16], Bakri balloon [17], or Seng-
staken-Blakemore tube [18,19]), which may be inserted ei-
ther after cesarean section or vaginal delivery, is an option
with interesting advantages, thus often preferred to gauze
packing. Indeed, placement of a uterine balloon can act as
a diagnostic test to screen those women who need hysterec-
tomy. In addition, it minimizes the risk of occult bleeding
and the removal of a balloon is not a painful procedure [20].
Nevertheless, uterovaginal packing is useful in controlling
hemorrhage from uterine atony and placental site bleeding
caused by placenta previa or placenta accreta [7]. Indeed,
uterine atony unresponsive to oxytocics is the most common
indication for its use [2]. Its foremost advantage is that it is
very simple and quick to perform and requires no special
equipment. Indeed, technical notes in packing positioning ad-
vise tight uniform packing to be carried out in all areas of the
uterine cavity, to be continued up to vagina to the introitus toSCO 5.0 DTD  JMIG1157_proof E
D
P
R
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F
maintain a tamponade effect on the uterine sinuses and pre-
vent concealed hemorrhage [3]. In spite of this, fear of the
concealment of continued bleeding and infection together
have led to uterovaginal packing falling into disfavor, al-
though good packing techniques with prophylactic antibiotic
therapy can minimize this complication [3–5]. Another com-
plication of uterovaginal packing is represented by difficul-
ties associated with its removal, which often requires a new
laparotomy [1,6,7]. This event mainly occurs after position-
ing of packing during a cesarean section. Indeed, a surgeon
who is dealing with a major hemorrhage might focus only
on bleeding control, committing the mistake of entrapping
the packing in the hemostatic stitches.
Until the 1990s, gynecologists were used to performing
office hysteroscopy only for diagnostic purposes while
patients, scheduled to have lesions removed or treated,
were always transferred to the operating department. Recent
technical developments pertaining to design and manufacture
of hysteroscopes and change of the distention medium from
carbon dioxide to normal saline have significantly increased
patient compliance, thus making it possible to perform even
operative procedures in outpatient setting without cervical
dilatation or anesthesia. Currently, surgeons skilled in hys-
teroscopy may not only perform targeted biopsies but also
treat a number of benign intrauterine pathological conditions
including Qpolyps, submucous myomas, synechiae, and septa
[21].
Throughout recent years, it was shown that even unusual
pathological conditions that traditionally represented a great
challenge for the gynecologist can be safely and effectively
treated by outpatient operative hysteroscopy [22].
In this article we report 2 cases of successful hysteroscopic
removal of uterovaginal packing, inserted during cesarean
section, which could not be removed vaginally with sponge
forceps as it was entrapped in 1 or more stitches. Without re-
cent technical and technological advancements in hystero-
scopy, these 2 cases would have required a more traditional
surgical approach with incredibly higher morbidity.
In the first case, the hysteroscopic approach allowed iden-
tification of the packing entrapped in the hysterotomy inci-
sion, whereas in the second case it identified the packing
stuck in a hemostatic stitch in correspondence with the right
uterine artery, which was carried out to stop a huge hemor-
rhage in this area during cesarean section.
In both cases the main intent of the operator was to prevent
the sutures, which were either hysterotomic or hemostatic,
from loosening; in particular in the second case it was even
decided not to cut the stitch fixing the gauze, but to wait
for physiologic hemostasis, before cutting the stitch during
a second office hysteroscopy.
Nonetheless, such an approach, which in theory is safe
and easy, can, at times, be difficult even for qualified and
skilled operators. Indeed, visibility within the uterine cavity
is considerably reduced in the case of the significantly higher
volume of uterus in early puerperium, the presence of a for-
eign body simulating an enormous submucous myoma, and21 October 2008  12:52 am  ce
T4 Journal of Minimally Invasive Gynecology, Vol-, No-,-/- 2008
ARTICLE IN PRESS
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460the cervical leakage of fluid distention medium as a result of
the packing extruding throughout the cervix.
Nevertheless, in both cases the hysteroscopic approach
and the described tips allowed overcoming the aforemen-
tioned difficulties and cutting of the stitches that held the
packing to the uterine walls, thus allowing its easy removal
in an outpatient setting.
Conclusions
Thanks to recent technological advancement, difficult
uterovaginal packing removal, which has traditionally repre-
sented a great challenge for the gynecologist, can now effec-
tively be considered a viable option that can be safely carried
out during outpatient hysteroscopy.
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CONCLUSIONS 
 
Healthcare providers are facing increasing demands for improvement in quality of 
life for patients. Improvements in service provision for women are being ensured by the 
introduction of minimally invasive technologies into all spheres of gynaecologic practice. 
Office hysteroscopy is an extremely exciting and rapidly advancing field of 
gynaecologic practice and there is a general consensus that it is the current gold standard 
for the evaluation of the uterine cavity and subsequent detection of intrauterine pathology. 
It is a safe, with a low incidence of serious complications, and simple procedure and, if it 
might always be carried out successfully in an outpatient setting, will definitely be a most 
attractive practice. Indeed outpatient hysteroscopy has already shown good correlation of 
findings compared with inpatient hysteroscopy, presenting distinct advantages such as 
reduced anaesthetic risks, enhanced time-cost effectiveness and patient’s preference, as 
a result of the rapid alleviation of anxiety, faster recovery and less time away from work 
and home.  
Treating the majority of uterine, cervical and vaginal pathologies in outpatient 
regimen is a revolutionary, vanguard concept. Up to 90s, gynaecologists performed 
hysteroscopy in the office setting only for diagnostic purposes while the patients were 
scheduled to have the lesions removed or treated always within the operating room theatre 
by means of resectoscope.  
At the beginning of 90s, the development of  rigid, semi-rigid and flexible smaller 
diameter scopes with working channels, through which mechanical instruments can be 
introduced and continuous flow systems has made it possible to treat the majority of 
uterine, cervical and vaginal pathologies in outpatient regimen without cervical dilatation 
and consequently without anaesthesia or analgesia. This new philosophy (“see and treat 
hysteroscopy”) reduces the distinction between a diagnostic and an operative procedure, 
shifting the focus in healthcare away from inpatient diagnosis and treatment. In other 
words,  the “see and treat” hysteroscopy introduces the concept of a single procedure in 
which the operative part is perfectly integrated in the diagnostic work-up.  
Mechanical operative instruments (scissors, biopsy cup, grasping, corkscrew) have 
long been the only way to apply the “see and treat” procedure in an outpatient setting. 
However, although grasping forceps and scissors were excellent for treating adhesions,  
anatomic impediments and endometrial polyps smaller than or the same size as the IUO, 
47 
 
bigger endometrial polyps or thick lesions (i.e myomas) were difficult to be treated 
successfully without cervical dilatation. 
Finally, a revolution occurred in 1997 with the introduction by Gynecare, Ethicon of 
a versatile electrosurgical bipolar system dedicated to hysteroscopy called Versapoint 
which represents a key point in the history of office operative hysteroscopy.  As a matter of 
fact, thanks to the use of 5 Fr bipolar electrodes the number of pathologies treated by 
office operative hysteroscopy has increased tremendously, reserving the use of 
resectoscope and operating room to a very limited number of cases.  
Bettocchi et al., (2002) first evaluated the benefits of this new 5 Fr bipolar 
electrosurgical equipment in the treatment of large benign intrauterine pathologies, 
demonstrating that the combination of a new generation small diameter hysteroscope and 
the Versapoint system enables the gynaecologist to treat in an office setting also myomas 
or polyps bigger than the IUO, with an excellent patient tolerance during the entire 
procedure.  
Today, thanks to further technological advancement and increased operator 
experience, some other uterine, cervical and vaginal pathologies or conditions which have 
traditionally represented a great challenge for gynaecologist can be treated safely and 
effectively by outpatient operative hysteroscopy. This represents the “new frontiers of 
office operative hysteroscopy” which should further increase and promote the acceptability 
and spreading of such philosophy.  
What’s about the future? Maybe in the future we could use endoscopes providing 
3D view or another possibility is to realize video- endoscopes for hysteroscopy thanks to 
“chip on tip” technology. This innovative technology allows to place  the CCD at the distal 
tip of the  instrument; besides, camera-on-tip technology provides rod-lens and fibers-free 
optical systems.  
Recently, in order to make work more efficient with an ergonomical design, prof 
Bettocchi designed an integrated S. E. T. H. S. (Storz Enhanced Technology 
Hysteroscopic System) hysteroscope. This innovative system  offers revolutionary benefits 
in terms of handling, quality and resistance compared to the traditional hysteroscopes. The 
ergonomy of the S. E. T. H. S is due to its mono-bloc system, quick to assembly and to 
disassembly, in which all connections in- and outflow  tubes are positioned in the lower 
part of the device.   
In conclusion, since novel instruments and techniques continue to emerge, the 
prospects for improvement seem unlimited. Thus it may be hypothesized that in the near 
48 
 
future, “see and treat” hysteroscopy would be proposed as the gold standard for the 
investigation and treatment of most benign gynaecological pathology. 
.  
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